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Introduction
An introduction to paediatric obesity
Defining paediatric obesity
The term's obesity and overweight are often used interchangeably, but they are
distinct conditions. Obesity indicates excess adipose tissue, whereas overweight
indicates excess weight for height, regardless of the composition of the weight.
The definition of obesity is, however, often based on measures of weight relative
to height. In adults, obesity is defined in terms of body mass index (BMI) or
Ouetelet Index, referring to the mathematician Lambert Adolphe Jacques
Ouetelet (i), and is calculated as weight in kilograms (kg) divided by the square of
the height in meters. The reason for the use of BMI instead of a more direct meas-
urement of adiposity, such as skinfold thickness, is that weight and height can be
obtained in a variety of clinical and field settings, with reasonable precision, using
instruments that are relatively inexpensive. Recently, an expert consultation on
obesity, convened by the world health organization (WHO), reported that obesity
in adults is defined as BMI a 30 kg/m* (2).This definition is based on longevity and
morbidity associations with various levels of weight (2,3). Indeed, for non-growing
individuals, BMI is almost independent of height and has a J-shaped relation with
mortality risk (4). In children and adolescents, however, BMI changes markedly
with age, dependent of the gender, race and maturation, which strongly co-varies
with height (5). For example, disproportionate accumulation of adipose tissue
occurs during female adolescence, whereas male adolescence is characterized by
accumulation of fat-free mass (6). Consequently, the differences in body composi-
tion during growth result in a relationship between weight-for-height measures
and adiposity, that is age-dependent and varies by race and gender (5,7,8).
Nonetheless, comparing children and adolescents of the same age, race and gen-
der, BMI comes close to presenting the least height bias (9), which makes it the
preferred measure of adiposity for routine clinical and public health purposes.
Another difference between children and adults is that the development of cut-
off levels, based on mortality or morbidity, is currently not possible. Childhood
mortality is unlikely to be related to increased adiposity, while sparse data on
childhood morbidity, adult morbidity, adult mortality, and adult obesity (10,11,12,
13,14,15,16,17), do not support a classification (6).
Therefore, in the absence of outcome-based criteria for children, the likelihood
that obesity will persist in adulthood with related risk of adult morbidity and
death following childhood-onset obesity, represents the best criterion by which to
judge the clinical validity of BMI in the paediatric age group. This integration of
obesity assessment in children and adults has led to a definition based on the
agreement that the paediatric percentiles identified in late adolescence by a BMI
of 30, should constitute the cutoff point for identification of childhood obesity (18,
19,20). Furthermore, because of the great concern associated with the diagnosis,
together with the high prevalence of eating disorders among adolescent girls,
specificity in the diagnosis of childhood obesity is considered of greater impor-
tance than sensitivity. Therefore, a cut-off that minimizes false positives, will be
more appropriate, even if it does not detect all children who are obese (21). The
combination of these factors has led to a definition of paediatric obesity for chil-
dren (6 - io years) and adolescents (22) as BMI > 95^ percentile in age and gender
related reference curves (6,23,24,25,26). Generally, these curves can also be used
for the calculation of a child's standard deviation score (SDS), which is a combined
adjustment for age and gender. Although this definition can only serve as a proxy
forthedegreeof obesity (5,20,27,28), changes in BMI SDS over time are helpful to
monitor changes in body size in order to evaluate therapeutic interventions.
Efforts are underway to develop an international reference population to compare
the prevalence of obesity among countries (20).
Increasing prevalence of paediatric obesity
As a result of the lack of an international reference population, the present global
reports of the prevalence of paediatric obesity should be interpreted with care.
Nevertheless, large-scale studies have shown that during the last decades, the
adiposity of the paediatric population has grown (29). The first alarming reports
came from the United States of America (USA), where paediatric obesity is consid-
ered the most pressing nutritional problem of recent time (30). From about 1980
until 1990, the number of obese children with BMI in excess of the 95^ percentile
rose from approximately 7.5 to 10.7% for children aged 6 -11 years, and from 5.7 to
10.8% for adolescents aged 12 -17 years (29). Some epidemiological surveys even
estimated a current prevalence of 13% (26). Generally, the prevalence of obesity in
children and adults in the USA has increased by more than 30% over the past
decade (31). Similar trends are provided by the National Studies of Health and
Growth of English and Scottish children from the 1970's to the 1990s (32,33). In
the Netherlands, initially, weight for height indices for children and young adults
had not increased from the 1950s to the 1980's (34), however,the last decade has
also showed an increase in obesity (35,36). These data are in agreement with sur-
veys in Dutch adults, which initially showed a fairly stable prevalence of obesity
during the 1980s, but recently demonstrated an increase in prevalence (37,38).
Other smaller studies (39,40,41,42,43,44,45) have indicated an increasing preva-
lence throughout Europe, North America and the Middle East. Even several devel-
oping countries now have witnessed their century old problem of under-nutrition
change into the problem of obesity (46,47,48,49,50). Besides a general increase
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in adiposity in the paediatric population, there is also evidence of an increasing
degree of obesity, mainly in older children and adolescents (44), which suggests
that the likelihood of persistence from childhood into adulthood will increase in
the future (30).
Risks and consequences of paediatric obesity
The way in which obesity affects health is assessed by examining its effects on
the duration of life and the presence or onset of premature disease.This epidemi-
ological approach has associated increased BMI (starting above BMI 25) in adults,
with excess morbidity and higher mortality rates (2,51). More specifically, the
detrimental effects of obesity include an increased risk for insulin resistance,
hypertension, dyslipidemia, cardiovascular disease, non-insulin-dependent dia-
betes mellitus, gallstones and cholecystitis, respiratory dysfunction, and certain
forms of cancer (52,53,54).
Although for most children, complications of childhood obesity do not become
apparent for decades, the metabolic consequences may already be evident in
young children. Even a young child, if severely obese, can suffer serious morbidity.
Prior to adulthood, the obese child may develop hypertension (55,56, 57,58, 59)
gallstones (60), liver steatosis (61,62), sleep apnea (63,64), and increased
intracranial pressure (65). In fact, there are few organ systems that obesity does
not affect in childhood. The most ominous finding is that one-third of the newly
diagnosed diabetics in the USA, between 10 -19 years of age, are type 2 diabetics,
especially poignant when considering that this condition was once called 'adult-
onset diabetes'(66).
Of equal concern are the teasing, discrimination and victimization of obese chil-
dren (30). In fact, teasing is among the most frequent complaints in the paediatric
age group. To avoid teasing many obese children choose younger children as
friends (67). Studies of children as young as 6 years of age suggest that over-
weight individuals are most likely to be described as lazy, lying, cheating, sloppy,
dirty, ugly and stupid (68,69). Consequently, obese children are uniformly ranked
by other children as the least desired friends (70) and even physicians describe
obese individuals as weak willed, ugly and awkward (71). A longitudinal study of
self-esteem among obese children (72), demonstrated that self-esteem and body
fatness were inversely related, while middle childhood is known as a critical peri-
od for the development of body image. Consequently, it has been suggested that
women who became obese during childhood are likely to have persistent severe
disturbances in body image (73). Discrimination against overweight adolescents,
as well as low self-esteem and low confidence, may contribute to the lower aca-
demic achievements observed among obese adolescents (74,75). A combination of
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these factors probably contribute to the finding that adolescent obesity is associ-
ated with less schooling, lower rates of marriage, lower income and higher rates
of poverty, even after adjusting for baseline family income, education and ethnici-
ty (76,77)-
Few data are available from children and adolescents regarding the intermediate
and long-term consequences of obesity. Associations have been shown between
BMI or changes in BMI in the paediatric age range and increased adult blood pres-
sure (78,79,80,81), adverse lipoprotein profiles (82,83,84,85,86,87), non-insulin-
dependent diabetes mellitus (88,89), and early atherosclerotic lesions (90).
Furthermore, excessive weight during adolescence predicts a number of adverse
effects on health later in life, including increased all-cause mortality and mortality
from cardiovascular disease and colon cancer among men (13,14,16,91,92,93).
Additionally, adult mortality is significantly increased among men who were
obese as adolescents (13,21). In a follow-up study of young Dutch men, recorded at
military registration, elevated adolescent BMI was associated with a relative risk
of 1.5 for all-cause and 2.5 for coronary heart disease mortality after 20 years (12).
Despite these associations, the strongest risk factors come from longitudinal data,
indicating that BMI tracks from childhood to young adulthood for boys as well as
girls (19, 94). Up to 80% of overweight (85^ percentileof BMI curve) children
become obese adults (17,19,95,96). The risk of adult obesity is greater for children
who are at higher levels of obesity and for children who are obese at older ages
(15). After adjustment for parental obesity, the odds ratios for obesity in adulthood
associated with childhood obesity ranged from 1.3 for obesity at 1 or 2 years of
age, to 17.5 for obesity at 15 to 17 years of age. That is, obese children under three
years of age without obese parents are at low risk for obesity in adulthood,
whereas, among older children, obesity is an increasingly important predictor for
adult obesity, regardless of whether the parents are obese. After six years of age,
the probability of obesity in adulthood exceeds 50% for obese children, compared
with about 10% in non-obese children (97).This finding appears to be in agree-
ment with the BMI curve, that shows, on average, a nadir at about 5 to 6 years of
age. An early nadir or rebound (less than 6 years) is associated with high BMI and
high skinfold thickness at the age of 21 years (98).
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The aetiology of paediatric obesity
4 popu/at/on perspect/Ve
What is the reason for this sudden increase in paediatric obesity? The first law of
thermodynamics dictates that high energy intake or low energy expenditure, or
these factors combined, ultimately explains weight gain. Surprisingly little, how-
ever, is known about the factors that cause the high energy intake and low energy
expenditure.
Evidence for an increase in energy intake
In western, affluent societies increased energy intake is often seen as the most
obvious reason for weight gain. In contradiction, there is evidence that in recent
decades the average energy intake of children in many countries has declined (29,
31,32,52,99). Surveys in young children in the UK have indicated a reduction of
energy intake of around 15% (100,101).
Analysis of economic and food availability data for 1962 -1994, however, revealed
a major shift in the structure of the global diet in all ages, marked by an uncou-
pling of the classic relationship between incomes and fat intake, and accelerated
further by high urbanization rates. Thus, large parts of the world have changed
their traditional food habits (i.e. consisting of a high percentage of carbohydrates
and low in fat), towards a more palatable diet (i.e. lower amounts of carbohy-
drates and higher amounts of fat). Whereas this, so called, nutritional transition,
has led to improved food security and health, the availability of cheap vegetable
oils and fats has resulted in greatly increased fat consumption particularly among
low-income populations (102). Furthermore, the increased palatability of this more
energy dense food is likely to result in an increased energy intake, easily leading
to a positive energy balance (103). Childhood obesity seems one of the particular
implications of these trends (47,104), as take-away and ready-prepared energy
dense foods make increasingly large contributions to the energy intake of chil-
dren around the world (2,105,106). These findings seem to be in contrast with the
data that the average energy intake in children is declining, which may indicate
selective underreporting of these high fat foods. A possible explanation for this
potential confounding factor in the measurement of habitual food intake, is that
generally, the child's intake is recollected by the parent, while the parent's capaci-
ty to accurately complete the questionnaire is affected by memory failure, level of
nutritional knowledge, and motivation. The amount of error is augmented fur-
ther by the inability of the parent to correctly appraise serving size, the degree of
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the perceived value of the food items to be recalled, and the fact that parents and
children tend to better remember preferred foods, than non-preferred foods (107,
108).
Evidence for a decrease in energy expenditure
Concurrent with the changes in diet structure are equally dramatic shifts in activi-
ty patterns among all age groups (109). While studies differ, several reports men-
tioned that the average child in the USA watches approximately 24 hours of tele-
vision per week (109, no, in, 112). Furthermore, the number of high school students
enrolled in physical education classes in the USA decreased between 1984 and
1990 and, consequently, fitness levels as measured by endurance tests have
declined, although the latter seems in contrast with the stable measures of aero-
bic power (VOj max. as a proxy variable of the physical activity level) that have
been found in Dutch children (113), and the comparable fitness levels in USA (114)
and Italian (115,116) overweight and non-overweight prepubertal children.
Nonetheless, the use of the computer with video games, internet and other simi-
lar sedentary activities is increasing (109,112) and many reports have correlated
decreased physical activity with obesity in children (110,112,117, n8,119,120,121) as
well as adults (122,123), suggesting that physical inactivity may explain the devel-
opment of the current epidemic of obesity. Some studies indicate that the
decrease in physical activity has led to such a strong decrease in total energy
expenditure, that the energy prescriptions, based on data of children and adoles-
cents measured several decades ago (124,125), are overestimating the current
energy needs in growing children, which may enhance a positive energy balance
in childhood (101,126,127,128,129).These suggestions, however, are not supported
by the results of the Dutch Voedingsraad ('Nutrition Council') that re-calculated
the energy requirements from infancy to adulthood from data reported until 1987
and found results that were comparable with previous prescriptions (130).
As with nutrition, activity reflects a strong familial component. A lot of the adult
activities, such as jogging, are individual activities, but not social or group activi-
ties designed to engage youth. This might be a reason why tracking of physical
activity is generally low to moderate during early childhood (131), and during ado-
lescence into adulthood (132). Saris et al. (113) studied the tracking of physical
activity variables in a large group of boys and girls between the ages 6 and 12
years, and found only in girls was there a tendency for a reduction in physical fit-
ness (expressed per kg body weight) (32). The strongest decrease in physical activi-
ty, or best adherence to sedentary activities (133), therefore, seems to occur just
before puberty, with a high risk of maintaining this behaviour into adulthood.
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Summarizing, evidence exists that on a population level, the composition of the
diet has changed, which, although riot supported by data, has possibly led to an
increased energy intake, while the industrialization has resulted in sedentary soci-
eties.
/nd/wdua/ perspert/Ve
Individual susceptibility to obesity
Despite the fact that westernized societies offer an obesity encouraging environ-
ment, not all children develop obesity. Probably, some individuals are more obesity
prone than others. A popular explanation is the theory of the 'thrifty genes' (134,
135). Since the energy stores in the human body are important for survival and
reproduction, the possibility to store energy in tissues, e.g. fat, must have had an
important role in the chances of survival of our ancestors in the environments of
food shortage, in which they evolved. For this reason, genes were selected that
promote energy intake and storage and minimize energy expenditure (136).
This is a popular theory to explain the idea that relevant genes mediate suscepti-
bility to obesity in a specific environmental context. The genes may affect energy
intake, energy expenditure, and partitioning of stored energy between lean tis-
sues and fat.
Related evidence comes from studies in twins, adoptees, and families (137,138)
that indicate that possibly as much as 80% of the variance in BMI is attributable
to genetic factors. Epidemiological data demonstrates, that before three years of
age, the primary predictor of obesity in adulthood is the parents'obesity status,
however, as the child grows, the child's obesity status itself becomes a more
important predictor, regardless of whether the parents are obese. Especially
before six years of age, obesity in both parents substantially increases the odds of
the child becoming an obese adult (97) (13). Parental obesity more than doubles
the risk of adult obesity among both obese and non-obese children under 10 years
of age (97). Familial resemblance, however, is not simple to interpret since it may
also be due to shared environmental factors.
The observation that the prevalence of obesity increased substantially over a sin-
gle decade, a period much too brief for any significant change to have occurred in
the genetic make-up of the population in the western societies, indicates that the
current relative adiposity is a product of the interaction between genetic predis-
position with regard to the storage of body fat, and an environment that is
extremely permissive to the expression of that genetic tendency. The physiologi-
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cal determinants (energy intake, energy output, or partitioning of energy stores)
that interact with these genetic factors, are not yet known. Small changes in any
of the many physiological systems (endocrine, gastrointestinal, central nervous,
peripheral nervous and cardiovascular) that affect these functions can, over time,
result in substantial changes in body weight (136). In any individual - and in the
same individual at different times in life - the relative influence of these environ-
mental and genetic factors may vary (136). Since the susceptibility to obesity is
likely to surface during childhood, the study of paediatric obesity is of great
importance in relation to the health problem.
Critical periods for the development of paediatric obesity
Generally, adiposity in boys increases in the prepubertal stage and declines fol-
lowing the growth spurt, whereas in girls, the percentage of fat mass remains rel-
atively constant prior to adolescence and increases during the adolescent growth
spurt (21,139). Increase in adiposity can be caused by an increase in adipocyte size
or number (21). Cross-sectional and longitudinal studies of adipocyte numbers
indicate a modest increase throughout childhood with a pronounced increase
after age 10 years (140,141)- Adipocyte size, however, increases to adult levels in
late infancy, resulting in an average fat mass of 15 - 25% (130,142), and then
decreases back to the level observed at early infancy (143). This fattening in infan-
cy coincides with the need of the newborn to survive periods of fasting by mobi-
lizing adipose triacylglycerol reserves (144). Thereafter, fat cell size diminishes and
remains constant until early adolescence (21). During childhood the adiposity
varies between 12 -15% in boys and 15 - 20% in girls (145), whereas during puberty,
boys often decrease in adiposity, while girls increase to 20 - 25% (146,147,148). Fat
deposition prior to puberty in boys has physiological importance as a reserve of
energy to support lean tissue growth at puberty. In girls, fat deposition is thought
to act as energy storage for the nutritional demands of pregnancy and lactation
(9). Obese children have increased numbers of fat cells regardless of age, as well
as increased adipocyte size, while weight reduction only reduces adipocyte size
(H9)-
Apart from changes in the fat content in the body, the period around puberty also
is characterized by changes in body fat distribution. Immediately prior to adoles-
cence, body fat shifts from mainly peripheral distribution to central distribution,
in both genders, with the most rapid increase in visceral fat occurring during late
adolescence (21).
Recent data suggest that the likelihood of persistence of obesity, and therefore
the likelihood of adverse consequences of obesity in adulthood, may be related to
the age of onset (150). During early life, such distinct critical periods for subse-
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quent weight regulation seem to occur during prenatal life, childhood, and ado-
lescence. Such a 'critical period' indicates that during this period, underlying bio-
logical systems are influenced irreversibly. These periods differ from 'high-risk'
periods that mostly occur later in life, such as pregnancy or menopause in
women. Evidence that obesity, developing at each of these periods, is associated
with an increased risk of persistence and subsequent disease, comes from epi-
demiological data (150,151,152,153,154,155). The mechanisms that promote this
increased risk of persistence of obesity, however, are poorly understood (21).
Evidence that the prenatal environment 'programmes' a range of physiological
and metabolic parameters, first came from studies in which low birth weight and
disproportionate body size at birth (thinness or shortness) have been related to
later disease (154). In a later study, males bom during or just after the Dutch
'Hunger Winter' (1944 -1945) were shown to have a slightly higher prevalence of
overweight at 19 years of age if maternal under-nutrition occurred during the first
two trimesters, and a slightly reduced incidence if maternal under-nutrition
occurred during the last trimester of pregnancy or if the infant was exposed to
famine conditions in the first 3 to 5 month of extra-uterine life (156). A more
recent study describing children of diabetic mothers, demonstrated that the
prevalence of obesity was increased at later ages, and extended through adoles-
cence (152). According to Barker (157), underlying mechanisms include setting of
the hypothalamus and sensitivity to hormones (i.e., endocrine pancreas).
The second critical period is the period of adiposity rebound during prepubertal
growth (153). As was mentioned earlier, early acceleration of the BMI after its nadir
at 5-6 years of age is associated with an increased risk of later obesity (98,158).
The final developmental stage with increased risk for adult obesity appears to be
the period of adolescence (21). Together with early infancy, the period of adoles-
cence, especially during the growth spurt, is characterized by rapid changes in
body composition. This dynamic period therefore seems an optimal moment for
studying the aetiology of paediatric obesity (159). Approximately 30% of obesity in
36-year-old women is related to obesity at this time, whereas in males, only
approximately 10% of obesity present at 36 years of age begins at adolescence
(160).
The concept of energy balance
The concept of energy balance arises from the law of conservation of energy. One
of the earliest reports studying the principle of energy conservation was written
in 1894 by Rubner (161), who demonstrated that an animal's heat balance is con-
sistent with the first principle of thermodynamics; namely, energy can neither be
created nor destroyed, but can only be exchanged between the body and its envi-
20
ronment. Like all living organisms, humans engage in a constant energy exchange
with the environment. The energy balance of the body is maintained only if the
energy equivalent of the food absorbed from the diet is equal to the energy value
of the work and heat generated. Although daily variations in food consumption
and bodily energy demands may produce short-term imbalances, it is clear that
the long-term maintenance of a stable body weight depends on a tight coupling
of energy intake and expenditure (162,163).
Consequently, independent of genetic, developmental or environmental factors
involved, obesity can only develop as a result of a prolonged positive energy bal-
ance.
The last decade many studies on aetiology of obesity were focussed on the search
for the phenotypic expression of the genetically susceptible individual. As dis-
cussed earlier, the phenotypic expression can be studied in several fields of
research. Eventually, each new finding, must relate to an effect on the energy bal-
ance. Whether this effect can be detected depends on the sensitivity of the meth-
ods to measure energy balance and the timing on which they are used.
An introduction to energy metabolism
The various chemical processes, which underlie the functions of the body, require
the continuous provision of energy (32). All the energy intake of humans is derived
from the chemical energy contained in the nutrients that are absorbed from the
diet. Quantitatively, the major source of this energy is that which is stored in the
C-H bonds of carbohydrates and lipids, and to a lesser extent, proteins. This chemi-
cal energy is liberated in the body through oxidative pathways that convert these
C - H bonds to COj and HOj (162). The heat generated by biological combustion is
utilized to maintain body temperature. Furthermore, the chemical energy of sub-
strates is transferred to high energy bonds, mainly within adenosine triphosphate
(ATP). Chemical (biosynthesis), osmotic (active transport), and mechanical (muscu-
lar contraction) work is thus made possible (164).Therefore, energy metabolism
can be defined as the oxidation of fuels producing carbon dioxide, water, heat and
external work. This overall process is referred to as energy expenditure or meta-
bolic rate, and represents the utilization of food energy to maintain the functions
of the body (32). The ratio of the volume of oxygen used (VOj) and carbon dioxide
released (VCOJ depends on the substrate being metabolized, and is described by
the respiratory quotient or respiratory exchange ratio (RER), calculated as
VCCyVOj.
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Measurement of energy intake
Most studies show that obese children and adolescents do not have higher ener-
gy intakes or even lower intakes than their non-obese peers do (165,166,167). The
validity of this data, however, is questionable.
The problem is, that energy intake, in the free living situation, cannot be validly
measured. The main reason for this is, that the measurement of energy intake
relies on self report, either by dietary interview or food questionnaire, placing all
the responsibility for an accurate measurement of food intake with the subjects
themselves. It may not be surprising, that this technique is prone to bias, with
under-recording particularly found in the obese (168,169). On the other hand, chil-
dren appear quite capable of self-regulating dietary intake under unsupervised
settings (21). While meal-to-meal variation in energy intake is large, the day-to-day
variation is much lower (170), although outcomes have been reported up to 22%
(171,172).The capacity to regulate their own intake appears to be negatively affect-
ed by the degree of parental control and attitude towards the child's intake (173,
174)-
Measurement of whole body energy expenditure
The expenditure of energy by the body requires the consumption of oxygen and
leads to the production of carbon dioxide and release of heat. Thus, whole-body
energy expenditure can be assessed by making calorimetric measurements, i.e.,
measuring heat released (direct calorimetry). Because of practical implications,
however, an alternative, more widely used approach is to assess energy expendi-
ture using indirect calorimetry, calculating energy expenditure from the rates of
oxygen use and carbon dioxide production (32). Most studies have used Weir's
equation (175): EE = 3.941 VOj +1/106 VCO^  - 2.17 U^
where U,, is measured from urinary nitrogen production. Weir showed that the
error from neglecting the protein correction is negligible and shows little varia-
tion between individuals. Energy expenditure can therefore be estimated with
sufficient accuracy from VO^ and VCOj alone.
The major components contributing to total energy expenditure or average daily
metabolic rate (ADMR) are sleeping metabolic rate (SMR).the energy cost of
arousal, the thermic effect of food or diet induced energy expenditure (DEE) and
the energy cost of physical activity or activity induced energy expenditure (AEE),
as was described by Ravussin (176). Often SMR and the energy cost of arousal are
taken together as energy expenditure for maintenance or basal metabolic rate
(BMR). BMR is normally the main component of ADMR. Therefore, ADMR is often
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simply divided into resting and non-resting energy expenditure. In adults, BMR,
DEE and AEE account for approximately 65-70%, 10-15% and 20-30% of ADMR,
respectively (32). Low energy expenditure in any of these components, however,
can contribute to the development of obesity or maintenance of the obese state.
Sleeping and basal metabolic rate
BMR is the energy required to maintain essential body functions under standard
conditions: lying awake,fasted 10 -18 hours, and at complete rest in a thermoneu-
tral environment. BMR includes the expenditure of energy for maintaining mem-
brane potentials, resting cardiorespiratory function and basal rates of turnover of
protein. To measure BMR, an air-tight canopy is placed over the head of the sub-
ject and connected to sensitive and stable Oj and COj sensors to sample the
inspired and expired air at fixed time intervals (177).
SMR is approximately o - 5% lower than BMR among adults (178) and is measured
during an overnight stay in a respiration chamber (179).The respiration chamber is
an open-circuit indirect calorimeter (14 m3) and maintains a constant air tempera-
ture during the night (179).
SMR and BMR are usually compared between subjects by standardizing to an esti-
mate of metabolic body size. Fat-free body mass (FFM) is generally accepted as
the best predictor for metabolic body size (163,180). Since the intercept in the
relationship between BMR and FFM is different from zero, the preferred way of
comparing SMR or BMR is by regression analysis or analysis of covariance.
Covariates to be included are FFM, fat mass (FM), age and gender. Throughout
childhood and adolescence BMR decreases relative to body weight (125). Although
BMR per kg body weight is fairly constant from 1 -4 years of age (about 55
kcal/kg/day), it decreases linearly thereafter until about 16 -18 years of age (about
30 kcal/kg/day).This is presumably caused by changes in the relative proportions
of metabolically active tissues comprising FFM (181). During adulthood BMR fur-
ther decreases about 2 -4% per decade, relative to body weight. The BMR
decrease with aging has been attributed primarily to a general decrease in FFM.
In addition, several factors (state of disease, caloric restriction, weight loss, caloric
excess, and weight gain) contribute to the within- and between-individual differ-
ences in BMR.
Nonetheless, in a study including obese as well as non-obese 8- to 12-year-old chil-
dren, variability between repeated-day tests of BMR was very low (within-individ-
ual variation of about 2%) (172).
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Diet induced energy expenditure
Diet induced energy expenditure, originally called 'specific dynamic action of food'
by Rubner (161), can be defined as the increase in energy expenditure above basal
fasting level, divided by the energy content of the food ingested, and is commonly
expressed as a percentage (163). DEE reflects the energy required for digestion and
absorption of foods, conversion of foods into nutrients, and storage of energy
(172). In adults, 90% of the DEE was observed within 4 hours after the meal (182,
183), although the postprandial rise in energy expenditure is thought to be com-
pletely terminated at approximately 10 hours after the last meal (163). In the con-
dition of energy balance, with normal diets, DEE is normally standardized to 8-
io% of ADMR (184). Although some studies have shown blunted DEE (185,186,187,
188) in the obese, others (189) have found a higher DEE for obese children. In fact,
DEE can be reduced during periods of under-feeding, or when consuming a high-
fat diet, or increased during over-feeding, or with a high carbohydrate intake.
Activity induced energy expenditure
Physical activity is a broad term that describes any bodily movement produced by
skeletal muscle that results in energy expenditure. Since mean 24h activity
induced energy expenditure is the most variable component of ADMR, it plays a
key role in the regulation of energy balance.
After the measurement of ADMR became possible with the introduction of the
doubly labelled water technique, truly quantitative estimates of AEE in daily life
have been made. The WHO has standardized the quantification of AEE by express-
ing ADMR as a multiple of BMR (124), indicating that the variation in ADMR is
mainly caused by metabolic body size and physical activity.Thus, the physical
activity level (PAL) is obtained by dividing ADMR by BMR. Several studies (180,190),
however, have suggested that using ratios to normalize biological data may lead
to spurious comparisons if the relationships between the variables have non-zero
intercepts, in analogy with the relationship between BMR and FFM. Analysis of
covariance, an approach based on multiple regression, has been suggested as an
alternative statistical technique to adjust data with non-zero intercepts (191).The
combination with other statistical approaches, to determine if they support a uni-
fied conclusion, has been suggested as a valuable strategy (192) to assess physical
activity.
The quantity of energy spent on physical activity, expressed as a proportion of
total energy expenditure, appears to increase from infancy and early childhood to
early adolescence (21). At infancy the measured PAL was 1.35 (193). Between 1 to 4
years of age, the PAL has been estimated as 1.6 (130), although this level seems an
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overestimation, since at five years the measured PAL was still around 1.4 (126).
From 9 to 12 years the influence of gender becomes stronger, resulting in a level of
1.61 for boys and 1.53 for girls (194), whereas the PAL reaches its peak around 12 -
18 years of age, namely around 1.8 in boys, and 1.7 in girls (195).
Evidence exists that the physical activity associated energy expenditure is inverse-
ly related to adiposity (118,196), although this topic is clouded with controversy
(197), especially because the energy cost for weight bearing activities is increased
for obese individuals (115). A frequently used method to correct AEE for weight
bearing activities is to divide AEE by weight. Since not all daily activities are
weight dependent, the denominator weight has to be adjusted with an exponent
of 0.66 to 0.75 in adults (192). It is impossible, however, to generalize this expo-
nent because of the large variation in physical activity and body sizes, especially in
youth.
One of the earliest reports about fat mass and physical activity came from Bruch
(198), who studied 140 overweight boys and girls 2 to 14years of age and reported
Vrre/i TJt/t-it t-'ri7i6ieti wcicitidL'uve. M'a'iiougn tnis cotfid De confirmed in girls in
summer camp or boys and girls in home or at school, other studies with children
from the same age could not find any difference (199). It must be noted, however,
that these studies all used alternative methods to assess physical activity, such as
oxygen uptake, heart rate monitoring, and movement counters (199).
On the other hand, several authors have suggested that sedentary activities or
the time devoted to physical activity, rather than a decreased physical activity
related energy expenditure, seems to be associated with body fatness in young
children (121,200,201). In a study by Epstein et al. (202) short term weight loss was
greater in a group of children who were instructed to reduce sedentary behaviour
than in children who were encouraged to increase exercise. Whether decreased
nonbasal energy expenditure increases the risk for the development of childhood
or adolescent obesity has not been established (21).
Average daily metabolic rate
The'gold standard'for measurement of energy expenditure under daily living
conditions, is the doubly labelled water (DLW) technique (203).The method has
been applied in humans from the early 1980's onwards (204), and is now validat-
ed and standardized (163). Validation studies in four laboratories resulted in an
accuracy of 1 - 3% and a precision of 2 - 8% (163). This technique is based on the
principle that the oxygen of expired COj is in isotopic equilibrium with the oxy-
gen of body water. When a subject is loaded with ^H^O, body water is enriched
with the stable isotopes =H and ^O. The decrease in '*O in the body water is a
measure for H^ O plus CO^  outputs and the decrease in *H is a measure for H^ O
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output alone. When the disappearance rate of both isotopes from the body fluid
(e.g. blood, urine, saliva) is measured, the difference between the two disappear-
ance rates is a measure of COj production (163).
After the dose, both isotopes equilibrate with the total body water pool (TBW).
Both tracers, '®O and *H, are stable isotopes, which occur naturally in the body
water at a level around 2000 and 150 ppm, respectively (205). The required excess
enrichment of 200 - 400 ppm does not have any measurable health conse-
quences. To convert the measurement of COj production to energy expenditure,
the energy equivalent of COj is needed. Often, an assumed RER of 0.85 is used. In
children, however, optimum accuracy requires estimations the food quotient (FQ)
from the macronutrient composition of the diet from records of dietary intake.
Although, these records are notorious for their underestimation of energy intake,
the macronutrient composition can be measured with reasonable validity using a
weighed dietary record or diet history (177,206). Since in the situation of energy
balance, FQ equals RER, the FOcan be used for ADMR calculation (163,205,207).
Energy cost of growth
The energy costs of growth consists of the energy content of the newly synthe-
sized tissues and the energy expended in the synthesis of these tissues. Whereas
the latter can only be estimated, the first can be measured seemingly simple by
determining total body weight (32). Indeed, for adults most excess energy storage
is in the form of fat with some increase in fat-free mass. For children, however, the
interpretation of energy storage is more difficult because of simultaneous, but not
equal, increases in the weights of different tissues (bone, muscle, organs, fat),
changes in the water and mineral content of body tissue, and changes in the meta-
bolic rates of various tissues during growth. Therefore, the form in which energy is
stored (protein, carbohydrate or fat) may vary, which makes an increase in body
weight and energy storage not necessarily constant.
The equivalent energy costs of growth of total energy requirements decreases
from 35% at i month to 3% at 12 months. During infancy the weight gain during
the first 6 months averages 4 g per kg body weight per day, while in the second
half of the first year the mean weight gain decreases to 1.5 g per kg body weight
per day (124,130). In addition, a relatively large amount of energy is lost in the urine
and faeces, dependent on the maturation of the gastro-intestinal tract (208). After
the first year, the energy costs for growth further decreases to about 2% of energy
intake (209). Nonetheless, also during infancy, BMR is by far the largest component
of daily metabolic rate (210). Even the adolescent growth spurt does not increase
the energy costs of growth to much above 3% of energy intake (210).
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Body composition
As stated above, BMR reflects a composite of metabolic rates from various tissues
that comprise body weight. From infancy to adulthood a transition occurs in the
extent to which some tissues take part in daily energy expenditure. During infan-
cy the brain will require most of the daily energy, while the liver is the highest
metabolically active organ in adulthood. More specifically, in adults, during basal
conditions, the major organs (e.g., brain, liver, heart) have the highest metabolic
rate (about 60-65% of BMR), but constitute the lowest percentage of body mass
(about 5%); muscle tissue has an intermediate metabolic rate (20% of BMR), but
constitutes about 35-40% of body weight; white adipose tissue has the lowest
metabolic rate (5-10% of BMR), and constitute roughly 20% of body mass (181,211).
Therefore, differences in body composition will affect BMR. Determination of body
composition is also necessary for assessment of the'nutritional'status (e.g.,
excess of fat mass) and for monitoring the effect of treatment or interventions
(163). The obese child, however, not only has a higher degree of adiposity, but also
tends to be taller, heavier, and, tends to have a larger fat-free mass than the non-
obese child.
Assessment of body composition
In obesity research, the most frequently used model for the study of body compo-
sition is the molecular model, in which the body's composition is divided into its
main molecular components: lipids (included essential and nonessential lipids),
water, protein, minerals and glycogen (212). Fat mass (FM) and fat-free mass (FFM)
are terms used frequently that refer to the classic two-component (2C) body com-
position model in which total body mass is broken down into fat and nonfat tis-
sue masses. A lack of direct quantification methods has led to the development of
various models and indirect methods for estimation of FM and FFM, all of which
are imperfect and require a number of assumptions, many of which are age-spe-
cific (108).
Densitometry is the estimation of body composition based on total body density
and requires measurement of body weight and body volume. Total body mass
(TBM) is obtained with an electric balance, body volume calculated by under-
water weighing. Underwater weighing is usually carried out in a special tank or a
large bath. This is the most widely used technique for measuring body volume
and uses the Archimedes' principle: the volume of an object submerged in water
equals the volume of water displaced by the object.Therefore, the difference
between weight in air and weight under water, corrected for the density of the
water at the temperature at the time of measurement, is the body volume.
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Simultaneously, the residual lung volume is measured by a helium-dilution
spirometer. Generally, the densities of FM and FFM are assumed to be 0.9 g/ml
and l.i g/ml, however, the density of FFM is known to be influenced by age, gen-
der and ethnicity (212), and little information exists in children (108). Other
assumed constants include water content and bone mineral content (BMC) of the
FFM.
Further improvement of this 2C-model, therefore, is achieved by dividing the FFM
in three more compartments and thus creating a four-component (4C) reference
model:
TBM = FM +TBW +total bone mineral content and remaining fat-free dry mass
In this model, TBM, body volume, total body water (TBW) and BMC are measured
separately, thus dividing body weight into fat, water, mineral, and protein, and
allowing evaluation of several assumed constant relations that are central to 2C-
models. By measuring BMC and TBW with techniques specifically designed for
these components, the 4C-model leaves the underwater weighing uninfluenced
by the TBW and BMC of FFM, such that it distinguishes not fat and FFM, but fat
and protein. The variability in the density of protein is less than that of FFM, mak-
ing this part of the model more reliable (213).
Bone mineral content is measured by Dual-X-ray Absorptiometry (DXA). DXA is
based on measurement of the ratio of tissue attenuation of X-rays at two ener-
gies (163, 214). In practice, the subject is scanned by the DXA. Approximately
10,000 pixel elements are collected during a typical whole-body scan. Of these
pixels, 40 - 45% are bone and soft tissue, the remaining pixels contain soft tissue
alone. The attenuation of X-ray by fat and fat-free soft tissues are different, allow-
ing quantitative calculation of the respective masses in each pixel without bone.
These data are then extrapolated to cover the whole body (163). The radiation
dose is dependent on the scan mode used, 0.01 - 0.06 mrem or
< 1/100^ of the equivalent radiation exposure of a chest x-ray (108). The duration
of the DXA measurements is approx. 15 - 30 minutes, depending on the size of the
individual.
Total body water can be determined with deuterium dilution. This measurement
is part of the doubly labelled water method that is described above. The subject
receives an orally administered dose of *HjO. *HjO enrichment in the body fluid is
measured in a body fluid, e.g., urine. Before administration of the dose, a back-
ground urine sample is taken. The dose is given in the evening, as part of the
ADMR measurement. Urine samples are taken loh after dose administration from
the second voiding the next morning (215). TBW is calculated as the *H dilution
space divided by 1.04 correcting for exchange of the *H label with non-aqueous H
of body solids (216).
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Additionally, bromide dilution can be measured to estimate the extracellular
water compartment (ECW). Bromide does not pass the cell membranes, and thus
equilibrates with the ECW. In practice, a known amount of NaBr is mixed with the
^HjO solution and, thus, administered simultaneously with the H^^ O dose. A
venous blood sample is obtained before and loh after ingestion of bromide.
Bromide concentration in serum ultrafiltrate is determined and corrected bromide
space is calculated according to Miller et al. (217).
The 4C-model is considered one of the most accurate methods of estimating
%FM (218) with relatively high precision (213). Like most of the multicomponent
models, however, the 4C-model is based on the measurement of densitometry by
underwater weighing. Unfortunately, underwater weighing is not possible in
young children or children with mental retardation. A recent study demonstrated
that the 2C-model based on the deuterium dilution technique showed negligible
mean error (1.3%) in measuring FFM relative to the 4C-model and was preferable
above other 2C-models for the assessment of body composition in children (213).
Furthermore, the published maturation specific values for FFM hydration by
Boileau et al. (219) were almost identical to those found in the 4C-model.
For these subgroups, therefore, a 2C-model based on the measurement of total
body water can be used as an alternative. FFM is assessed with the assumption of
FFM containing all body water. Hydration factors of FFM are based on maturation
specific values (219). Tanner's puberty ratings can be used to determine the level
of maturation of the child (220).
Energy metabolism in Prader-Willi syndrome
An individual with a predisposition to obesity will stay lean in an environment of
food deprivation or high demand of physical activity, whereas an individual not
genetically predisposed may still become obese in an environment that includes
tasty, energy dense foods and few inducements to physical activity (136).
Paediatric obesity is therefore caused by a combination of susceptibility and envi-
ronment. Energy metabolism studies in obesity are searching for the phenotypic
expression of the genetic susceptibility to obesity.
Some evidence suggests that a reduced energy expenditure may be involved in
the aetiology of childhood obesity, genetically (221,222,223) or behaviourally influ-
enced (224). Data indicates that lowered ADMR contributed to latter weight gain
in infants who became overweight (163). Other cross-sectional studies do not sup-
port the concept that reduced energy expenditure may be related to obesity, nor
found differences in FM related to variation in energy expenditure components
(114,225). In addition, no significant correlation was found between components
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of energy expenditure in children, and body fat in mothers or fathers (190). It is
conceivable, however, that differences in energy expenditure may have different
effects on energy balance at different stages of the maturation process (163).
When studying the physiological mechanisms of the development of paediatric
obesity, a population is needed that is prone to become obese. The Prader-
(Labhart)-Willi syndrome (PWS) is the most recognized form of genetic obesity in
humans. If unmanaged, the child with PWS will almost surely become obese.
Currently, the precise aetiology of any specific instance of human obesity, includ-
ing PWS, remains unknown. Understanding the energy metabolism of this rare
dysmorphic syndrome, however, might also give insight into the development of
obesity in the population at large, and the paediatric age group in particular.
An introduction to Prader-Willi syndrome
Prader-Willi syndrome was first described in the medical literature in 1956 by
Prader, Labhart and Willi (226), and is characterized by hypotonia in the neonatal
period, mental retardation of a variable degree, hypogonadism, failure to thrive,
small hands and feet and obesity (227).The incidence of PWS is estimated to be
about l in 25,000 live births (228). Although the short stature combined with
hypogonadism and obesity suggested a central endocrine (i.e. hypothalamic) dys-
function, confirmation of this hypothesis has been sparse (229,230). In 1993, a
consensus for the diagnostic criteria was reported, but mis-diagnosis still occurs.
Under-diagnosis in younger children and over-diagnosis in obese retarded adoles-
cents and adults are both common (227). Clinical diagnosis of PWS is still consid-
ered difficult because of the subtle nature of the dysmorphic features, and the
wide discrepancy between the clinical presentation in infancy and that which is
seen in childhood, adolescence, and adulthood (231). Indeed, the symptoms of
PWS change dramatically with age. The classic concept of PWS is that of a two
stage disorder - a perinatal hypotonic phase,followed by a childhood obese
phase. Some include a third, adolescent phase with particular behavioral prob-
lems (232). Hypotonia is often already present during pregnancy, resulting in
decreased fetal movements and polyhydramnios, and presumably accounting for
an increased incidence of breech delivery and a higher incidence of delivery by
caesarian section (233).
Ideally, the classic perinatal hypotonic phase will allow an early clinical diagnosis
of PWS, which in turn can be confirmed by genetic testing. The basic defect in
PWS seems to be an absence of function of genes on the proximal long arm of
chromosome 15 that are normally expressed in a monoallelic fashion only from
the paternal chromosome (231). This defect is most commonly a result of a c/e
novo interstitial paternal deletion (60 - 70%) or maternal UPD (uniparental dis-
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omy; 30 - 40%) (231). UPD occurs for the whole of chromosome 15. This can be in
the form of heterodisomy, in which both mother's chromosomes 15 are inherited
by the child, or as isodisomy, in which the two identical chromatids from one
chromosome 15 are inherited. In approximately 1% of patients imprinting centre
mutations have been reported (234). There is no evidence for the common dele-
tion or UPD in these individuals. The majority, but not all, of these patients have
inherited small microdeletions in a region of i5qn-qi3 which has been determined
the imprinting centre (235). Contrary to the other two genetic mechanisms these
'imprinting mutation'families may have a high recurrence risk for transmitting
this defect to their offspring (234).
Energy metabolism studies in Prader-Willi syndrome
Prader-Willi syndrome is the most common syndromal cause of obesity in chil-
dren and obesity is the most prominent health threat in patients with this syn-
drome (236). Following the hypotonia related feeding problems in the neonatal
period, obesity develops in early childhood, when no intervention is undertaken.
Hyperphagia in combination with an seemingly unsatiable hunger are obvious
reasons for this sudden increase in weight (236,237). However, because of the lim-
itations of current methods in quantifying energy intake, very little is known
about the actual intake.
The first observations that suggested a decreased energy expenditure in PWS
were done by Pipes and Holm (237). They followed 14 children with PWS (12 males)
during growth in periods ranging from 10 months to almost 7 years, and com-
pared them with standard growth data from the literature. Eight children were
successful in maintaining their weight loss on 60% of normal energy intake. It
was concluded that children with PWS must be restricted to fewer calories than
nonsyndromal obese children of comparable ages in order to maintain their
weight in appropriate growth channels. The authors suggested that hypoactivity
as a result of hypotonia in this syndrome might be a contributing factor, especial-
ly since parents often characterize their children as tiring easily, sleepy, and not
having enough strength to keep up with peers. Low muscle tone and poor coordi-
nation might result in inactivity and a low energy output. On the other hand, the
hypotonia generally improves as the obesity develops.
Nardella et al. (238) measured physical activity levels of 12 individuals with PWS
and 13 nonretardated children during a two week summercamp with scheduled
daily activities.They ranged in age from 11 to 22 years and were all put on the
same 1000 calories per day diet, with 23-23-54 as E% respectively for protein, fat
and carbohydrate. Two instruments for measuring physical activity were used: a
pedometer providing a means of converting impulses of movement into distance,
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and an actometerto measure the intensity of physical activity.The study demon-
strated a wide range of physical activity levels among PWS persons in a recre-
ational setting.The investigators concluded that it is not valid to stereotype such
individuals when describing their physical activity levels.
Because of the difficulties in using actometers in the handicapped population,
Davies et al.(239) measured physical activity levels with the DLW method. In 10
PWS subjects (5 males, 5 females) (age: 6.01 -16.00 y) ADMR and BMR were meas-
ured and compared with a group of 60 healthy school children (age: 7.00 -18.00
y) recruited from the region of the research centre. After adjustment for age, fat-
free mass, and gender by multiple regression, ADMR and BMR were found to be
not significantly different between both groups. The physical activity level, howev-
er, was significantly reduced in the PWS group.
Another reason for a possible decreased energy expenditure in PWS, which was
suggested by Holm (237), was the reduced amount of active metabolic tissue
mass in children with PWS.This hypothesis was investigated by Schoeller et al.
(240) who measured ADMR and FFM using the DLW method and deuterium dilu-
tion technique, respectively.They demonstrated that ADMR for the PWS subjects
was on average 46% lower than for the obese controls. Furthermore, they con-
cluded that PWS patients had small fat-free masses for their age and that stan-
dard skinfold measures for assessing fat mass were not reliable in PWS subjects.
The reason for this peculiar body composition was not clear but was suggested to
be associated with neuroendocrine factors mediated by the hypothalamus such
as growth hormone.
Hill et al (241) measured BMR in a large group of PWS subjects and controls at the
annual meeting of the PWS association held in Louisville, Kentucky. Their findings
demonstrated that BMR in PWS is decreased even when adjusted for the lower
FFM in this syndrome. The authors suggested that a low energy expenditure
exists initially for persons with PWS but may return to normal as obesity becomes
greater.
To summarize, the field of paediatric obesity research has gained interest in PWS
since the syndrome is the best known genetic syndrome linked to obesity. The
positive energy balance has been related to an increased energy intake as well as
a decreased energy expenditure. Although the unsatiable hunger makes an
increased appetite plausible, there are only few reports that have documented
energy intake. These reports have demonstrated that energy intake after weight
loss is decreased compared with obese controls. Although it is possible that PWS
children underreport to a greater extend than obese controls, the low energy
intake may also be explained on the basis of a decreased total energy expendi-
ture. The DLW method offers a valid approach to objectively assess total energy
expenditure. The sparse data on energy expenditure in PWS that exists, however,
leaves the question of whether this syndrome is associated with a decreased
energy expenditure, still in debate. Furthermore, in the case of a decrease in ener-
gy expenditure, the next question is, whether this can be explained on the basis
of an altered body composition. Finally, the question needs to be addressed
whether the peculiar body composition in PWS is purely the result of the suggest-
ed hypothalamic lesion or is also related to a sedentary lifestyle, which is associat-
ed with this syndrome.
Treatment strategies in paediatric obesity
The treatment of childhood and adolescent obesity has been almost uniformly
unsuccessful (242). As previously discussed, energy metabolism is tightly bal-
anced, which is why there are no easy means through which weight control can
be achieved. Dietary intake and energy spent on physical activity represent the
only discretionary components of energy intake and expenditure. Behaviour con-
tributes significantly to both (21). Interventions are therefore focussed on influ-
encing the behaviour of the obese individual, mostly family based. In adults, three
major types of treatment are used: dietary intervention, a prescribed exercise pro-
gramme and medication (32). The latter is not recommended for use in children,
unless they present with complications of obesity that require certain, rapid
weight loss, and they need to be referred to specialized paediatric obesity treat-
ment centers (243). According to the recommendations of an expert committee
on this topic (243), the primary goal of obesity therapy should be healthy eating
and physical activity (244). Especially in younger children, the family should be
ready to make modifications in eating and activity habits (245). Detailed informa-
tion about treatment strategies can be found in several review articles (20,32,67,
245). In terms of energy metabolism, in order to achieve a negative or, in the case
of young or less obese children often, less positive energy balance, all interven-
tions are based on a decrease of energy intake or an increase in energy expendi-
ture or a combination of both. With a few exceptions (246,247), the effect of these
interventions on energy metabolism, however, is seldom studied.
Outline of the thesis
Paediatric obesity is a complex phenotype that revolves around the influences of
genes, development and environment. Although the exact contributions of each
of these factors is unclear, together they result in a prolonged positive energy bal-
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ance.The study of the different components of whole body energy expenditure
will give direction to the search for these genetic, developmental and environ-
mental factors, and possibly will give insight into strategies that can cope with
the increasing problem of paediatric obesity.
This thesis attempts to address the relative contribution of the major compo-
nents of daily energy expenditure to the development and maintenance of paedi-
atric obesity. In the first part of this thesis, energy metabolism will be studied in a
group of children and adolescents with high genetic susceptibility to obesity,
namely young patients with Prader-Willi syndrome. In the second part, energy
metabolism will be determined in a group of nonsyndromal obese adolescents,
since adolescence is one of the critical periods for persistence of obesity in adult-
hood. These goals will be pursued through the following specific objectives:
- To determine basal and total energy expenditure in children and adolescents
with Prader-Willi syndrome in relation to body composition and metabolic body
size
- To assess the relationship of physical activity and growth hormone function
with body composition in Prader-Willi syndrome
- To measure the effect of fat mass and gender on basal and total energy expen-
diture in nonsyndromal obese adolescents
- To determine the effect of obesity intervention with sibutramine, an satiety
enhancing drug, on basal and total energy expenditure in nonsyndromal obese
adolescents during restriction of energy intake
In the first two chapters, following the introduction, the effect of Prader-Willi syn-
drome (PWS) on energy metabolism is discussed. Children and adolescents with
PWS are compared with nonsyndromal obese peers, matched for biological age
and gender. Energy expenditure, under basal conditions, and adjusted for body
composition, at rest by ventilated hood measurement and during sleep using the
respiration chamber, is determined in chapter 2. To demonstrate the effects of
PWS status on basal energy metabolism, the relationship between fat mass and
fat-free mass in this syndrome is further explained. In chapter 3, average daily
metabolic rate is measured by the doubly labelled water technique, with particu-
lar consideration given to activity related energy expenditure. Several methods
are discussed that are used to assess the level of physical activity and each is con-
sidered on their merits.
The answer to the question of whether the altered body composition in children
with PWS is related to decreased levels of physical activity and impaired growth
hormone function, is addressed in chapter 4. This chapter discusses the results of
the first 2 chapters, however, from a different perspective, in combination with a
measure of growth hormone function.
Prior to the description of the effect of energy restriction on energy metabolism
of (nonsyndromal) obese adolescents, a compilation of doubly labelled water
studies from the literature is presented in chapter 5. The effect of gender and
body composition in this age group is addressed and the biological background
discussed.
Chapter 6 presents the results of a randomized and placebo controlled, double-
blind, intervention study on the effect of sibutramine, a serotonin and noradrena-
lin re-uptake inhibitor, in combination with an energy restricted diet and exercise
programme, on energy expenditure and body composition in obese adolescents.
In the last chapter, chapter 7, the results and interpretations of the previous chap-
ters are discussed to come to a general conclusion about the implications of this
thesis to the aetiology and treatment of obesity in the paediatric age group.
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Abstract
Background: Obesity in Prader-Willi syndrome (PWS) seems related to a decreased
basal metabolic rate (BMR). In addition, abnormal sleep patterns reported in PWS,
might affect sleeping metabolic rate (SMR).
Objective: To assess BMR and SMR, adjusted for FFM, in young PWS patients.
Design: Subjects were seventeen PWS subjects (10 females, 7 males, age 7.5-19.8 y)
and 17 obese controls, matched for gender and bone age. SMR was measured in a
respiration chamber, BMR with a ventilated hood system and body composition
by deuterium dilution.
Results: BMR, SMR were significantly lower in the PWS group compared with the
control group (5.36 ± 1.18,4.62 ± 1.08 MJ/day, compared with 6.38 ± 1.55,5.60 ±
1.52 MJ/day, respectively) (p < 0.05). When FFM was included in the analysis, multi-
ple regression showed no differences in BMR and SMR between both groups.
When weight was included in the analysis, instead of FFM, the SMR was
decreased in the PWS group. FFM was lower in the PWS group, both in absolute
value as well as adjusted for height.
Conclusion: BMR and SMR are decreased in young patients with PWS, because of a
lower FFM.
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Introduction
Prader-Willi syndrome (i) (PWS) is a clinically diagnosed genetic disorder and
results from the absence of normally active paternally inherited genes at chromo-
some I5(qii-qi3)(2). About 70-75% of the patients has an interstitial deletion in
this region. The majority of the remaining PWS patients have a maternal uni-
parental disomy for chromosome 15. The major clinical criteria (3) for the diagno-
sis of PWS include neonatal and infantile central hypotonia with feeding prob-
lems in infancy, hypogonadism and global developmental delay resulting in mild
to moderate mental retardation (4). Supported by other symptoms such as short
stature, altered temperature sensitivity, high pain threshold and characteristic
behaviour problems (e.g. - temper tantrums or obsessive/compulsive behaviour),
this syndrome is strongly suggested to be based on dysfunction of various hypo-
thalamic centre's (5,6,7). PWS is also known as the most common human genetic
disorder linked to obesity (8). The high prevalence of obesity in PWS is likely
caused by a combination of low energy expenditure and an almost unsatiable
hunger that starts in early childhood (9,10).
Schoeller et al.(n) were the first to report that common formula's using age, gen-
der, height and weight to predict basal metabolic rate (BMR), would overestimate
BMR in adult PWS patients. They found that the Cunningham formula (12), that
uses fat-free mass (FFM) in the equation, did not overestimate BMR significantly.
Later studies, however, could either not confirm the decreased BMR in young PWS
patients (13), or contradictory found a reduced BMR, even when adjusted for FFM
(14). The question therefore, whether BMR, adjusted for FFM, is decreased in young
PWS patients, is still unanswered.
BMR is composed of two components, sleeping metabolic rate (SMR) and arousal.
The respiration chamber measures SMR overnight and offers an alternative meas-
urement of metabolic rate in the inactive and fasted state. In addition, parents
and carers often report excessive sleepiness, daytime hypersomnolence and sleep
disturbance at night in PWS patients. Studies have shown abnormal sleep with
abnormal REM sleep cycles and multiple brief REM periods suggesting a specific
disruption to the timing of REM/NREM cycles (15,16,17), possibly causing an alter-
ation in SMR in patients with PWS.
As a result of contradictory reports of basal metabolic rate and of abnormal sleep
patterns in patients with Prader-Willi syndrome, the aim of our study was to
measure basal and sleeping metabolic rate, adjusted for fat-free mass, in children
and adolescents with Prader-Willi syndrome, compared with obese controls.
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Subjects and methods
Subjects
Seventeen PWS subjects (age 7.5 -19.8 y) were recruited with the assistance of the
Dutch Prader-Willi Association. The subjects were assessed according to the Holm
criteria (3). The Holm system provides a quantitative measure of PWS symptoms.
PWS was preferably confirmed by either a deletion on chromosome 15 or uni-
parental disomy. When only clinical data were available critical evaluation took
place by the same clinical geneticist. The PWS subjects were gender- and bone-
age-matched with nonsyndromal obese controls (age 6.3 -15.3 y) recruited from
the regional public health department. Bone-age was determined by assessing
epiphysal maturation by the same paediatric endocrinologist using an X-ray of
the mid portion of the left hand and standard growth data (18). None of the PWS
subjects was receiving hormone therapy or treatment with human growth hor-
mone before or during the study.
Controls with endocrine causes or other secondary causes of obesity were exclud-
ed. Subject characteristics are shown in Table 2.1.
Before the start of the study the parents gave written informed consent con-
firmed by an oral approval of the child. The study was approved by the medical
ethical committee of Maastricht University.
To We 2. J
Body compos/t/on, energy expend/ture and other c/iowcterut/cs o/sub/erts vvrtri Prader-W/7//
syndrome ("PIVS^  and obese contro/ sub/erts'
PWS Controls
n (F/M) 17 (10/7) 17 (10/7)
Bone age (y)
Age (y)
Height (m)
Weight (kg)
FFM (kg)
FM (kg)
BMI (kg/m*)
FFMI (kg/m*)
FMI (kg/m*)
SMR (MJ/day)
BMR (MJ/day)
' mean ± sd; FFM, fat-free mass; FM, fat mass; FFMI, fat-free mass index; FMI, fat mass index; SMR, sleep-
ing metabolic rate; BMR, basal metabolic rate
" , " " Significantly different from control group (Independent-samples t-test): " p < 0.05,"' p < 0.01
12.7
ii.g
i-43
5O.o
27-5
22.4
235
129
io.6
4 6 2
5-36
±
±
±
±
±
±
+
±
+
±
±
2-9
3-4
0.16
19-7
9 - 9 "
11.7
6.0
2.3 •••
4-5
1.08 '*
1.18 "
12.7
n.3
1.49
61.5
359
25.6
26.0
15-4
10.6
5.60
6.38
±
±
±
±
±
±
1+
±
±
±
±
3-2
2.6
0.20
256
13-4
12.7
6.5
2-7
4.0
1.52
1-55
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Methods
SMR was measured overnight in a respiration chamber. Following this, BMR and
body composition were determined by ventilated hood and deuterium dilution,
respectively.
The subject and parent were invited to come to the laboratory at 19.00 hours
after a normal dinner. At 22.00 hours the subject entered the respiratory cham-
ber. The hours in between were used to familiarize the subject with the study
equipment, do a practice session with the ventilated hood, and produce a back-
ground urine sample for body composition analysis.
Body composition was measured with the dilution technique according to the
Maastricht protocol (19). In summary, the subject received an orally administered
dose of DjO of o.i g/l Total Body Water (TBW), diluted in 75 ml tap water, as the
last drink before bedtime. TBW was estimated from age- and sex-specific formu-
las (20). After the dosing the subject went into the respiratory chamber and was
asked to go to sleep before 22.30 h. A urine sample was taken loh after dose
administration from the second voiding the next morning. Isotope abundance in
urine was determined with an isotope-ratio mass spectrometer (Aqua Sira.VG
Isogas Ltd. (Micromass, Manchester) UK). TBW was calculated as the *H dilution
space divided by 1.04 correcting for exchange of the *H label with non-aqueous H
of body solids (21). FFM was assessed with the assumption of FFM containing all
body water. Hydration factors of FFM were based on maturation specific values
(22). Maturation was assessed according to Tanner's puberty ratings (23). Fat Mass
(FM) was calculated by subtracting FFM of the subject's total body weight. To
allow for comparisons between subjects, FM and FFM were expressed as an index:
FFMI (kg/m*) and FMI (kg/m*), respectively. Patients with PWS experience specific
periods of growth stunting, leading to changes in age related body composition.
In this way we have corrected for the large variation in height, in analogy with the
BMI, BMI = FFMI + FMI.
SMR was measured during a 12 hr overnight stay in the respiration chamber
which was described in detail previously (24).The respiration chamber, an open-
circuit indirect calorimeter (14 m3) was maintained at a constant air temperature
of 18 °C during the night. The chamber was ventilated with fresh air at about 40
l/min. Activity of the subject was measured by an analog ultrasound radar sys-
tem. SMR was calculated automatically according to Weir (25), between 23.00 h
and 6.30 h over the 3-hour interval with the lowest radar count. The next morning
the subject came out of the respiratory chamber at 6.30 h to do their first morn-
ing voiding and immediately returned to bed for BMR measurement in an adja-
cent room. Because the subject was not active that morning the BMR measure-
ment was started after lying supine for 10 minutes.
Oxygen consumption and carbon dioxide production were measured by means of
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computerized, open circuit, ventilated hood system between 7.00 h and 8.00 h
AM, for 40-50 minutes, when the subject was lying supine, watching television.
Gas analyses were performed using a paramagnetic oxygen analyzer (Servomex,
Crowborough, UK) and an infrared carbon dioxide analyzer (Uras 3G, Hartmann &
Braun, Frankfurt, Germany). BMR was calculated according to the Weir's formula
over the 14-min. interval with the lowest standard deviation.
Before the subjects consumed any food or drink, after voiding and whilst wearing
under-clothing, body weight was measured on an electronic scale (E1200, Mettler
Instrumente AG, Greifensee, Switzerland). Height of subjects was measured using
a stadiometer.
Statistical analysis
Differences between the independent variables of the PWS group and control
group were analyzed by the two-sample f-test.The grouping variable PWS status
was defined as: PWS = i; controls = o. A multiple-linear-regression model with
BMR as the dependent variable and bone age, FFM, FM, gender and PWS status as
independent variables was used to analyze the differences between both groups
adjusted for these independent variables. Firstly, the difference in regression
slope, of the influence of FFM on BMR, was tested using an interaction variable of
PWS status and FFM (PWS'FFM) after correction for the variables in the equation.
Secondly, the difference between groups, again corrected for these independent
variables, was estimated and tested for significance using linear regression
assuming equal slopes. This analysis was also done for SMR as the dependent
variable, but now with weight, bone age, gender and PWS status as the independ-
ent variables, using an interaction variable of PWS status and weight
(PWS*weight).The significance level was chosen at 5%. Data were expressed as
means ± sd. SPSS release 6.1 for Macintosh (SPSS Inc. Chicago, Illinois, USA) was
used as the statistical package.
Results
Clinical characteristics of PWS patients and controls are shown in Table 2.1. There
were no statistically significant differences in age, height, weight and BMI
between both groups. Additionally,Table 2.1 shows the body composition and
energy expenditure results.The FFM and FFMI were significantly lower in the PWS
group (p < 0.05 and p < 0.01, respectively), whereas the FM and FMI were similar
in both groups.The SMR and BMR were also significantly lower in the PWS group
(p < 0.05). FFM was plotted against BMR in Figure 2.1. When BMR was expressed
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as a function of FFM in separate linear regression lines for the PWS group and the
control group, the R* was 0.91 and 0.83, respectively. Both lines were not signifi-
cantly different as was evident from multiple regression when BMR was predicted
by bone age, FFM, FM and gender with PWS status as the grouping variable.The
coefficients of bone age and FM were also not significant (Table 2.2). When SMR
was plotted as a function of FFM, the regression lines of the PWS group (R* =
0.94) and the controls (R* = 0.91) were remarkably similar (Figure 2.2). In Table 3
the observed variability in SMR was explained by the variables bone age, gender,
weight and PWS status, resulting in a significant difference in SMR between both
groups. FFMI was plotted as a function of FMI (Figure 2.3). In this plot the differ-
ence between both regression lines was statistically significant (p < 0.001).
Since the interaction variables PWS*FFM and PWS'weight were not significant in
the regression analyses, these variables were not included in the related tables.
g. 2.7
Boso/ metobo//c rote (B/Vlff, /n MZ/WayJ as a/unrt/or? o//at-/ree moss (FF/W, /n fa^ p/ofted/or
the Prader-I/W/// group fPWS,/7//ed c/Vr/es,) and obese contra/ group fcontro/s, open squares/
The regress/on equot/on/or PWS: B/Wff = 0.77 ff/W + 2.27 (ff* = o.9^;jfo/- contro/s.- S/Wff = o.7J
«7W + 2.60 (I?* = 0.S3/
1O
Tob/e 2.2
J?esu/ts o/mu/tip/e-//near-regressibn ono/ysis o/Me /n/fuence o/bone oge,/ot-/ree moss
/ot mfljj CFM^  gender and Prader-lV//// syndrome (PWSj on bosa/ metobo/ic rate (B/W£/
Variable Coefficient' SE
Bone age (y)
FFM (kg)
FM (kg)
Cender3
PWS4
0.017
0.096
0.014
- 0.548
- 0.175
0.055
0.017
0.013
0.179
0.204
-0.095 -
0.061 -
- 0.012 -
- 0.916 -
-0.593 -
0.129
0.131
0.039
-0.181
0.244
0.756
0.000
0.285
0.005
0.399
1 The partial regression coefficient which is the change in BMR for a change in a specific variable adjusted
for the other independent variables in the equation
* The range of values that includes the population value of the coefficient
3 Gender was defined as: Female = 1, Male = o
4 Grouping variable PWS status was defined as:PWS = 1, Obese controls = o. The interaction variable
PWS'FFM was not significant
F/'g. 2.2
S/eep/ng metobo/i'c rate (SM/?, /n A4y/doy^  os o/unct/on o//ot-/ree moss (FFM, in <rg /^or tne
Prader-lV///i group ffWS, /?//ed c/rc/es^ ond obese contro/ group (contro/s, open squores| Tne
regress/on equation /or PWS: S/Wff = OJJ FF/M + J.70 ^ _ o.94);_/br contro/s: SMff = 0.77 FF/M +
7.73 fl?* = 0.97/
1O
FFM (kg)
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Proder-W/7// syndrome fPWS] on s/eep/ng metobo//c rote fSMR/,
Variable P Coefficient' SE
Bone age (y)
Cender3
Weight
PWS4
0.039
- 0.505
0.052
- 0.380
0.043
0.149
0.006
0.157
- 0.050 -
- 0.810 -
0.040 -
- 0.701 -
0.128
0.200
0.064
0.059
0.380
0.002
0.000
0.022
1 The partial regression coefficient which is the change in SMR for a change in a specific variable adjusted
for the other independent variables in the equation
* The range of values that includes the population value of the coefficient
3 Gender was defined as: Female = 1, Male = o
4 Grouping variable PWS status was defined as: PWS = 1, Obese controls = o. The interaction variable
PWS'weight was not significant
F/g. 2.3
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The PWS regress/on //ne /s s/gn;//cont/y dZ/ferent/rom the regress/on /ine o/ the contro/s
('A^u/t/p/e-//neor-regress/on ono/ys/s: p < O.OOJ/
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Discussion
The present study demonstrates that children and adolescents with PWS have a
decreased energy expenditure both during rest and during sleep compared with
gender and bone-age matched controls. Previous reports (21,26), indicating a
decreased BMR in this syndrome, were based on studies with small groups of
adult PWS patients, without a control group. In a more recent study (13) that
measured BMR in children and adolescents, 10 subjects with PWS were compared
with a cohort of 60 healthy school children. Although the difference in BMR
between both groups was not significant, the difference further decreased after
adjusting for age, gender and FFM. Therefore, in order to study the relationship
between FFM and energy expenditure in PWS, a control group is needed that is
matched for age and gender. However, possibly because of the suggested hypo-
thalamic insufficiencies, most children with PWS have a delay in biological matu-
ration. Calendar age often overestimates the physical development of a PWS child
(8). Bone age measurement, as a means of assessing the rate of maturational
change throughout the growing period, provides an estimate of physiological
maturation (27). Thus, in the present study, the control group was matched for
gender and bone-age.
To adjust BMR for FFM, BMR was plotted as a function of FFM. Since FFM
explained more than 87% of the observed variability of BMR, the reduction of
BMR must mainly be the result of a low FFM. Indeed, the similarity of the regres-
sion lines of both groups demonstrates that the relationship between FFM and
BMR in PWS is comparable with the relationship in nonsyndromal obese children.
There is a small, not significant difference in intercepts, as well as equal slopes for
both lines. This finding differs from a report by Hill et al. (14), who found a
decreased BMR, even when adjusted for FFM, compared with two groups of lean
and obese controls. The authors suggested that low energy expenditure initially
exists for persons with PWS but returns to normal, as these patients grow older
and obesity becomes greater. In the present study using multiple regression, bone
age nor FM could significantly explain the observed variability in BMR with FFM in
the analysis. Moreover, having PWS or not was not important to predict BMR,
whilst adjusted for FFM. A possible explanation for this conflicting result might be
that the study by Hill et al. used bioelectrical impedance analysis to measure FFM
instead of a dilution technique. Especially the high correlation between the skin-
fold measurements and the bioelectrical impedance outcome suggests that the
latter may overestimate the actual FFM, since skinfolds are known to underesti-
mate the amount of FM in PWS due to the altered distribution of body fat (11).
Another reason might be that the differences within and between studies are
caused by the residual variability of the BMR measurement. Previous studies have
reported that it was difficult for PWS children to lay quiet for a BMR measure-
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ment, often leading to no satisfactory measurement at all (13,14). By measuring
SMR overnight in the respiration chamber, the influence of agitation is much
lower. Thus, FFM could explain 93% of the observed variability (Figure 2.2). Other
variables as FM, gender and bone age could therefore only play a minor role in the
prediction of SMR. However, when body weight is used to predict SMR, instead of
FFM, the grouping variable PWS status is significant, even when adjusted for bone
age and gender, indicating that indeed young PWS patients have a decreased
SMR.
Thus, the decreased BMR and SMR must be the result of a decreased FFM. In the
present study the FFM is significantly lower in the PWS group, both in absolute
value as well as adjusted for height (FFMI). FFMI is an objective measure for com-
paring healthy subjects with patients with growth deficiency. Indeed, when cor-
rected for height the difference in FFM is even more significant (p < 0.01).
Furthermore, it is also necessary to adjust FFM for the effect of FM, since an
increase in FM will induce an increase in FFM. When FFMI is plotted as a function
of FMI, however, the slope of the PWS group is significantly lower compared with
the control group, indicating that for each unit increase in fat mass the increase
of fat-free tissues will be reduced in the PWS group.
The precise etiology of the reduction in growth of FFM in PWS is still unclear. The
profound hypotonia in PWS might prevent the child from becoming physically
active, resulting in low stimulation of muscle and bone tissue and consequently
leading to a growth deficit of FFM.
A more general explanation relates the deficit in FFM to a dysfunction of the
hypothalamic systems. Abnormalities of the somatotrophic axis would explain
why most patients have a blunted growth hormone (GH) response to various
provocative stimuli, or show decreased 24-hour GH secretion (28,29,30, 31). In
addition, decreased levels of gonadotrophins, consistent with hypogonadotrophic
hypogonadism, suggest a dysfunction of the hypothalamic-pituitary-gonadal axis
(7). Although a structural hypothalamic lesion has not been found, a recent study
demonstrated a complete absence of the posterior pituitary bright spot on mag-
netic resonance imaging, indicating a disturbed function of the hypothalamic-
hypophyseal system (6). It is known from several studies that the use of growth
hormone in subjects with PWS has a positive effect on increasing height as well
as on decreasing percentage body fat (31,32,33). Currently, prolonged trials of
growth hormone treatment are undertaken to explore different dosage regimens
and possible long term adverse effects of these interventions.
In conclusion, this is the first report that demonstrates the energy expenditure to
be decreased in rest as well as during sleep in children and adolescents with
60
Prader-Willi syndrome compared with obese subjects matched for bone-age and
gender. The decreased energy expenditure is the result of a reduction of fat-free
mass, in absolute value as well as adjusted for height.There was no difference
between the groups, when basal metabolic rate or sleeping metabolic rate was
adjusted for fat-free mass.
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Abstract
Objective: To measure activity related energy expenditure in Prader-Willi syn-
drome (PWS) corrected for body size.
Subjects: 17 PWS subjects (10 females, 7 males, age 7.5 -19.8 y) and 17 obese con-
trols, matched for gender and bone age.
Methods: Basal metabolic rate (BMR) was measured by ventilated hood and aver-
age daily metabolic rate (ADMR) was measured with doubly labelled water.
Activity induced energy expenditure (AEE) was calculated as 0.9ADMR - BMR.
Activity related energy expenditure was corrected for body size using the follow-
ing measures: AEE per kg body weight (AEE/kg), ADMR/BMR (PAL), and the resid-
ual of the regression of ADMR on BMR (rADMR). Group differences were analyzed
by analysis of covariance adjusting for bone age, fat mass (FM) and gender.
Results: ADMR, AEE and PAL were lower (p < 0.01) in the PWS group compared
with the control group (7.14 ± 1.72 MJ/day, 1.07 ± 0.69 MJ/day and 1.33 ± 0.15
Ml/day compared with 9.94 ±+ 2.64 MJ/day, 2.56 ± 1.03 MJ/day and 1.55 ± 0.12
MJ/day, respectively). The variance of AEE/kg and PAL was significantly explained
by gender and PWS status, while AEE was additionally explained by FM.The vari-
ance of rADMR was explained by PWS status and not by FM or gender.
Conclusion: Activity related energy expenditure is decreased in PWS compared
with controls adjusted for bone age, FM and gender.
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Introduction
Prader-Willi syndrome (PWS) is known as the most common human genetic disor-
der linked to obesity (i).This complex, multisystem disorder is characterized by
perinatal and neonatal hypotonia, followed by a childhood obese phase (2,3). The
obesity is likely to be caused by a combination of low energy expenditure and
high energy intake (4, 5). Eating problems, characterized by hyperphagia often
combined with food stealing are well-reported problems in PWS (4,6), however,
the actual energy intake is difficult to measure with current methods. The doubly
labelled water technique offers a valid method to measure the individual's daily
metabolic rate (ADMR) (7), which consists of basal metabolic rate (BMR), activity
induced energy expenditure (AEE) and diet induced thermogenesis (8,9). In a pre-
vious report we have demonstrated that the low energy expenditure in rest as
well as during sleep could be explained by a relative low fat-free mass (FFM) as
one of the major compounds of the pathophysiological background of PWS (10).
Schoeller et al (5) demonstrated that the average daily metabolic rate (ADMR) in
PWS patients as well as the level of physical activity were significantly lower com-
pared with obese controls. Other investigators (11) were unable to confirm the
decreased ADMR in patients with this syndrome. One of the problems of compar-
ing physical activity between subjects with large differences in body weight is the
correction for body size.The relatively low fat-free mass, resulting in a high adi-
posity level in PWS is an extra complication to this matter. Measuring physical
activity directly by an actometer or pedometer could provide an alternative
approach to this problem and has indeed been used measuring physical activity
in PWS children (12). However, because of the large variation in physical activity,
the investigators could not find a difference between PWS children and obese
controls. Another possibility is to measure activity using the doubly labelled water
method in combination with BMR, and correct the results for body size differences
to test if they support a unified conclusion (13).
As a result of contradictory reports of total energy expenditure and physical
activity levels in PWS, the specific objective was to examine whether the activity
related energy expenditure, corrected for body size, is different in PWS subjects
compared with matched obese controls.
Methods
Subjects
Seventeen PWS subjects (10 females, 7 males) were recruited with the assistance
of the Dutch Prader-Willi Association. The subjects were assessed according to the
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Holm criteria (14). The Holm system provides a quantitative measure of PWS
symptoms. PWS was preferably confirmed by either a deletion on chromosome 15
or uniparental disomy. When only clinical data were available critical evaluation
took place by the same clinical geneticist. The PWS subjects were gender- and
bone-age-matched with nonsyndromal obese controls recruited from the regional
public health department. Bone-age was determined by assessing epiphysal mat-
uration by the same paediatric endocrinologist using an X-ray of the mid portion
of the left hand and standard growth data (15). It is preferable to use bone age
instead of calendar age in studying energy metabolism in PWS, because it pro-
vides a correction for the potential delay in biological maturation of PWS subjects
(16). None of the PWS subjects were receiving hormone therapy or treatment with
human growth hormone (GH) before or during the study. Controls with endocrine
causes or other secondary causes of obesity were excluded. All subjects were
measured within three months during the summer. Subject characteristics are
shown in Table 3.1. Before the start of the study the parents gave written
informed consent confirmed by an oral approval of the child. The study was
approved by the medical ethical committee of Maastricht University.
Tab/e.j.i
Body composrtvon and other character/st/cs o/sub/crts iv/th Prader-I/W/// syndrome (PW5J and
obese confro7 sub/'erts'.
PWS Controls
n(F/M) 17(10/7) 17(10/7)
Bone age (y)
Age (y)
Height (m)
Weight (kg)
BMI (kg/m*)
%RBW (%)
FFM (kg)
FM (kg)
%FM (%)
mean ± s.d.; %RBW, percentage relative body weight; FFM. fat-free mass; FM, fat mass; % FM, percentage
fat mass
Significantly different from control group (Independent-samples r-test): p < 0.05
12.7
ii.g
1-43
50.0
23-5
142
27-5
22.4
43-7
±
+
±
+
i+
i+
i+
+
±
2-9
3-4
0.16
19-7
6.0
3O
9-9*
11.7
7-9
12.7
11.3
1.49
61.5
26.0
148
359
25.6
39-i
±
±
±
+
±
±
±
±
±
3-2
2.6
0.20
25.6
6-5
29
134
12-7
8.8
Chapf«3
Physical activity in Prader-Willi syndrome
General outline of protocol
Procedures for energy expenditure and body composition measurements
ADMR and total body water (TBW) were measured by doubly labelled water
according to the Maastricht Protocol (7). BMR was measured by ventilated hood.
The subject and parent were invited to the laboratory at 19.00 hours after a nor-
mal dinner. At 22.00 hours the subject produced a urine sample to determine the
background isotope level. As a last consumption before the night the subject
received an orally administered mixture of ^H^o and Hj'80. After the dosing the
subject went to sleep in a respiration chamber of which the results were previ-
ously reported (10). The following morning the subject came out of the respiratory
chamber at 6.30 h to do the first morning voiding and immediately returned to
bed for BMR measurement in an adjacent room. Because the subject was not
active that morning, the BMR measurement was started after lying supine for 10
minutes. Oxygen consumption and carbon dioxide production were measured by
means of computerized, open circuit ventilated hood system, for 40-50 minutes,
when the subject was watching television. Gas analyses were performed using a
paramagnetic oxygen analyzer (Servomex, Crowborough, UK) and an infrared car-
bon dioxide analyzer (Uras 3G, Hartmann & Braun, Frankfurt, Germany). BMR was
calculated according to Weir (17) over the 14-min. interval with the lowest stan-
dard deviation.The same morning a urine sample was taken from the second
voiding loh after dose administration. Isotope abundance in the urine was deter-
mined with an isotope-ratio mass spectrometer (Aqua Sira, VG Isogas Ltd.
(Micromass, Manchester) UK).TBW was calculated as the *H dilution space divid-
ed by 1.04, correcting for exchange of the *H label with non-aqueous H of body
solids (18). Fat-free mass (FFM) was assessed with the assumption of FFM contain-
ing all body water. Hydration factors of FFM were based on gender and matura-
tion specific values (19). Maturation was assessed according to Tanner's puberty
ratings (20). Fat Mass (FM) was calculated by subtracting FFM of the subject's
total body weight. Before the subjects consumed any food or drink, after voiding
and whilst wearing under-clothing, body weight was measured on an electronic
scale (E1200, Mettler Instrumente AG, Greifensee, Switzerland). Height of subjects
without shoes was measured using a stadiometer.
Isotope disappearance rate in the urine from the samples of day 1,8 and 14 from
the following 14 days was used to calculate carbon dioxide production. Carbon
dioxide production was converted to ADMR with a respiratory exchange ratio
(RER) equal to the food quotient (FQ) that was derived from a one-week food
diary. This weighed dietary record, was handed to the parent(s) and subject, after
instruction on how to measure portion size. They were asked to record brand
names, methods of preparation, and ingredients of mixed dishes. The same dieti-
cian reviewed the record with the parent(s) and subject and calculated the energy
intake and macronutrients.
Measures of activity related energy expenditure
Four different measures of activity were assessed from ADMR and BMR measure-
ments. Firstly, AEE was calculated using the formula 0.9 ADMR - BMR, correcting
for 10% diet induced energy expenditure. Secondly, in order to correct for weight-
bearing activities, AEE was divided by total body weight, leading to AEE/kg. Thirdly
the physical activity level (PAL) was determined by dividing ADMR by BMR. Finally,
the residual of ADMR (rADMR) was calculated from the regression of ADMR on
BMR (Figure 3.1).
•Average Do;7y /Wetabo//c forte f/4D/Wff, /n Al//dov^ as o/unct/orj 0/B050/ A<1etabo//c ffate fBMff,
m Ai//rfoy) p/otterf/or fhe Prader- W/7// group (PWS, /n////ed c/rc/es^ and obese contro/ group
(contro/s, ;n open souores/ Trie regress/on equot/'on/or PIVS: 4DA^S = 7.32 BMff + 0.06 f/?* =
= 7.6) BM/? - 0.34 CS^  = 0.90/
12.5 -
3 4 5 6 7 8 9
BMR(MJ/day)
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Statistical analysis
Differences between the independent variables of the PWS group and the obese
control group were analyzed by the two-sample t-test. Analysis of covariance was
used to calculate the difference in ADMR between both groups, defined by the
binary variable PWS status, adjusted for bone age, BMR, FM and gender as the
other independent variables in the model. Firstly, the difference in regression
slope, of the influence of BMR on ADMR, was tested using an interaction variable
of PWS status and BMR (PWS'BMR) adjusted for the variables in the model.
Secondly, the difference between groups, again adjusted for these independent
variables, was estimated and tested for significance using linear regression
assuming equal slopes. An analysis of covariance was also done for each of the
measures of activity as the dependent variable, consequently using bone age,
gender, FM and PWS status as independent variables.The significance level was
chosen at 5%. Data were expressed as means ± sd. SPSS release 6.1 for Macintosh
(SPSS Inc. Chicago, Illinois, USA) was used as the statistical package.
Results
Energy expenditure and body composition
Clinical characteristics of PWS patients and obese controls are shown in Table 3.1.
There were no statistically significant differences in age, height, weight, BMI,
%RBW ([(body weight/ weight predicted by height and gender)*ioo]) between
both groups. FFM was smaller in the PWS group, while FM and %FM were similar.
FQ was also similar in both groups (PWS and controls: 0.87 ± 0.02).
BMR, ADMR as well as the measures of activity related energy expenditure were
significantly lower in the PWS group compared with the controls (Table 3.2). BMR
adjusted for weight (BMRweight) was lower in the PWS group, while BMR adjusted
for FFM (BMRFFM) was not different. Likewise, ADMR was adjusted for weight and
also for FFM, however, both calculations were lower in the PWS group compared
with the controls (p < 0.001). ADMR was plotted against BMR in Figure 3.1. When
ADMR was expressed as a function of BMR in separate linear regressions for the
PWS group and the control group, the R* was 0.83 and 0.90 respectively. From a
further linear regression model, it was evident that, corrected for BMR, bone age,
FM and gender, the difference in ADMR between PWS and controls was signifi-
cant. The coefficients of BMR, gender and PWS status significantly explained the
variance of ADMR. Because the interaction variable PWS*BMR was not significant
in the regression analysis, this variable was not included in the table (Table 3.3).
Energy expenrf/ture measures and ca/cu/at/'ons o/sub/'ects w/th Prader-VW/7/ syndrome
and obese contro/ 5t/b/ect5\
PWS Controls
n (F/M)
BMR (MJ/day)
BMRwe,,h, (MJ/day)
BMRpfm (MJ/day)
ADMR (MJ/day)
ADMR^igh, (MJ/day)
ADMRpfM (MJ/day)
AEE (MJ/day)
AEE/kg (KJ/day*kg-i)
PAL
17 O0/7)
5-36
5-17
5-31
7-14
6.28
6.55
107
23.11
i-33
±
±
±
±
±
+
±
±
±
1.18*
i-57*
1.38
1.72 "
2.60 ***
2.02 **"
0.69 " *
17.05 '**
0.15 " *
17 (10/7)
6.38
6.57
6.43
9-94
10.80
10.54
2.56
46.09
i-55
±
±
±
±
±
±
±
±
±
i 55
1.92
1.86
2.64
3.12
3.04
1.03
17-79
O.12
' mean ± s.d.; BMR. basal metabolic rate: BMR^ght. BMR adjusted for weight; BMRpjn,, BMR adjusted for
fat-free mass; ADMR. average daily metabolic rate; ADMR^,^,, ADMR adjusted for weight; ADMRpf,,.
ADMR adjusted for fat-free mass; AEE. activity induced energy expenditure; AEE/kg, AEE per kg body
weight; PAL, physical activity level (ADMR/BMR)
" , " , *** Significantly different from control group (Independent-samples t-test):
* p < 0.05," p < 0.01," ' p < 0.001
Tob/e 3.3
ffesu/ts o/mu/t/p/e-//7)eor-regress/on ano/ys/s o / the /n/7uence o/bosa/ metobo/Vc rote (B/Vlff|
bone oge,/ot moss ("M/IJ, gender ond Proder- lrV/7// syndrome fPM/5^ on overage do/7y metobo//c
rote C4DA1^ /n
Variable p Coefficient' SE 95% Cl
BMR (MJ/day)
Bone age (y)
FM (kg)
Cender3
PWS4
1.285
0.011
0.027
- 0.743
-1.394
0.211
0.082
0.020
0.327
0.327
0.853
-0.157
-0.015
- MH
- 2.064
1.716
- 0.179
0.069
- - 0 . 0 7 3
- 0.725
0.000
0.892
0.193
0.031
0.000
' The partial regression coefficient which is the change in ADMR for a change in a specific variable adjusted
for the other independent variables in the equation
* The range of values that includes the population value of the coefficient, with 95% probability
3 Gender was defined as: Female = 1, Male = o
4 Grouping variable PWS status was defined: PWS = 1, Obese controls = o.The interaction variable PWS'BMR
was not significant
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Measures of activity related energy expenditure
Table 3.4 presents the results of the difference between the PWS and obese con-
trol group for AEE, AEE/kg, PAL and rADMR adjusted for bone age, FM, gender. The
variance of AEE was significantly explained by FM, gender and PWS status. When
AEE/kg or PAL was used as dependent variable, the coefficient of FM was not sta-
tistically significant. Only the coefficient of PWS status significantly contributed
to the variance of rADMR.
ToWe 3.4
flest/fts o/mu/t/p/e-//neo/'-regress/on ono/yses o/the /n/7uence o/bone age,/at mass ("fAI/ gen-
der and Prader-W/7// syndrome (PWS^ on measures o/art/Vrty re/ated energy expenditure.
Activity parameter'
AEE (MJ/day)
AEE/kg (KJ/day*kg~')
PAL
rADMR (MJ/day)
Variable
Bone age (y)
FM (kg)
Gender3
PWS4
Bone age (y)
FM (kg)
Cender3
PWS4
Bone age (y)
FM (kg)
Gender3
PWS4
Bone age (y)
FM (kg)
Cender3
PWS4
p Coefficient*
0.046
0.033
- 0.785
-1.386
-1.515
- 0.287
-13.88
- 24.00
- 0.001
0.002
-O.I 21
- 0.218
- 0.074
0.008
- 0.469
-1.080
SE
0.060
0.015
0.259
0.247
1.167
0.302
5.069
4.826
o.on
0.003
0.046
0.044
0.069
0.018
0.300
0.285
P
0.451
0.042
0.005
0.000
0.204
0.350
0.010
0.000
0-933
0.510
0.015
0.000
0.293
0.675
0.128
0.001
AEE: activity induced energy expenditure, 0.9ADMR - BMR ; AEE/kg: AEE per kg body weight: PAL: physical
activity level, ADMR/BMR; rADMR: residual of ADMR on BMR.
The partial regression coefficient which is the change in the parameter for a change in a specific variable
adjusted for the other independent variables in the equation
Gender was defined as: Female = 1, Male = o
Grouping variable PWS status was defined: PWS = 1, Obese controls = o.
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Discussion
The present study demonstrates a low activity related energy expenditure in chil-
dren and adolescents with Prader-Willi syndrome as reflected in the following
parameters: AEE, AEE/kg, PAL, and rADMR. To control for the possible effects of
body composition, biological maturation and gender on the measures of activity,
each of the parameters was adjusted for fat mass (FM), bone age and gender.
Daily physical activity can be divided into weight-dependent and non-weight-
dependent activities. Although at present the doubly labelled water method func-
tions as the golden standard to calculate the energy expended for activity in a
free-living situation, the optimal adjustment for body weight as a correction for
weight-bearing activities is still under debate (13,21,22).The most direct method
of measuring absolute activity related energy expenditure is by subtracting ADMR
with BMR, correcting for io% of diet-induced energy expenditure:
AEE = 0.9 ADMR - BMR.The present results show that the variation in AEE
between subjects is not only caused by PWS but also by the differences in FM.
Because at least part of the routine daily activities are weight dependent, a higher
FM will result in a higher energy cost performing the same, weight dependent,
tasks. In a study with prepubertal children (23), FMdid not correlate with AEE. This
is possibly related to the energy efficiency of physical activity that improves with
maturation, which may lead to a higher sensitivity towards the effect of FM on
activity when age increases. Moreover, in an earlier report by the same group, AEE
was found to correlate significantly with FM (24).
AEE divided by total body weight (25,26) is an alternative approach assuming that
all activity induced energy expenditure is related to weight-bearing activities.
Previous studies, in children (27,28), as well as adults (29,30) used this approach
to demonstrate that obesity was associated with decreased levels physical activi-
ty. Others (22,31,32,33) could not find an effect of obesity. In the present study
however, AEE/kg was not influenced by FM. Moreover, FM could not take away the
influence of PWS status on AEE/kg, indicating that adiposity cannot explain the
decreased activity related energy expenditure in PWS, not even for weight bearing
activities. Since the majority of daily activities involve only limb movements and
are not weight dependent, it has been suggested for sedentary adults to divide
AEE by weight°-5 (13). However, such an exponent is likely to be population specif-
ic. The amount and intensity of whole-body movements during the day is proba-
bly related to age, gender and especially to disease or disability. Even if such group
specific exponents for weight correction would be determined, one of the general
problems of using AEE as a measure of activity remains the positive correlation
with ADMR. As AEE will generally increase for higher values of ADMR, AEE as a
measure of activity cannot be validly compared between groups with large differ-
ences in ADMR.
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Correcting for metabolic body size by dividing ADMR by BMR is a way of losing
the positive correlation between ADMR and BMR, leading to the measurement of
physical activity index or level (PAL).The results show that the subjects with the
highest PAL are the boys in the obese control group. Other studies (27,34,35),
measuring PAL in adolescents, did not show a gender difference in PAL during
childhood through adolescence. Probably, the gender difference is caused by an
average higher BMR in boys from the control group, as was previously demon-
strated in obese adolescents (27). An important assumption when comparing the
PAL between groups is a constant relationship between ADMR and BMR.The posi-
tive intercept of the PWS group and the negative intercept of the control group
(Fig. 3.1) show that the assumption is incorrect. Although the gender difference in
BMR within the control group was not significant, the combination with the neg-
ative intercept of the control group will result in a higher PAL for boys by mathe-
matical definition (8,21). Therefore, the PAL is not the most appropriate way to
compare groups with significant intercepts in the regression of ADMR on BMR, in
spite of the similar ranges of BMR and ADMR in both study groups.
A valid technique suggested as an alternative approach to adjust data with non-
zero intercepts is the analysis of covariance by multiple regression (22). In this
technique, the residuals from the regression of ADMR on BMR (rADMR) are itself a
(relative) measure of the activity related energy expenditure corrected for BMR,
assuming independence, a normal distribution of the data and a significant cor-
relation between the dependent and independent variable. In the present study,
BMR was the best single determinant of ADMR in the PWS as well as the control
group, explaining respectively 90% and 83% of its variance, which was even high-
er than in other studies (22,27). Interestingly, when rADMR is used as measure of
activity, gender is no longer statistically significant, which indeed indicates that
the gender difference in the previous measures of activity was in fact a BMR
effect. Again, this approach points out a decrease in activity related energy expen-
diture in PWS patients.
One of the modulators for activity related energy expenditure is seasonality.
Goran et al. (36) showed that the AEE, and as a result also ADMR, in prepubertal
children was significantly higher in the Spring compared with Autumn, even
when adjusted for body composition. In the present study the PWS and control
subjects were all measured during the Summer avoiding this potential confound-
ing factor. It is unclear whether seasonality has influenced the results of the other
studies on energy metabolism in PWS, because the season of measurement was
not mentioned in any of the reports. In the study by Schoeller et al. (5) the average
ADMR of the PWS group was 53% of that of obese controls, which is lower than
the 72% that was found in the present study. In Schoeller's study a standard RER
of 0.85 was used to calculate ADMR, while in this report RER was equal to FQ, that
74
was derived from a food record. Since FQ was similar in the PWS and control
group it is unlikely that this discrepancy in methods could help understand the
group difference in ADMR. It is more likely that this is influenced by our younger
study population. On the other hand, the average activity related energy expendi-
ture was 60% lower for the PWS group in the present study, where Schoeller et al.
observed only a 40% reduction.The difference might be explained by the use of
an equation derived by Ravussin et al (25) to calculate the ADMR, containing FFM,
% activity and weight as explanatory variables. This equation was developed from
respiration chamber measurements, when in the present study ADMR was meas-
ured by doubly labelled water. It is likely that inter-individual differences in activi-
ty cannot be detected in a laboratory setting as easily as in a free-living situation,
which presumably resulted in a small coefficient for activity in Ravussin's formula.
Davies et al (11) measured PAL in a group of io children with PWS and compared
them with a cohort of schoolchildren from an existing database. Although the
authors were not able to detect a statistically significant difference in ADMR, and,
given the small difference in age, the absolute outcome of ADMR, AEE and PAL
results of the PWS subjects are remarkably similar. Therefore, as the authors sug-
gested,the small study sample was probably the cause of the insignificant differ-
ence in ADMR between groups.
The cause of PWS children spending less energy on activity cannot be answered
by the present study. The dysfunction of various hypothalamic systems, as one of
the possible reasons for the low FFM in patients with this syndrome, might well
be the underlying cause. The hypotonia in early childhood and underdevelopment
of muscle strength and coordination with delayed motor milestones may lead to
a lack of capability and interest to be physically active. Additionally, the possible
functional growth hormone deficiency and decreased levels of gonadotrophins
(37) might take away the natural urge of children to be lively and playful.
In conclusion, the present study demonstrates that AEE is lower in children and
adolescents with PWS than in obese controls, matched for bone age and gender.
In addition, all measures of activity related energy expenditure corrected for body
size and adjusted for bone age, gender and FM, support the conclusion that PWS
patients are less active during childhood and adolescence.
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Abstract
Objective: To study the relationship of fat mass (FM), extracellular-to-intracellular-
water ratio (ECW/ICW) and bone mineral density (BMD) with growth hormone
(GH) function and physical activity (PA) in Prader-Willi syndrome (PWS).
Study design: Subjects were 17 PWS patients (10 females, 7 males, age 7.5-19.8 y)
and 17 obese controls, matched for gender and bone age. FM and ECW/ICW were
measured by bromide-deuterium dilution, BMD by dual-energy X-ray absorptiom-
etry, GH function by fasted serum IGF-I concentration and PA by doubly labelled
water in combination with basal metabolic rate by ventilated hood.
Results: The PWS group had a similar FM, but a lower fat-free mass (FFM), where-
as the ECW/ICW was higher compared with controls (0.87 ± 0.07 and 0.80 ± 0.06 ,
respectively (p < 0.01)). FM was inversely related with PA in the PWS group, where-
as IGF-I was positively correlated with FFM, ICW and BMD of the limbs. BMD tend-
ed to be lower in PWS patients.
Conclusions: In children and adolescents with PWS, adiposity is mainly caused by
a reduced FFM, and ECW/ICW is increased. Both findings are related to GH func-
tion and PA. BMD, especially in the limbs, tends to be reduced in PWS and is relat-
ed to GH function.
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Introduction
Prader-Willi syndrome (PWS) was first described by Prader, Labhart and Willi as a
syndrome of hypotonia, hypogonadism, mental retardation and obesity (i). At
present, PWS is known as a complex genetic disorder, resulting from the absence
of normally active paternally inherited genes at chromosome 15(911-13). In the
majority of the cases this genetic defect is caused by an interstitial deletion in
this region, or a maternal uniparental disomy for chromosome 15, whereas a
minority is the result of an imprinting mutation (2).
Although, nowadays, early recognition of the syndrome and dietary intervention
seem to prevent the PWS child from becoming massively obese, obesity is still one
of the major causes of morbidity and mortality in PWS. PWS is also the most com-
mon genetic disorder linked to obesity (3).The main characteristics of PWS, sup-
ported by other clinical features such as short stature, delayed or incomplete
puberty and osteoporosis (4), suggest abnormalities of the somatotrophic and
hypothalamic-pituitary-gonadal axis, however, a structural lesion has not yet been
discovered (5,6,7,8). Moreover, the pattern of adiposity in PWS and the reduced
lean and bone mass, especially in the limbs (9), have a close resemblance to the
body composition present in children with growth hormone deficiency (GHD).
Although GHD cannot be confirmed in all patients, the effect of growth hormone
(GH) intervention does support a functional GHD (10). Consequently, a functional
GHD might result in an increased extracellular-to-intracellular water ratio
(ECW/ICW) as was shown in GHD adults (11). In PWS, however, body water com-
partments have not been studied before.
Another possible factor that may influence these alterations in body composition
is inactivity. PWS children are known to be less active than nonsyndromal controls
(12). Although the inverse relationship between obesity and activity has been
established in nonsyndromal or primary obesity (13,14) and discouragement of
sedentary activities is now an important element in the prevention of childhood
obesity (15), it is unclear whether this relationship also exists in secondary obesity,
like Prader-Willi syndrome. A positive effect of activity on body composition might
lead the way to alternative intervention strategies, which combine physical activi-
ty with hormonal therapy to prevent the development of obesity in PWS.
The aim of the present study was to measure fat mass, body water compartments
and bone mineralization in patients with PWS, compared with controls with non-
syndromal obesity matched for gender and bone age, and to associate these body
composition parameters with growth hormone function and physical activity in
PWS.
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Methods
Subjects
Seventeen PWS subjects (age 7.5 -19.8 y) were recruited with the assistance of the
Dutch Prader-Willi Association. The subjects were assessed according to the Holm
criteria (4).The Holm system provides a quantitative measure of PWS symptoms.
PWS was preferably confirmed by either a deletion on chromosome 15 or uni-
parental disomy. When only clinical data were available, critical evaluation took
place by the same clinical geneticist. The PWS subjects were gender- and bone-
age-matched with nonsyndromal obese controls (age 6.3 -15.3 y) recruited from
the regional public health department. Bone age measurement, as a means of
assessing the rate of maturational change throughout the growing period, pro-
vides an estimate of biological maturation, and is therefore a better matching cri-
terion than calendar age (16). Bone-age was determined by assessing epiphysal
maturation by the same paediatricendocrinologist using an X-ray of the mid por-
tion of the left hand and standard growth data (17). None of the PWS subjects
was receiving hormone therapy or treatment with human GH before or during
the study. Controls with endocrine causes or other secondary causes of obesity
were excluded. Subject characteristics are shown in Table 4.1. All subjects were
measured in the summer months avoiding the potential confounding factor of
seasonal variation in activity (18).
Before the start of the study the parents gave written informed consent con-
firmed by an oral approval of the child. The study was approved by the medical
ethical committee of Maastricht University.
c7?ararter/st/cs o/sub/erts vv/'t/i Prader-W/7/f syndrome (PWS,} and obese contra/ subjects'.
PWS Controls
n (F/M) 17 (10/7) 17 (10/7)
Bone age (y)
Age (y)
Tanner (1-5)
Height (m)
Weight (kg)
BMI (kg/m*)
' mean ± s.d.; Tanner, sexual development stage according to Tanner (25)
12.7
11.9
2.6
1-43
50.0
23-5
±
±
+
±
±
±
2-9
3-4
1.6
0.16
197
6.0
12.7
11.3
2.6
1.49
61.5
26.0
±
±
+
+
+
±
3-2
2.6
i-7
0.20
25.6
6-5
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General outline of protocol
Total energy expenditure or average daily metabolic rate (ADMR) and total body
water (TBW) were measured according to the Maastricht Protocol for the meas-
urement of body composition and energy expenditure with labelled water (19).
Each subject was invited with a parent to the laboratory at 19.00 hours after a
normal dinner. Around 22.00 hours the subject produced a urine sample to deter-
mine the background isotope level. As a last consumption before the night the
subject received an orally administered stable isotope mixture of *HjO and r-^o.
A known amount of sodium bromide (< 60 mg bromide / I. estimated TBW; Ph.
Eur., Genfarma, Maarssen.The Netherlands) was offered directly after the doubly
labelled water drink and thus administered simultaneously with the ^H^o dose.
After the dosing the subject went to sleep in a bedroom at the laboratory. The fol-
lowing morning the subject was waken up at 6.30 h to do the first morning void-
ing. After voiding the subject immediately returned to bed for measurement of
basal metabolic rate (BMR) in an adjacent room. After the BMR measurement, a
blood sample and urine sample, taken from the second voiding, was collected loh
after dose administration. Isotope abundance in the urine from samples of day 1,
8 and 14 from the following 2 weeks, was determined with an isotope-ratio mass
spectrometer (Aqua Sira, VG Isogas Ltd (Micromass, Manchester) UK).The bromide
concentration in serum ultrafiltrate was determined with high performance liquid
chromatography.
In the same morning, before the subjects consumed any food or drink, after void-
ing and whilst wearing under-clothing, total body weight was measured on an
electronic scale (Ei2oo, Mettler Instumente AG, Greifensee, Switserland). Height of
subjects without shoes was measured using a stadiometer.
Furthermore, a total body scan was made with a dual energy X-ray absorptiome-
ter (DXA) (DPX-L, Lunar Corp., Madison, Wl, USA)
Basal metabolic rate
The BMR measurement was started after lying supine for 10 minutes. Oxygen
consumption and carbon dioxide production were measured by means of a com-
puterized, open circuit ventilated hood system, for 40-50 minutes, while the sub-
ject was watching television. Gas analyses were performed using a paramagnetic
oxygen analyzer (Servomex, Crowborough, UK) and an infrared carbon dioxide
analyzer (Uras 3G, Hartmann & Braun, Frankfurt, Germany). BMR was calculated
according to Weir (20) over the 14-min. interval with the lowest standard devia-
tion.
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The isotope disappearance rate in the urine from the samples of day i, 8 and 14
was used to calculate carbon dioxide production. Carbon dioxide production was
converted to ADMR with a respiratory exchange ratio (RER) equal to the food
quotient that was derived from a one-week food diary calculated by a dietician.
The total observed variance in ADMR, plotted as a function of BMR, is subdivided
into two components - that which is attributable to the regression with BMR and
that which is not attributable to this regression, the residual of the regression.
The residual of each subject represents the variance in physical activity related
energy expenditure, and can be used as a relative measure of physical activity.
Activity related energy expenditure was therefore defined as the residual from
the regression of ADMR as a function of BMR (rADMR) (Figure 4.1). This measure
was chosen instead of the physical activity index (ADMR/BMR), because of the
non-zero intercept in the regression of AMDR with BMR. The use of ADMR/BMR
ffg.4.7
Arti'w'ty re/ated energy expenditure,) /Average dai/y metobo/ic rote (ADMtf, /n A/l//doy) OJ 0
/unction o/basa/ metabo/i'c rote (B/V1ff, in /Vl//tfayJ p/otted/or the Prader-Wi7// group ^PIVS,
/?//ed c/rc/es,) and obese contro/ group (open squares/ The dotted //nes represent examp/es 0 /
the res/duo/ o/the regression /or o speo//c sub/ert, which /'s a re/atiVe measure 0/activity
re/ated energy expenditure.
•3 "
12.5 -
1O -
7-5 -
5 -
2-5 -
•
• jr •
3 4 5 6 7 8 9
BMR (MJ/day)
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may lead to a misinterpretation of the physical activity level in the younger sub-
jects with lower values of BMR (21,22).
Body composition by deuterium dilution
Fat-free mass (FFM) was assessed with the assumption of FFM containing all body
water (TBW).TBW was calculated from isotope abundance in the urine, as the *H
dilution space divided by 1.04 correcting for exchange of the *H label with non-
aqueous H of body solids (23). Hyd ration factors of FFM were based on gender and
maturation specific values (24). Maturation was assessed according to Tanner's
puberty ratings (25). Using a two-compartment model, fat mass (FM) was calcu-
lated by subtracting FFM of the subject's total body weight, and also expressed as
percentage of total body weight (%FM).7b allow for comparisons between sub-
jects, FM and FFM were expressed as an index: FFMI (kg/m*) and FMI (kg/m*),
respectively. Patients with PWS experience specific periods of growth stunting. In
this way we have corrected for the large variation in height, analogous with BMI,
where BMI = FFMI + FMI (26).
Extracellular water
Total body water can be divided into intracellular water (ICW) and extracellular
water (ECW).The ECW compartment was determined by bromide dilution. The
bromide concentration in serum ultraflltrate was determined from a blood sam-
ple, collected 10 hours after ingestion of bromide. Corrected bromide space was
calculated according to the method of Miller et al. (27). ICW is calculated by sub-
tracting ECW from TBW.
Bone mineral content, bone mineral density and percentage fat mass by DXA
On the same day, total bone mineral content and total bone mineral density were
measured by DXA, using a paediatric scan mode. Bone mineral content (BMC) was
measured as total mass, as well as calculated as a percentage of FFM, as deter-
mined by DXA. Bone mineral density (BMD) as well as BMC were separately calcu-
lated for the limbs (BMD,;n,bs. EMC,;,^). All DXA measurements were calculated
by Lunar software (version i.5g). Furthermore, the percentage fat mass (%FM<j,<a)
was calculated as an alternative measurement to be compared with %FM, provid-
ed by the deuterium dilution method.
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Measurement of serum ICF-I
The serum IGF-I concentration was measured using a commercially available
assay (RIA: Nichols Institute Diagnostics, San Juan Capistrano, CA, USA). IGF-I was
only determined in the PWS group. The measurement was performed in serum
taken from the same fasted venous blood sample as for the bromide dilution pro-
tocol.
Statistical analysis
Differences between the independent variables of the PWS group and the obese
control group were analyzed by the two-sample r-test.
A multiple-linear-regression model with ECW/ICW as the dependent variable, and
bone age, FMI, gender, PWS status and rADMR as independent variables, was used
to analyze the difference in ECW/ICW between both groups, adjusted for the inde-
pendent variables.
Specifically for the PWS group, the partial correlation coefficients of IGF-I and
ECW/ICW, and of IGF-I and ICW, adjusted for bone age and FMI were calculated.
Additionally, the correlation coefficients of IGF-I and FM, and of IGF-I and FFM,
adjusted for bone age were assessed. Finally, the partial correlation coefficients of
IGF-I and measures of bone mineralization, adjusted for bone age and body
weight were calculated.
The significance level was chosen at 5%. Data were expressed as mean ± s.d. SPSS
release 6.1 for Macintosh (SPSS Inc. Chicago, Illinois, USA) was used as the statisti-
cal package.
Results
Age, height, weight and BMI of the subjects of the PWS and obese control group
were not statistical significantly different, as shown in Table 4.1. Sexual matura-
tion in both groups, ranged from pre- to post-pubescent.
FFM as well as FFMI were lower in the PWS group. On the contrary, FM, %FM and
FMI values were not significantly different. TBW, measured by deuterium dilution
technique, was significantly lower in the PWS group. ECW and ICW were lower,
however, ECW/ICW was higher in the PWS group. Because of difficulties obtaining
blood samples, ECW values were not obtained in one subject of the PWS group
and one subject of the control group (Table 4.2). %FM<),<a was comparable with
%FM, measured by deuterium dilution. BMC, expressed as a percentage of FFM,
was higher in the PWS group, however, the other measurements of bone mineral-
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ization, although not significant, tended to be lower in the PWS group, especially
for the limbs (Tables).
7db/e 4.2
Body compos/tibn reso/ts by bromide- and deuter/um d//i/t/on o/sub/'erts tvitri Proder-lV/7/i
syndrome fPWVSJ ond obese contro/ sub/erts'.
PWS Controls
n (F/M) 17 (10/7) 17 (10/7)
FFM (kg)
FM (kg)
%FM (%)
FFMI (kg/m*)
FMI (kg/m*)
TBW (L)
ECW (L) •
ICW (L) •
ECW/ICW •
' mean + s.d; FFM. fat-free mass; FM. fat mass; % FM. percentage fat mass; FFMI. fat-free mass index; FMI, fat
mass index; TBW, total body water; ECW, extracellular body water; ICW, intracellular water
« 2 x n = 16
" , " Significantly different from control group (Independent-samples t-test):' p < 0.05," p < 0.01
Tob/e 4.5
Body composrt/on resu/ts by duo/ x-ray obsorpt/ometry o/sub/erts vv/tri Prader-W/7// syndrome
fPlVS^ ond obese contro/ sub/erts''.
275
22.4
43-7
12.9
10.6
20.5
9.6
11.2
0.87
±
±
±
±
±
1+
±
±
±
9 9 '
11.7
79
2 - 3 "
4-5
7 - 1 '
3-3*
4.0 *
0.07 **
359
25.6
39-1
15-4
10.6
26.7
12.3
15-5
0.80
±
±
+1
±
±
±
±
±
±
134
12.7
8.8
2.7
4.0
9.8
4-1
4 9
0.06
PWS Controls
n (F/M)
TBMC (g)
bs(g)
*-• (%)
TBMD (g/cm*)
17 (10/7)
1564
315
6.0
5-3
1.005
0.832
44-9
+
±
±
±
±
±
±
590
143
0.7'
0 9
0.126
0.157
8.9
17
1897
439
5-2
5-2
1.036
0.888
40.2
(10/7)
+
±
±
±
±
±
±
803
216
1.1
1.2
0.152
0.181
12.1
mean ± s.d.; TBMC, total bone mineral content; BMC|;m(,s' b°"e mineral content of the limbs;TBMC%pFW'
total bone mineral content as a percentage of fat-free mass: B M C ^ F M |, bone mineral content of the limbs
as a percentage of fat-free mass of the limbs; TBMD, total bone mineral density; BMDijmbv bone mineral
density of the limbs; %FM(j^j, percentage fat mass by dual energy absorptiometry
Significantly different from control group (Independent-samples t-test):' p < 0.05
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The mean IGF-I level for the PWS group was 151.8 (± 94.7) Ng/ml, which is within
the low-normal range. IGF-I, adjusted for bone age, showed a positive correlation
with FFM (p < 0.05), however, the correlation with FM was not significant. There
was no significant correlation between IGF-I and ECW/ICW, when corrected for
bone age and FMI, whereas for ICW, the partial correlation coefficient of IGF-I was
significant (p < 0.01). IGF-I, adjusted for bone age and body weight, was positively
correlated with EMD,^^ (Table 4.4).
There was no effect of physical activity on BMDnmbs (Figure 4.2). FMI plotted as a
function of rADMR resulted in a negative relation, but only for the PWS patients
(p < 0.05), not for the controls (Figure 4.3).
The increased ECW/ICW in the PWS group was confirmed by multiple regression,
correcting for bone age, FMI, gender and activity. Using this model, other signifi-
cant determinants in explaining the variance in ECW/ICW, besides PWS status,
were bone age and FMI (Table 4.5).
TaWe 4.4
Port/a/ corre/af/'on coe#7c/errts o//Cf-/ ftj and body compos/Y/'on parameters /n paf/enfs w/fh
Prader-VW///' syndrome
Variable' r» Variable r*
FM -0.31 FFM 0.6*
Variable M Variable M
ECW/ICW 0.06 ICW 0.77"
Variable r* Variable r<>
- 0.28 TBMD 0.37
-0.25 BMD|in,bi 063 *
' FM, fat mass; FFM, fat-free mass; ECW/ICW, ratio of extracellular-to-intracellular body water; ICW, intracel-
lular water; T B M C ^ F F M ' " ' ^ ' bone mineral content expressed as a percentage of fat-free mass; BMC^ffm^,
bone mineral content of the limbs expressed as a percentage of fat free mass of the limbs; TBMD, total
bone mineral density (g/cm*); BMD|;^^, bone mineral density of the limbs (g/cnv)
' Partial correlation coefficient of IGF-I, adjusted for bone age
1 Partial correlation coefficient of IGF-I, adjusted for bone age and fat mass index
* Partial correlation coefficient of IGF-I, adjusted for bone age and body weight
p < 0.05," p < 0.01
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Sone minero/ density o/the /imbs (BA/ID,,^^ /n g/cm^ os o/unrt ion o/oct/V/ty re/ated energy
expenditure (r/4D/Wff, in /VL//day,) p/otted/or trie Prader-W/7/i group (PWS,/?//ed circ/es,) ond
obese contro/ group (contro/s, open squares/ Trie regression /ines were not significant. The
straight ond dotted /ine represent the mean S/viD,,,^ o/PWS ond contro/s, respect/Very.
E
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i
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rADMR (MJ/day)
Tobie 4.5
Sesu/ts o/mu/t/p/e-/ineor-regression ono/ysis o/ the ;/i/fucnce o/bone age,/at mass index
(FA/I/J, gender, act/Vity frAOM^I, and Prader-lVi//i syndrome (PIVS I^, on the ratio o/extrace//u/or-
to-intrace//u/ar water ^fClV//CW;.
Variable P Coefficient' SE
Bone age (y)
FMI (kg/m^)
Cender3
rADMR
PWS4
- O.O1O
0.006
0.015
- 0.013
0.054
0.004
0.003
0.023
0.013
0.024
- 0.018 -
0.001 -
- 0.032 -
-0.039 -
0.004 -
- 0.001
0.012
0.062
0.013
0.104
0.026
0.046
0.520
0.318
0.034
The partial regression coefficient which is the change in ECW/ICW for a change in a specific variable
adjusted for the other independent variables in the equation
The range of values that includes the population value of the coefficient
Gender was defined as: Female = I, Male = o
Grouping variable PWS was defined as: PWS = I. Obese controls = o.
88
Fat moss /nrfex (FA/I/, in Urg/m*,) os a/unction o f artiVrty re/oted energy expenditure
in Ai//rfqy^ p/otted/or trie Prflrfcr-WiV/i group (PW5,/?//ed c/rc/es,) and obese confro/ group
(open squares/ The regress/on /ine o/ the contro/s was not s/gn//icont. The dotted /ine rep-
resents the mean F/W/ o/the contro/group. The regress/on equation/or FW5: FM/ = -3.30
= 0.36; p < 0.05I
-1
rADMR (AAJ/day)
Discussion
In the present study, fat mass, body water compartments and bone mineralization
in patients with PWS were compared with nonsyndromal obese controls, and
related to GH function and PA. Previous reports showed a combination of
increased FM and reduced FFM in patients with PWS (28,29).The present results
demonstrate that the adiposity in PWS is more characterized by an underdevelop-
ment of FFM, than of excessive growth of FM. Although weight and BMI tended
to be lower in the PWS group, the differences were not significant.The FFM, how-
ever, was significantly lower in the PWS group, both in absolute value as well as
corrected for height (FFMI), whereas the absolute and relative measures of fat
mass (FM, FMI and %FM) were similar. The use of indices for FFM and FM, which
correct for height, offer a comparison in body composition based mainly on body
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weight, analogous with BMl.The lower BMI in the PWS group is therefore
explained by a reduction in FFMI, resulting in a similar level of adiposity in both
groups. BMI underestimates the adiposity in PWS and is not the appropriate
measure for comparison with nonsyndromal individuals.
The underdevelopment of FFM as the basis for adiposity in PWS is probably
caused by a functional GHD, as supported by the positive relationship between
IGF-I and FFM, adjusted for bone age, in combination with an absent correlation
between IGF-I and FM.
Although the effect of physical activity on FFM is well-established, the relation-
ship between activity and FM in healthy children and adults is still in debate (22,
30,31). Some studies have shown a positive relationship between activity related
energy expenditure and adiposity, mainly because of the increasing energy costs
for weight bearing activities (32). Others reported no effect of adiposity on activi-
ty, when corrected for body weight or BMR (33). In the present study, the control
group showed no effect of activity related energy expenditure, corrected for BMR,
on adiposity, whereas in PWS patients adiposity was inversely related with activi-
ty. Since the data in the present study were obtained in a cross-sectional manner,
it remains unclear whether in PWS patients a reduced activity causes an increase
in body fat, or whether the higher level of body fatness restricts them from being
physically active.
It has been speculated that besides GHD and physical inactivity, puberty delay
could also be responsible for the reduction in FFM (9). In the present study the
subjects were matched for bone age and gender, resulting in a closely resembling
puberty development, ranging from pre- to post-pubescent, as was confirmed by
the sexual maturation stages of Tanner (25). In spite of the similarity in puberty
development and sexual maturation, the reduction of FFM is still present, which
does not support puberty delay as a explanatory factor for this reduction.
The reduced lean body mass in PWS resembles that of individuals with growth
hormone deficiency (GHD) (34,35). It has been shown in adults that GHD was
associated with shrinking of the ICW compartment, possibly as a result of protein
catabolism (n, 36).The higher ECW/ICW in the PWS group seems to support the
hypothesis of functional GHD. In the obese state, however, the ECW compartment
(plasma water, interstitial water including lymph and connective tissue water,
including bone and cartilage) increases with the level of adiposity (37,38). In fact,
the strong relation of ECW with FM, is thought to be one of the reasons why a
high ECW/ICW is associated with cardiovascular diseases, such as hypertension
(39). Multiple linear regression is therefore needed to correct for the effect of adi-
posity on ECW/ICW. Furthermore, it is known that ECW/ICW shows a gender spe-
cific decrease during maturation (40).The present results show, that, even when
corrected for adiposity, as well as for gender differences and physiological matura-
tion, ECW/ICW was higher in the PWS group compared with nonsyndromal obese
controls.There was no significant relationship between ECW/ICW and GH func-
tion when corrected for maturation and adiposity, however, ICW showed a posi-
tive correlation with IGF-I, using the same correction. It is therefore likely that the
higher ECW/ICW is caused by two separate effects: firstly, an increase in ECW as a
result of adiposity, and secondly, a decrease in ICW as a results of diminished GH
function.
Although the fasting level of IGF-I cannot be used as the'gold standard'for GH
function, IGF-I is known to be principally regulated by GH (41) and proposed to be
used as marker for GH status in disturbed GH secretion (42,43). In healthy chil-
dren, IGF-I changes with age, puberty development and outdoor temperature,
when short-term variations are mainly influenced by weight changes and illness
(44). All of these factors were controlled for in the present study. Arguably,
although IGF-I levels in PWS patients have been reported to range from normal to
subnormal in PWS (35,45,46), as was confirmed in the present study, it may still
be possible that the growth hormone function is diminished because of a loss of
sensitivity for growth hormone metabolites.
It has been reported that patients with PWS, often already at adolescence, frac-
ture easily following minor trauma (47). A functional GHD in PWS could be
responsible for the specific reduction of bone mass in the limbs. The positive asso-
ciation between IGF-I and BMDnmbs. adjusted for bone age and body weight, sup-
ports this relationship. Moreover, the present data show an increased BMC in rela-
tion to FFM in the PWS group, in combination with a tendency towards lower
absolute measure of BMC, especially in the limbs (p = 0.051). This would suggest
that, on the level of the total body there is a relatively larger deficit of muscle
mass, whereas in the limbs a relatively stronger reduction of bone mass is pres-
ent. Brambilla et al. (9), who measured bone mineralization in children as well as
in adults with PWS, found a significant difference in BMC of the total body as well
as in the limbs, but only in the older PWS group, whereas the BMC in relation to
FFM was normal. Presumably, the abnormalities of the somatotrophicand hypo-
thalamic-pituitary-gonadal axis in PWS will have a stronger effect on bone
metabolism after growth, leading to an increased risk for osteoporosis starting
from adolescence.
Assuming that the specific reduction of bone mass in the limbs of patients with
PWS is mainly the result of altered hormonal function, activity is not likely to have
a strong effect on bone mineralization, as confirmed by Figure 2. Bone mass is
known to be positively affected by physical activity (48) and, acquired during ado-
lescence, it is an important determinant for the risk of osteoporosis later in life
(49). The effect of growth on bone mineralization in this group of young subjects,
however, most likely outweighs the effect of physical activity.
From a clinical point of view, assuming causal relationships, increased levels of
IGF-I as well as PA would have beneficial effects on adiposity and ECW/ICW, each
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via a different mode of action, and would therefore provide an interesting combi-
nation for therapeutic purposes. IGF-I would lead to an increase in FFM, whereas
PA decreases FM, in both cases decreasing the level of adiposity. Consequently, the
decrease in FM would lead to a decrease in ECW/ICW.This reduction in ECW/ICW
would also be achieved when ICW is increased as a result of increased levels of
IGF-I. Furthermore, IGF-I may have an additional positive effect on BMD|jn,bs-
In conclusion, adiposity in children and adolescents with Prader-Willi syndrome
(PWS) is mainly the result of a reduced fat-free mass, which is related to growth
hormone function. Furthermore, adiposity is negatively related to physical activity
in these patients. Children and adolescents with PWS have an increased extracel-
lular-to-intracellular water ratio, even when adjusted for adiposity, gender and
biological maturation. Finally, growth hormone function is positively related to
bone mineral density in the limbs, which already tends to be reduced in these
young patients.
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Abstract
Objective: To examine the relation between average daily metabolic rate (ADMR),
basal metabolic rate (BMR), body composition and gender in adolescence, and to
test current BMR prediction equations.
Study design: Twenty-four obese adolescents from The Netherlands (NL-O) were
pooled with nonobese subjects from Northern Ireland (UK-N) and obese and
nonobese subjects from the United States (US-0 and US-N, respectively) (n = 90).
Multiple regression models were used to calculate differences in BMR and ADMR.
Results: Fat-free mass (FFM), BMR and ADMR were higher in the obese compared
with the nonobese group (53.2 ± 10.7 kg, 8.35 ± 1.57 MJ/day, 13.64 ± 2.78 MJ/day,
compared with 41.0 ± 8.1 kg, 6.42 ± 0.94 MJ/day, 11.16 ± 2.21 MJ/day). BMR was also
higher in the obese group when adjusted for FFM, age and gender, which were
significant determinants in the analysis. WHO equations overestimated BMR in
obese boys, and underestimated BMR in nonobese boys. The physical activity level
(= ADMR/BMR) was lower in the obese group (1.64 ± 0.19 compared with 1.73 ±
0.21), however ADMR adjusted for BMR was equal in both groups.
Conclusion: BMR, but not ADMR, is increased in obese and in male adolescents.
Adult WHO BMR equations are recommended for obese adolescents.
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Introduction
The prevalence of overweight and obesity in children and adolescents is rapidly
increasing in Western societies (i, 2,3,4). Obesity during adolescence is associated
with elevated blood pressure and lipid profiles that increase the risk of obesity-
related disease and mortality (5,6,7,8). Awareness is growing, that the long-term
cardiovascular health of the next generation of adults is an issue of concern (9,10,
11). Moreover, the obese adolescent has the highest risk of becoming an obese
adult (12), regardless of parental obesity (13). Since adult obesity remains difficult
to treat (14), this age group is of increasing interest as a target for obesity treat-
ment (15). Knowledge of energy metabolism in adolescents is therefore of vital
importance for future obesity interventions.
Obesity is a condition of excess adipose tissue. The excess weight that results
from this condition does not only consist of fat mass (FM), but also of fat-free
mass (FFM). Generally, energy expenditure is increased, not only because the
increased FFM results in a raise in basal metabolic rate (BMR), but also because of
higher energy costs for weight bearing activities (16). During adolescence, howev-
er, growth spurts and biological maturation may have additional effects on body
composition and energy expenditure (17,18). As a result of these potential con-
founding factors, several studies measuring basal metabolism in obese adoles-
cents (19,20,21,22,23,24,25), have tested the validity of existing BMR prediction
equations (26), often leading to new equations (25, 26). Only one study has
addressed the effect of obesity on BMR as well as total energy expenditure, or
average daily metabolic rate (ADMR) in this age group (27).
The aim of the study was to examine the relationship between ADMR, BMR and
body composition in obese and nonobese male and female adolescents. Because
of economic restraints, our objectives were achieved by using results from our
own study center, pooled with data published in literature. The specific objectives
were: 1) to examine the nature of the relationship between ADMR, BMR and FFM
in adolescents; 2) to determine the effects of obesity and gender on ADMR and
BMR in this age group; and 3) to assess whether existing FAO/WHO/UNU equa-
tions can be used to predict BMR in lean as well as obese adolescents.
Methods
A 'Medline' and cross-reference search was performed for existing data sets on
ADMR and BMR in adolescents. Inclusion criteria were: 1) individually reported
measures of FFM, BMR and ADMR from peer-reviewed journal articles; 2) subjects
between 12 and 18 years of age and with no disease states other than obesity; 3)
total body water (TBW) and ADMR had to be measured by labelled water (free liv-
- I
ing) and BMR by ventilated hood. FFM had to be calculated byTBW.
The results were extracted from each report and entered into a database. For each
individual, information about gender, body weight, height, FFM, FM, BMR and
ADMR was extracted into the database. Subject characteristics are shown in
Table 5.1.
Subjects and protocol of study center Maastricht
Twenty-four obese subjects (age 12.0 -17.4y) with body mass index (BMI) and tr i -
ceps skinfold thickness greater than or equal to the 97^ Percentile for age- and
gender (28), were recruited from the regional public health department and pae-
diatric outpatient clinic of the university hospital Maastricht. Subjects with
endocrine causes or other secondary causes of obesity were excluded. Before the
start of the study the parents gave written informed consent confirmed by an
oral approval of the child. The study was approved by the medical ethical commit-
tee of Maastricht University.
Height, weight and BMR measurements have been described in detail previously
(29), and TBW and ADMR were measured according to the Maastricht protocol for
the measurement of body composition and energy expenditure with labelled
water (30).
BMR prediction equations
BMR was calculated according to the prediction equations of the Food and
Agriculture Organization of the United States, World Health Organization, and
United Nations University (FAO/WHO/UNU) (18) on the basis of weight (WHOi),
and weight in combination with height (WHO2) for age 10 -18 years, as well as 18
- 30 years (WHOi.a and WH02.a, respectively):
0.0732 * Weight + 2.72 (MJ/day)
0.0510 * Weight + 3.12 (MJ/day)
69.4 * Weight + 322.2 * Height + 2392 (kJ/day)
30.9 * Weight + 2016.6 * Height + 907 (kJ/day)
0.0640 * Weight + 2.84 (MJ/day)
0.0615 * Weight + 2.08 (MJ/day)
64.4 * Weight -113.0 * Height + 3000 (kJ/day)
55.6 * Weight +1397.4 * Height +146 (kJ/day)
WHOi:lO-
WH02:
WHOi.a: 18
WH02.a:
18 y
-3oy
Males
Females
Males
Females
Males
Females
Males
Females
Sufr/ffcf c/wracter/sf/a <^otese and nonofese otfo/escenfe'.
Variable
n (F/M)
NL-O
24 (11/13)
US-0
27 (12/15)
Obese
51(23/28)
UK-N
16(8/8)
US-N
23 (10/13)
Nonobese
39 O8/21)
Age (y)
Height (cm)
Weight (kg)
BMI (kg/m*)
13-9
163.4
85.0
317
±
±
±
±
i -3*
6.4
1 6 . 2 "
49 *
15.0
166.8
101.4
36.3
+
±
±
±
i-9
79
23.2
77
14-5
165.2
937
34-1
±
±
+
±
17
7-4
21.7 •»*
6.9 »»*
13-5
158.6
477
19.0
±
±
+
±
1.6
10.9
8.3*
29
14-3
164.2
55 3
20.5
±
±
±
1-3
8.6
9-5
2.8
14.0
161.9
52.2
19.9
±
±
±
±
i-5
9-9
97
2.9
1 mean ± s.d.
NL-O, obese group of the Maastricht area; US-O, obese group of the Boston area; UK-N, nonobese group of the Belfast area; US-N, nonobese group of the Boston area
* , " Significantly different from US-O:" p < 0.05," p < 0.01
• • • Significantly different from nonobese: p < 0.001
* Significantly different form US-N: p < 0.05
s *
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Statistical analysis
Firstly, all study samples were divided into the obese or nonobese group. Obesity
was defined as BMI above the 95^ Percentile for age and gender according to the
current recommendations (31). Differences in independent variables between the
obese and nonobese groups and between the countries, as well as gender differ-
ences within the pooled groups, were analyzed by the two-sample t-test.
Differences in the mean of the measured and predicted BMR in males and
females were determined with a paired t-test, as a measure of accuracy. The mean
absolute error (MAE) for each subgroup was calculated to measure the precision
of the BMR prediction.
Secondly, a multiple-linear-regression model with BMR as the dependent variable,
and FFM, age, and gender as independent variables, was used to analyze the dif-
ference in BMR between the obese and nonobese adolescents, defined by the
binary variable group. The regression coefficient indicates the difference in BMR
between the groups, adjusted for the independent variables. The difference in
regression slope, of the influence of FFM on BMR, was tested using an interaction
variable of group and FFM, and group and gender after correction for the variables
in the equation. Consequently, the difference between groups, corrected for these
independent variables, was estimated and tested for significance using linear
regression assuming equal slopes.The same procedure was done with ADMR as
the dependent variable, again with FFM, age and gender as independent vari-
ables, and obesity as the grouping variable. This analysis was repeated with BMR
instead of FFM as covariate.
Finally, to detect differences between centers these procedures were repeated
within the obese as well as the nonobese group, with the study center as the
grouping variable.
The significance level was chosen at 5%. Data were expressed as mean ± s.d. SPSS
release 6.1 for Macintosh (SPSS Inc. Chicago, Illinois, USA) was used as the statisti-
cal package.
Results
Of the five BMR and ADMR studies in adolescents (27,32,33,34,35) that were
found in literature, two reports met the inclusion criteria: Bandini et al. (27) who
measured obese (US-O) as well as nonobese adolescents (US-N) in the Boston
region (MA, US) and Livingstone et al. (33) who measured children and adoles-
cents of age 7,9,12 and 15 years in the Belfast area (Northern Ireland, UK). For the
present analysis only the adolescent groups (12 and 15 years) of Livingstone's
report were included (UK-N). Furthermore, FFM was indirectly calculated via
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weight and FM, the latter based on skinfold measurements.The results, however,
were similar when FFM was measured by dilution technique (33). In the study by
Bandini et al. (27), as well as in our own center, FFM was calculated by dividing
TBW by 0.73. Thus, two groups of US and Dutch obese (US-Oand NL-O)and US
and UK nonobese adolescents (US-N and UK-N) were formed, resulting in a total
group of 90 subjects.There were no statistically significant differences between
the groups for gender and height, while in the obese as well as the nonobese
group, the US subjects were heavier than their European counterparts.
Furthermore, the US-0 group had a higher age than the NL-0 group (Table 5.1).
FFM, FM, percentage fat mass (%FM), BMR, ADMR and physical activity level (PAL
(=ADMR/BMR)) were all higher in the obese adolescents. Within the obese group
FFM and FM were higher in the US-0 subjects compared with the NL-0 group,
while %FM was similar. Additionally, BMR, ADMR and PAL were higher in US-O.
Within the nonobese group, there was a higher FFM, BMR and ADMR in the US-N
group compared with UK adolescents (Table 5.2).
Between males and females, there were no differences in age, height, weight or
BMI within both groups (not shown). In addition, FFM was similar, while %FM was
lower in the males compared with the females, but only in the nonobese group
(17.1 ± 5.4 compared with 25.9 ± 7.0 %(p < 0.0001)). Furthermore, BMR was higher
in males compared with females, for the obese as well as the nonobese group
(8.90 ± 1.58 compared with 7.69 ± 1.31 MJ/day (p < 0.01), and 6.95 ± 0.84 compared
with 5.81 ± 0.64 MJ/day (p < o.ooi), respectively). A significant difference between
males and females was also found in ADMR for both the obese and the nonobese
group (14.45 ± 269 compared with 12.67 ± 263 MJ/day (p < 0.05), and 12.17 ± 2.02
compared with 9.98 ± 1.83 MJ/day (p < o.oi, respectively).There were no gender
differences in PAL.
The BMR of the obese subjects, plotted as a function of FFM, results in a regres-
sion line which is shown superimposed on the regression line of the nonobese
group (Figure 5.1). BMR adjusted for FFM resulted in a higher BMR for the obese
group compared with the nonobese group, even when adjusted for age and gen-
der (Table 5.3). For the complete study sample FFM accounted for 80 % of the
observed variance. BMR adjusted for FFM was not different between US-N and
UK-N, nor between US-0 and NL-0 (not shown). Other significant determinants in
the prediction of BMR were age and gender.
WHOi as well as WHO2 overestimated the measured BMR in the obese males
(MAE = 723 and 562 kJ, respectively), however, underestimated BMR in the
nonobese males (MAE = 405 and 412 kJ, respectively), as was demonstrated by the
differences in the means, which are shown in Table 5.4. Conversely, WHO2 under-
estimated BMR in obese females (MAE = 591 kJ), while the BMR of obese as well as
nonobese females was adequately predicted by WHOi (MAE = 189 and 19 kJ,
respectively). WHOi.a and WH02.a underestimated BMR in the nonobese males
FaWe 5.2
f nergy expendtfi/n; one/ tooy com/»osStion o/obese and nonobese adolescents'.
Variable NL-0 US-0 Obese UK-N US-N Nonobese
FFM (kg)
FM (kg)
%FM (%)
BMR (MJ/day)
ADMR (MJ/day)
PAL
49.0
359
42.0
781
12.14
1.56
+
±
±
±
±
±
8.5"
9.6*
49
1.32-
2 . 1 9 * "
0.18 **
56.8
44.6
43i
8.83
14.98
1.71
±
±
±
±
±
*
11.4
15.1
6.8
1.65
2.58
0.18
53-2
40.5
42.6
8-35
13.64
1.64
±
±
±
±
±
±
10.7 • • •
13.4 • • •
6.0 • • •
1.57 " •
2.78 • • •
0.19*
36.6
11.0
22.8
6.02
10.28
1.72
±
±
±
±
±
±
6.4 H
54
79
0.86*
1.38*
0.18
44.1
11.2
20.0
6.71
11.77
175
±
±
±
±
±
±
7-8
5-0
7-2
0.91
2.49
0.24
41.0
11.1
21.2
6.42
11.16
1-73
±
±
±
±
±
±
8.1
5.1
7-6
0.94
2.21
0.21
1 meants.d.
NL-O, obese group of the Maastricht area; US-O, obese group of the Boston area; UK-N, nonobese group of the Belfast area; US-N, nonobese group of the Boston
area
*, " , * " Significantly different from US-O: * p < 0.05," p < 0.01, * " p < 0.001
# »#« Significantly different from nonobese: * p < 0.05, • • • p < 0.001
V " Significantly different form US-N:' p < 0.05, ** p<o.oi
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and females (MAE = 773 and 778 kJ, and 517 and 136 kJ, respectively), however, the
measured BMR in obese males as well as females was best predicted by WHOi.a
(MAE = 33 and 119 kJ, respectively). Therefore, WHO2 had the least MAE for the
nonobese males and females, while WHOi.a had the least MAE in the obese males
and females. In Figure 5.2 BMR is a function of the BMR prediction of the WHO2
for the nonobese and WHOi.a for the obese adolescents, as these prediction equa-
tions had the smallest MAE in each group.
ADMR plotted as a function of FFM resulted in two similar regression lines for the
obese and the nonobese group (not shown).This function was similar between
the study centers within both groups (not shown), and when adjusted for age and
gender, while only gender was a significant determinant in the analysis (Table 5.5).
FFM accounted for 66 % of the observed variance, which could be increased by
including age and gender in the equation, adding 5 % to the explained variance.
fig.5.7
Saso/ metabo//c rote (B/Wff, /n M//dayJ os a/unrt/on o//at-/ree moss (FF/M, ;n /eg,) p/otted/or
the obese (/7//ed symbo/s^ and nonobese group (open symbo/s^; Fema/es are represented by tr/-
ang/es, ma/es by c/'re/es. The regress/on //ne/or the obese.-
B/Wff = 0.J2 /77W + 7.99 (fl* = 0.67^,/or nonobese 8/Wff = o.og FF/W + 3.05 (dotted //ne, ff* =
0.50/ The regress/on //ne o/the obese group w s/gn/ficant/y d/j^erent/rom the regress/on //ne
o/the nonobese group fA4u/t/p/e-//near-regress/on ana/ys/s.p < 0.05/
2O 30 40 50 6O 7O 8O 9O
FFM (kg)
104
7ab/e 5.3
l?esu/ts o/mu/t/p/e-//near-regress/on ono/ys/s o/ the /n/7uence o//ot-/ree moss
gender ond obes/ty, on boso/ metobo//c rote (B/W^.
oge.
Variable P Coefficient' SE 95%
FFM (kg)
Age (y)
Gender3
Croup*
0.122
-0.238
- 0.627
0.564
0.009
0.053
0.149
0.171
0.105 -
-0.344 -
-0 .923 -
0.224 -
0.140
-0.132
- 0.332
0.904
0.000
0.000
0.000
0.001
' The partial regression coefficient which is the change in BMR for a change in a specific variable adjusted
for the other independent variables in the equation
* The range of values that includes the population value of the coefficient, with 95% probability
3 Gender was defined: Female = 1, Male = o
4 Croup was defined: Obese = 1, Nonobese = o
Measured Boso/ metabo//c rote (measured BMfl, /n /Vl//doy^ os a/unct/on o/pred/cted BMff by
FAO/tVHO/UNU equaf/ons (/n MJ/day). The obese group (////ed symbo/s,) ;s pred/cted by adu/t
BA4^ equat/ons bosed on we/ght, ond tne nonobese group (open symbo/sj /s pred/cted by ado-
/escent equat/ons based on height and we/ght. femo/es ore represented by tr/ong/es, mo/es by
c/rc/es. The dotted //ne represent the //ne o//dent/ty.
CQ
3
re
predicted BMR (MJ/day)
7<7 We 5.4
WO/IVHO/UA/U' pred/rt/on eiyi/of/ons/or baso/ metobo//c rote (B/Wffj 0 / mo/w ond/emo7es /n trie obese and nonobese groups-
Group
Obese
Nonobese
Gender
Males
Females
Total
Males
Females
Total
BMR
8.90
7.69
8-35
6.95
5.81
6.42
(MJ/day)
± 1.58
± 1.31
± 1.57
± 0.84
± 0.64
± 0.94
WHOi
9.62
7.88
8.84
6.55
5 79
6.19
(MJ/day)
±
±
±
±
±
±
1 .63 -
1.10
1.65 •»«
0.75 «
0.48
0.74"
WHO2
9.46
7.10
8.40
6.54
5-74
6.17
(MJ/day)
±
±
±
±
±
±
1.56"
0.72 "
1.72
0.74 »
0.38
0.72*
WHOi.a
8.86
7.81
8-39
6.18
529
5-77
(MJ/day)
± 1.42
± 1.32
± 1.46
± 0.66 «*
± 0.58 «
± 0.76 ***
WHO2.
8.87
6.73
7-91
6.18
4-45
5-38
a (MJ/day)
± 1-43
± 1.19 •
± 1.70 «»
± 0.65 »«
± 0.52 s«
± 1 . 0 5 " *
' FAO/WHO/UNU, Food and Agriculture Organization/ World Health Organization/ United Nations University:
WHOi: equations based on weight for age 10 -18 years
WH02: equations based on weight and height for age 10 -18 years
WHOi.a: equations based on weight for age 18 • 30 years
WHO2.3: equations based on weight and height for age 18-30 years
* mean ± s.d
Significantly different from BMR of obese males: p<o.OL p< 0.001
* , " Significantly different from BMR of obese females:' p <o.O5." p< 0.01
* ' , * • • Significantly different from BMR of obese group: • • p < 0.01, • •* p < 0.001
M, W Significantly different from BMR of nonobese males: M p <o.Oi.'" p < 0.001
*', *** Significantly different from BMR of nonobese females:" p < 0.01, **' p < 0.001
*, * * * Significantly different form BMR of nonobese group: * p < 0.05, p < 0.001
5:
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g
Average do/7y metabo//c rate (>4DMff, /n MJ/day) OJ a/unrt/on o/boso/ metabo//'c rate (BM£, /n
M//doy) p/otted/or the obese (/?//ed symbo/sj ond nonobese group (open symbo/s,); femo/es
ore represented by tr/flng/es, mo/es by c/rc/es. The regress/on //ne/ar trie obese: ADMR = j.46
SAi/? + j.44 (i?2 = o.6S^,/or nonobese 4DMR = J.82 SMS - 0.55 (ic/otted //ne, ^ = 0.60).
6 9
BMR (MJ/day)
12
ADMR plotted as a function of BMR also resulted in similar regression lines for the
obese and nonobese group (R* = 0.68 and 0.60, respectively) (Figure 5.3).
Combining both groups, BMR accounted for 71 % of the observed variance, while
age, as the only other significant predictor for ADMR (Table 5.5), increased the
explained variance to 72 %.
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ToWe 5.5
/fesu/ts o/mu/t/p/e-///iear-regress/on ana/ys/s o/the /n/7uence o//ot-/ree moss fffM) or boso/
metot>o//c rate (B/Wff,), od/'usted/or oge, gender, obes/ty, on average da/7y metabo//c rate
Variable
ADMR
ADMR
FFM (kg)
Age (y)
Gender3
Croup4
(i Coefficient'
0.211
-0.241
-1.069
0.044
BMR (MJ/day) 1.445
Age (y)
Gender3
Group4
0.215
- 0.332
- 0.419
SE
0.020
0.121
0339
0.390
0.136
0.102
0.360
0.407
95% Cl
0.170 -
-0.483 -
-1.744 -
- 0.731 -
1.174 -
0.012 -
-1.049 -
-1.230 -
0.252
O.OO1
- 0.395
0.819
1.716
0.418
0.384
0.392
p
0.000
0.050
0.002
0.910
O.OOO
O.O38
0.359
0.307
The partial regression coefficient which is the change in ADMR for a change in a specific variable adjusted
for the other independent variables in the equation
The range of values that includes the population value of the coefficient with 95% probability
Gender was defined: Female = 1, Male = o
Group was defined: Obese = 1, Nonobese = o
Discussion
Due to a scarcity of studies on total energy expenditure in obese as well as
nonobese adolescents, the present study aimed to combine the energy expendi-
ture and body composition data from obese adolescents from the Maastricht
region with individual data from the US (Boston area) (27) and the UK (Belfast
area) (33) to determine the effect of obesity and gender on energy metabolism in
this age group.
BMR, adjusted for FFM, was higher in the obese group. Although gender and age,
as known predictors for BMR, were significant parameters in the regression, a sta-
tistical difference between the obese and nonobese group remained. The differ-
ence in BMR was also consistent throughout the four study centers. These find-
ings therefore confirm the conclusions by earlier reports (19,27,36), although oth-
ers did not find a difference between obese and nonobese adolescents (37). When
FM was included in the analysis, the difference between obese and nonobese sub-
jects was lost. However, this does not imply that in obese adolescents FM is
(more) metabolically active. One explanation is that obesity causes changes in
chemical composition of FFM (38,39). Using theoretical calculations it was shown
that the density of FFM, due to a relative increase in TBW, was decreased in the
obese state leading to an overestimation of FM, when measured by underwater
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weighing (40). In the present study, however,TBW was measured directly by deu-
terium dilution, which cannot explain the increased BMR. Another explanation is
that the increased BMR adjusted for FFM is not based on an underestimation of
FFM, but on an increase in mass of metabolically active organs. Obesity might be
related to a relative increase in internal organ mass compared with muscle mass.
Since the major organs of the body (brain, heart, kidney and liver, including
splanchnic bed) have high basal metabolism levels compared with skeletal muscle
(41), a higher proportion of these organs in FFM would be reflected by an increase
in BMR, even when adjusted for FFM.
In contrast with Katch et al.(ig) but in agreement with Bandini et al. (27), this
study showed a higher BMR in males, independent of body composition. The gen-
der difference was also reflected by similar measures of FFM between the sexes of
both groups, while BMR was higher in obese as well as nonobese males. As with
the condition of obesity, one could speculate that the relative organ mass in
females is smaller than in males or, as was shown in adults, that the Na+ - K+ -
ATPase activity is reduced in females (42), which is also related to a lower BMR
(43). Another explanation comprises the effect of puberty. It is well-known that
girls are starting puberty a few years earlier than boys, at approximately age io
and ending at age 14, compared with age 12.5 to 16 in boys (44). Since in the pres-
ent study, the age ranges of boys and girls were similar (14.1 ± 1.6 compared with
14.5 ± 1.6 y), it is likely that the girls are more advanced in their biological develop-
ment than boys, and a greater proportion of them will be postpubertal, i.e. a
greater proportion of boys were in their high metabolically active phase of puber-
ty than girls, leading to a specific increase in BMR for boys. Moreover, Tanner stage
(45), as a measure of sexual maturation, has shown to be a significant contributor
in the explanation for the differences in BMR between the sexes (26,27). On the
other hand, Katch et al. (19) were not able to find a difference in BMR for puberty
stage in 10-16 year old obese adolescents and the gender difference was also
described in prepubescent children (46). Unfortunately,Tanner stage was not
assessed in the UK-N group and therefore not included as a variable in the analy-
sis. Additional determinants of energy expenditure, other than body composition,
age and sex, are ethnicity, physical fitness and glucose tolerance (47). Apart from 2
boys and 1 girl with an impaired glucose tolerance test in the US-0 group, there
was again no information available regarding these issues. An important assump-
tion to allow pooling of the data is therefore, that these determinants are not dif-
ferent between Ireland and the Netherlands, as these countries are only part of
either the obese or the nonobese group.
Recently, existing equations to estimate BMR in nonobese children aged 10-15
have been thoroughly evaluated (26). The authors concluded that weight was the
single most important factor in the equations for either gender and that the
FAO/WHO/UNU equations performed best in predicting BMR in this specific age
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group. In the present data, however, not all subgroups were well-predicted by
FAO/WHO/UNU equations. WHOi as well as WH02 were good predictors of BMR
in nonobese females, but underestimated the BMR in nonobese males, resulting
in a general underestimation of energy expenditure in the whole nonobese group.
The underestimation of energy requirements was in fact anticipated by the FAO
expert committee, because their database included subjects who may have been
on limited energy intakes before BMR measurement, as well as Indian subjects
who were found to have BMR's approximately 10% below the average (i8).The
heavier nonobese group of the study of Bandini et al. is probably the reason that
they did not find a difference using the WHO standards (27). Yet in the present
obese group, the BMR in males was overestimated by WHOi as well as WHO2,
resulting in a general overestimation of BMR by FAO/WHO/UNU-equations for
obese males. For the total obese group the estimation by WHO2 seemed similar
to the measured BMR, however, this was merely caused by a compensating effect
of underestimated BMR in females. The overestimation of BMR by WHO standards
in 10-16 year old healthy children has been reported before, in obese as well as in
nonobese subjects (24). We do not have an explanation for these conflicting find-
ings, other than that the measurement of BMR is known to be subject of much
error. Concluding from this data, the WHOi.a provides the best BMR prediction for
the obese adolescents, while WHOi adequately predicted BMR in obese as well as
nonobese females, but provided the worst prediction for obese males. Thus, a
combination of the use of WHO2 for nonobese and WHOi.a for obese adolescents
results in the best f i t along the line of identity (Figure 5.4), although the amount
of variation around the same line shows, as already concluded by the FAO expert
committee, that equations cannot substitute for the direct BMR measurements.
The gender effect on ADMR is also based on BMR differences, since gender has
only a negative effect on ADMR, when corrected for age and FFM, however, not
when adjusted for BMR.Therefore, in concordance with data of 4-10 year old chil-
dren (48), the present study showed no effect of gender on activity related energy
expenditure. Conversely, in a meta-analysis of adult data (49), the gender differ-
ence was demonstrated for ADMR, also when adjusted for BMR and independent
from FM.The latter may indicate that the gender effect in activity related energy
expenditure does not surface before adulthood.
Despite the effect of obesity on BMR, ADMR is not directly influenced by an excess
of FM, when adjusted for FFM. This would suggest that the increase in BMR would
be compensated by a decrease in nonbasal energy expenditure, mainly consisting
of activity induced energy expenditure. The ratio of ADMR/BMR (PAL) provides a
measure of activity related energy expenditure, corrected for BMR, assuming that
diet induced energy expenditure is a constant proportion of ADMR (18). In the
present study, the PAL of the male adolescents was within the range of 1.6 -1.75,
as suggested by the FAO/WHO/UNU. The average PAL of female adolescents was
higher than suggested (1.5 -1.65) (18), resulting in an underestimation of the cal-
culated ADMR in this subgroup by the FAO/WHO/UNU, as was reported earlier
(34).
The obese group had a lower PAL, indicating a lower activity level, which would be
in contradiction with the literature that is generally in agreement that obese and
nonobese subjects have similar total energy expenditure levels after normalizing
for differences in body composition (49). Surprisingly, the low PAL of the NL-0
group was the reason for this difference. Since many Dutch adolescents rely on
their bicycles for transportation and spend only about 1.5 hr per day watching tel-
evision (50), a higher PAL might have been anticipated. In fact, in a previous study
in 7-10 year old children of the Maastricht area a mean PAL of 1.83 ± 0.23 was
found (51). Furthermore, the low PAL cannot be explained by an overestimation of
the BMR, because the BMR, adjusted for FFM, was similar between the NL-0 and
US-0 group. In this context, an alternative way of measuring differences in activi-
ty related energy expenditure, is by analysis of covariance based on multiple
regression (52). Using this technique, which is most valuable in adjusting data
with non-zero intercepts, such as the present data (Fig.53),the relationship of
ADMR with BMR in obese and nonobese male and female subjects was compared
using BMR as a covariate. In fact, this analysis showed that the activity related
energy expenditure is indeed similar in both groups. It also demonstrates that, in
this age group, physical activity increases with age. Although the positive effect of
age on ADMR, after adjustment for BMR, was marginal, it might in part explain
the low PAL in the younger NL-0 group and the high PAL that was found in 15-
year-old Swedish adolescents (35). On the other hand it is remarkable that studies
have shown that physical activity decreases both in boys (53) and girls (54) just
before puberty, while this study demonstrates that activity, adjusted for gender
and body composition, further increases during adolescence towards adulthood.
In conclusion, an attempt to combine sparse data on energy metabolism in obese
and nonobese adolescents has been made. The present study combined energy
expenditure and body composition data from different centers, and indicates that,
during adolescence, BMR is increased in the obese state and in males, which is
independent from differences in body composition.The FAO/WHO/UNU equa-
tions underestimate BMR in nonobese, and overestimate BMR in obese male ado-
lescents. For the obese subgroup the adult FAO/WHO/UNU BMR prediction equa-
tions, based on weight, are recommended. ADMR of obese adolescents, adjusted
for body composition or BMR, is comparable with that of their nonobese peers,
indicating that activity related energy expenditure is not different between obese
and nonobese adolescents.
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Abstract
Background: The increasing prevalence and the disappointing results in the treat-
ment of paediatric obesity, urges the need for new treatment strategies.
Objective: To measure the effect of sibutramine on body composition and energy
expenditure in obese adolescents.
Design: A randomized, double-blind, placebo-controlled study of 24 obese adoles-
cents (age 12 -17 years) treated either with sibutramine or placebo in combination
with an energy restricted diet and exercise plan for 12 weeks, followed by a follow-
up period of 12 weeks with the same diet and exercise plan, however, without the
study medication. Basal metabolic rate was measured by ventilated hood and
adjusted for gender, fat mass and fat-free mass (BMRj^). Average daily metabolic
rate (ADMR) was measured by doubly labeled water. The change in BMI was the
principal measure of efficacy.
Results: During intervention, BMRj^ was decreased in the placebo group, and sig-
nificantly different compared with the sibutramine group.The changes in ADMR
were not significant between both groups. Although only the sibutramine group
had a significant amount of weight loss, the change in BMI or FM was not signifi-
cantly higher in the sibutramine group compared with the placebo group (-3.3 ±
1.5 vs -1.3 ± 1.5 kg/m*, respectively). The difference in reported adverse events
between both groups was not significant.
Conclusion: Sibutramine prevents the decrease in BMR associated with energy
restriction and is therefore of potential support in the treatment of obesity in
adolescence.
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Introduction
Obesity in childhood and adolescence is increasing worldwide and now consid-
ered an epidemic in many industrialized countries. Although children and espe-
cially adolescents suffer from the psychosocial consequences, public health pro-
fessionals are above all concerned for the increase in cardiovascular diseases and
diabetes in the coming generation (i, 2,3,4, 5). While obese children below the age
of six have about 25% chance of becoming an obese adult, up to 75% of the obese
adolescents will stay obese when they enter adulthood (6). Moreover, obesity dur-
ing adolescence compared with before adolescence is more predictive of morbidi-
ty and mortality later in life (7). Aiming to prevent adult obesity, and minimizing
the risk of treating children who are in no need of intervention, there is an
increasing emphasis on treatment of obese adolescents. Increasing prevalence of
'unhealthy' dietary practices or even eating disorders, particularly among adoles-
cent girls and young women (8,9), demonstrates the vulnerability of this age peri-
od and forces the physician even more to seek effective medical care for the
appropriate target group.
Recently, an expert committee (10) recommended that adolescents whose BMI is
above the 95^ percentile for age and gender should be considered overweight (11)
and treated. The primary goal of the treatment program should be healthy eating
and increased physical activity, eventually leading to weight loss. The treatment
should focus on family based behavioral changes. Pharmacological therapy of
obesity is only recommended if complications require rapid weight loss and
should only be used in specialized paediatric obesity treatment centers. The effect
of drug treatment on energy metabolism during adolescence, therefore, has never
been studied. In recent years, pharmacological treatment was of low supportive
value. A recently developed anti-obesity agent, sibutramine hydrochloride
(Meridia™, Knoll Pharmaceutical Company, Mount Olive, NJ, USA), has been
shown to be effective in achieving long-term weight loss in adults (12,13,14)- The
metabolites of sibutramine are serotonin and noradrenalin reuptake inhibitors
with no releasing activity (15,16).
In adults, sibutramine is well-tolerated in doses up to 20 mg administered as a
single morning dose (17,18,19), while weight loss was seen up to 24 weeks with a
minimal dose of 5 mg (20). The anti-obesity activity of sibutramine results from
its dual mode of action: it reduces energy intake by increasing satiety (21), and it
increases energy expenditure by stimulating thermogenesis (22). Whether sibu-
tramine has the same weight reducing and thermogenic effects in obese adoles-
cents has not been investigated.
The present study was designed for obese adolescents to evaluate the efficacy
and safety of sibutramine, in combination with an energy restricted diet and exer-
cise program, on body composition and energy expenditure.
- I
Methods
Subjects
Adolescents with primary obesity from the regional public health department and
paediatric outpatient clinic of the university hospital Maastricht participated in
the study. Participants were between 12 and 18 years of age, had a BMI and triceps
skinfold thickness greater than or equal to the 97*" Percentile for age- and gender
(23) and failed to lose or maintain weight after at least one supervised attempt of
weight loss. Patients with endocrine causes or other secondary causes of obesity
were excluded as well as patients with any significant physical or medical illness,
that could influence the results of the study. Subject characteristics are shown in
Table 6.1. Before the start of the study the parents gave written informed consent
confirmed by an oral approval of the child. The study was approved by the medical
ethical committee of Maastricht University.
Tob/e 6.7
Sub/ert chororter/sfrcs'.
Sibutramine Controls
n (F/M)
Age(y)
Bone age (y)
Tanner (0-5)
Height (m)
Weight (kg)
BMI (kg/m*)
FFM (kg)
%FM (%)
BMR (MJ/day)
ADMR (MJ/day)
12
14.1
15-5
3-7
1.63
80.8
30.1
46.6
42.1
774
12.12
(6/6)
±
±
±
±
±
+
+
±
±
±
1.0
0.9
1.2
0.05
15.6
4-5
8.2
5-2
1.23
i-93
12
13.8
15.1
3-6
1.63
89.2
33 3
48.6
455
7.89
12.55
(5/7)
+
+
±
+
±
±
±
+
±
+
1-5
i-3
1.8
0.08
16.4
5-0
9.0
3-9
1-45
2.10
mean ± s.d.; Tanner, sexual development stage according to Tanner (25); FFM, fat-free mass; %FM. percent-
age fat mass; BMR. basal metabolic rate; ADMR, average daily metabolic rate
There were no significant differences between the sibutramine group and placebo group
Methodology and treatment
The trial was a randomized, double-blind, placebo-controlled, parallel-group com-
parison of two treatment regimens and conducted between April and October
1998. The study was divided into two phases. The first phase included a random-
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ized treatment period of 12 weeks, which included of an energy restricted diet, an
exercise plan and either placebo or sibutramine 5 mg, taken once daily in the
morning. After two weeks the dose was increased to 10 mg daily. The second
phase consisted of a follow-up period of 12 weeks with continuation of the diet
and exercise plan. Throughout the study the emphasis was put on lifestyle modi-
fication. The study medication was provided by Knoll Pharma BV (Amsterdam, the
Netherlands).The study complied with Good Clinical Practice guidelines (24).
Study schedule
At screening, a complete medical history and physical examination, including
Tanner staging (25), was performed.
During the double-blind treatment period, subjects visited the center at: o (base-
line), i, 2,3,4,6,8,10 and 12 weeks. At baseline, laboratory assessment, ECG, bone-
age, vital signs, dietary assessment, body composition and total energy expendi-
ture were measured. At each following visit, the subject and parent(s) were invit-
ed by the physician for determination of vital signs and compliance of the treat-
ment and exercise plan.The subject with parent(s) were asked to keep a daily
record of the use of the trial medication and time spent on physical activity. The
compliance was assessed by counting returned capsules and checking the med-
ication and activity record. In addition, the subject with parent(s) was seen by the
study dietician for dietary evaluation, except for the visit on week 3 that only
included an appointment with the physician. At the end of the treatment period
body composition and energy expenditure measurements were repeated. During
the follow-up period the subjects visited the center at weeks: 13,14,16,18,20,22,
24, undergoing the same treatment and measurements as during the treatment
period, however, without sibutramine or placebo. The follow-up period also ended
with body composition and energy expenditure measurements. Unfortunately,
due to a temporary world wide scarcity of doubly labeled water (26), total energy
expenditure could not be measured in the second phase.
Dietary and exercise advice
Dietary advice was based on energy requirements. The energy prescription was
calculated from measured basal metabolic rate multiplied by an estimated physi-
cal activity level minus 500 kcal.The dietary intake could not be lower than 18-20
kcal per kilogram of ideal body weight with a minimum of 25% of calories provid-
ed by fat.The estimated physical activity level was determined using an activity
questionnaire (27).
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Physical activity was prescribed, based on individual preferences as well as infor-
mation obtained by the activity questionnaire. The prescription contained a daily
bout of exercise of at least 30 minutes of moderate to vigorous levels of exer-
tions, however, the participants were encouraged to do more. Furthermore,
emphasis was put on the implementation of additional physical activities, regard-
less of intensity, in the daily routine (28,29).
Measurements
Vital signs
Blood pressure (mm Hg) and heart rate (HR, beats/minute) was measured after
sitting for five minutes, using a regular adult cuff for an arm circumference of 23 -
33 cm or a large adult cuff for an arm circumference of 34 - 41 cm. Systolic blood
pressure (SBP) was determined by the first Korotkoff sound and diastolic blood
pressure (DBP) by the fifth Korotkoff sound.
Bone age assessment
Bone age was determined by assessing epiphysal maturation by the same paedi-
atric endocrinologist using an X-ray of the mid portion of the left hand and stan-
dard growth data (30).
Dietary assessment
A 7 days weighed dietary record form was handed to the parent(s) and subject,
after the dietician gave instructions on how to measure portion size. They were
asked to record brand names, methods of preparation, and ingredients of mixed
dishes. The dietician reviewed the record with the parent(s) and subject and calcu-
lated the energy intake and macronutrients.The outcome of daily energy intake
and macronutrient consumption will be the topic of a separate report. For the
present analysis only the food quotient (FQ) was needed for assessment of the
respiratory exchange ratio (RER) to calculate total energy expenditure (31).
Body composition
In the morning, before the subjects consumed any food or drink, after voiding and
whilst wearing under-clothing, total body weight was measured on an electronic
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scale (E1200, Mettler Instrumente AG, Greifensee, Switserland). Height of subjects
without shoes was measured using a stadiometer. Body composition was
assessed using a four-component (UC) reference model: Total body weight = fat
mass (FM) + total body water (TBW) + total bone mineral content (TBMC) and
remaining fat-free mass (32).
This multicompartment model is based on the classical two compartment model,
determined by densitometry, measured by underwater weighing with simultane-
ous lung volume measurement. Furthermore, the fat-free mass (FFM) compart-
ment is divided into three subcompartments.two of which are separately meas-
ured, namely TBW and TBMC.
TBW was measured with deuterium dilution according to the Maastricht protocol
for the measurement of body composition and energy expenditure with labelled
water (31).TBMC was assessed by dual-X-ray absorptiometry (DXA) (DPX-L, Lunar
Corp., Madison, Wl, USA). The 4C- model is considered one of the most accurate
methods of estimating %FM (33).
Energy expenditure
Total energy expenditure or average daily metabolic rate (ADMR) is divided into
basal metabolic rate (BMR), diet-induced energy expenditure (DEE), and activity
induced energy expenditure. DEE was calculated as io% of ADMR. ADMR was
measured according to the Maastricht protocol for the measurement of body
composition and energy expenditure with labelled water (31). BMR was measured
by ventilated hood, as been previously described (34). BMR consists of sleeping
metabolic rate (SMR) and arousal. SMR was measured during a 12 h overnight stay
in the respiration chamber which was described in detail previously (35). The respi-
ration chamber, an open-circuit indirect calorimeter (14 m3) was maintained at a
constant air temperature of 18 °C during the night. The chamber was ventilated
with fresh air at about 40 l/min. Activity of the subject was measured by a modi-
fied analog ultrasound radar system. SMR was calculated automatically according
to Weir (36), between 23.00 h and 6.30 h over the 3-hour interval with the lowest
radar count.
The physical activity level (PAL) was calculated as ADMR/BMR. As an alternative
measure for physical activity, ADMR was adjusted for BMR using the residuals of
ADMR when plotted as a function of BMR (ADMRa^). BMR was adjusted for gen-
der, FFM and FM
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Statistical analysis
Differences in continuous variables between the sibutramine group and the
placebo group at baseline were analyzed by the two-sample t-test. The number of
patients required per treatment group to detect a difference between treatment
groups in mean change in BMI at endpoint of 1.0 kg/m*, based on an estimate of
variance (s.d.) of 0.65, an overall significance level of 5%, and a power of 90% (37),
was 9. Allowing a drop-out rate of 30%, the number of patients needed in each
group was 12. The principal measure of efficacy was the change in BMI during the
intervention period.The difference between both groups, in changes in BMI, as
well as other continuous variables of vital signs, body composition and energy
expenditure, was evaluated by analysis of covariance. For each variable the change
from endpoint to baseline was used as the dependent variable in the analysis
with group and the baseline value as explanatory variables. Similar analyses were
performed for the change from endpoint intervention to endpoint follow-up.
Furthermore, an efficacy analysis on an intention-to-treat basis was performed
according to the last observation carried forward method (38). Thus, for subjects
who dropped out, the last weight constituted the endpoint of iniervensiMM or fel-
low- up. The change from baseline to endpoint intervention for continuous vari-
ables within each group was assessed by paired t-test. Continuous data are
reported as mean ± s.d. The significance level was chosen at 5%. SPSS release 8,1
for Macintosh (SPSS Inc. Chicago, Illinois, USA) was used as the statistical package
Results
Subject characteristics at baseline are shown in Table 6.1,There were no statsstkal
differences in age, biological maturity, energy expenditure or body composjtaors, in
spite of a clinically relevant difference in weight and BMI between the sibu-
placebo group.
Effects on body composition and energy expenditure
Intervention period
None of the changes in body composition and energy expendituie were signifi-
cantly different between the sibutramine and the placebo group, except ibr PAL
and BMRJJJJ (Table 6.2). BMR^ remained constant in the sifauteffiine group, but
tended to decrease in the placebo group, leading to a significant difference
between both groups (Figure 6.1). Vice versa, PAL remained constant in the sabu-
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7ob/e 6.2
Changes/rom bose//ne to endpo/'nt /nferve/ih'on in body composition and energy expend/ture
/or comp/eterc o//nte/vent/'on.
Baseline Intervention
Croup Sibutramine Placebo Sibutramine Placebo
n (F/M)
Height (m)
Weight (kg)
BMI (kg/m*)
FFM (kg)
%FM (%)
SMR (MJ/day)
BMR (MJ/day)
ADMR (MJ/day)
PAL
BMRadj (MJ/day)
ADMRajj (MJ/day)
11 (6/5)
1.63 ± 0.06
82.2 ± 15.6
30.6 ± 4.4
47.4 ± 8.0
42.0 ± 5.4
6.96 ± 0.65
7.70 ± 1.28
12.23 ± 1-99
1.57 ± 0.16
7.96 ± 1.67
12.08 ± 2.87
12 (5/7)
1.63 ± 0.08
89.2 ±16.4
333 ±
48.6 ±
45-5 ±
7.24 ±
7-89 ±
12.88 ±
i.6o ±
767 ±
12.86 +
5-0
9.0
3-9
1.17
i-45
1.84
0.42
i-79
2.80
n (6/5)
1.65 ± 0.06
79.0 ±16.3
29.0 ± 4.7
46.8 ± 8.3
40.4 ± 5.6
6.60 ± 0.64
7.60 ± 1.26
12.03 ± 2.68
1.56 ± 0.17
7.96 ± 1.90
11.04 ± 396
12(5/7)
1.64 ±
87.2 ±
32.2 ±
48.7 ±
44-2 ±
6.96 ±
737 ±
1363 ±
1.86 +
704 ±
14-53 ±
0.07
15.1
4-2
9.0
4.0
1.03
1.25
1.92
0.30*
1.86*
3.22
FFM, fat-free mass; FM, fat mass; %FM, percentage FM, SMR, sleeping metabolic rate; BMR, basal metabolic rate:
ADMR, average daily metabolic rate; PAL physical activity level (ADMR/BMR); BMR,^. BMR adjusted for gender,
FM and FFM; ADMRj^, ADMR adjusted for BMR
" Significantly different from Sibutramine group (p < 0.05)
tramine, but increased in the placebo group (p < 0.01), resulting in a significant
group difference.The change in ADMRajj, however, was not significant between
both groups.
The change in BMI from baseline to intervention in the sibutramine and placebo
group, adjusted for the BMI at baseline, was - 3.3 and -1.3 kg/m*, respectively (SE =
1.5 in both groups). However, even without the correction for initial BMI, the
decrease in BMI reached a higher level of significance in the sibutramine group
(p < 0.001) than in the placebo group (p < 0.05). This is explained by an increase in
height in both groups (Sibutramine: p < 0.01; Placebo; p < 0.05), while only the
sibutramine group significantly lost weight during the intervention period (p <
0.05). The decrease in %FM, however, was comparable in both groups (p < 0.05)
(Table 6.2).
One subject of the sibutramine group discontinued the intervention period pre-
maturely. Inclusion of this subject at intervention endpoint did not alter the
results (last observation carried forward method) (Table 6.4). In both groups, SMR
decreased significantly during intervention (p < 0.05), while BMR only tended to
decrease in the placebo group (p = 0.057).The respiratory exchange ratio (RER),
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however, increased significantly in the sibutramine group (from 0.82 ± 0.04 to
0.85 ± 0.05; p < 0.05), but not in the placebo group (from 0.81 ± 0.03 to 0.84 ±
0.05; p = 0.11). The changes in ADMR and ADMRg^ were not significant in both
groups, however, PAL did increase significantly in the placebo group (p < 0.01;
Table 6.2).
figure 6.J
Soso/ metobo//c rote od/usted/or/ot-/ree moss,/ot moss ond gender /
/ntervent/on endpo/nt ^ ond Fo//ow-up endpo/nt (79. Trie criange/rom base/me to /nterven-
t/on ond/rom /ntervent/on to/o//ow-up wos s/gn/y/cont/y d/jQ%rent between trie s/butram/ne
ond trie p/ocebo group (p < 0.05/
Sibutramine Placebo
9-1
8 -
7 -
1
B B
Follow-up period
None of the changes in body composition and energy expenditure were signifi-
cantly different between the sibutramine and the placebo group, except for
BMRjjjj, which tended to decrease in the sibutramine group and increase in the
placebo group, leading to a significant difference between both groups (Figure 6.1).
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7oWe 6.3
Changes/rom e/idpo/rrt ;nfervenf/on to endpo/nt/o//ow-up /'n body compos/t/on one/ energy
expend/tore/or comp/eters o//o//ow-up.
Intervention Follow-up
Croup Sibutramine Placebo Sibutramine Placebo
n (F/M)
Height (m)
Weight (kg)
BMI (kg/m*)
FFM (kg)
%FM (%)
SMR (MJ/day)
BMR (MJ/day)
BMRjdj (MJ/day)
n (6/5)
1.65 + 0.06
79.0 ±16.3
29.0 ±
46.8 ±
40.4 ±
6.60 ±
7.60 ±
796 ±
47
8.4
5-6
0.64
1.26
1.90
9
1.64
877
32.6
48.2
45.0
6.91
736
6.95
(3/6)
± 0.06
±14.7
± 4-7
± 8.2
± 3-6
± 0.96
± 1.27
± 2.02
n
1.65
81.6
29-7
49-3
39-1
6.94
741
744
(6/5)
± 0.06
±16.8
±
±
±
±
±
±
4-7
8.6
6.4
1.09
1.44
1.88
9 (3/6)
1.65
87.9
323
49-9
429
7-19
7.86
7.82
± 0.06
±151
± 51
± 8.0
± 48
± 1.03
± 1.25
± 1.69*
FFM, fat-free mass; FM, fat mass; %FM, percentage FM; SMR, sleeping metabolic rate; BMR, basal metabolic rate;
BMR,,j,, BMR adjusted for gender, FM and FFM
" Signifccanly different from Sibutramine group (p < 0.05)
During follow-up, body weight increased significantly in the sibutramine group (p
< 0.05), which was mainly the result of an increase in FFM (p < o.oi). The increase
in BMI, however, was not significant, partly due to a small increase in height (1.645
compared with 1.653 ™) i" the sibutramine group. Adjusted for initial BMI, the
increase in BMI in the sibutramine group was 0.6 kg/m* (SE = 0.4) compared with
a decrease of 0.2 kg/m* (SE = 0.4) in the placebo group. The %FM tended to
decrease during the follow-up period in both groups (Table 6.3).
At the beginning of the follow-up period, 3 subjects from the placebo group
dropped out of the study because of lack of efficacy during the intervention peri-
od. Inclusion of these subjects at endpoint of follow-up did not affect the out-
come (last observation carried forward) (Table 6.4).
BMR tended to increase in the placebo group (p = 0.057), while the lower mean
RER did not change significantly in both groups.
Safety
In the placebo group the DBP dropped significantly during intervention
(p < 0.001), while the HR tended to increase in this period (p = 0.05) as well as the
SBP (Table 6.6). In the sibutramine group the changes in HR and blood pressure
from baseline to intervention endpoint were not significantly different. None of
Height (m)
Weight (kg)
BMI (kg/m*)
Baseline
Sibutramine Placebo
12 (6/6) 12 (5^7)
Intervention
Sibutramine Placebo
12 (6/6) 12 (5/7)
1.63 ± 0.05
80.8 ± 156
30.1 ± 4-5
1.63 + 0.08
89.2 ± 16.4
333 ± 5-0
1.65 ± 0.06
78.0 ± 15 9
28.7 ± 4-6
1.64 ± 0.07
87.2 ± 151
32.2 ± 4-2
Follow-up
Sibutramine Placebo
-
12 (6/6) 12 (5/7)
1.65 ± 0.06 1-65 ± o°7
804 ± 165 87.3 ± 15-3
29.3 ± 4-6 320 ± 4-5
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the changes in HR or blood pressure were significantly different between the
sibutramine or placebo group.There were no statistically or clinically significant
electrocardiographical changes between both groups. During the follow-up peri-
od no significant changes in HR or blood pressure were recorded.
During the whole study period 41 adverse events were reported in the sibu-
tramine group compared with 22 in the placebo group, however, the difference
was not significant.
The most common events are summarized in Table 6.5. One subject, who was on
sibutramine, dropped out prematurely because of symptoms of clinical depres-
sion. After discontinuation of study medication the symptoms disappeared. No
serious adverse events were recorded.
lob/e 6.5
/Wve«e events by treatment group/or /ntervent/bn ona'/o//ovv-i/p per/brf.
Total no. of adverse events reported
Total no. of subjects reporting adverse events
Total no. of withdrawals due to adverse events
Most commonly reported events
(no. of patients reporting)
Flu syndrome
Headache
Abdominal complaints
Agitation
Increased appetite*
Rash
Dizziness
Dysmenorrhea
Joint problem
The total number of adverse events reported was not significantly different between the sibutramine and the
placebo group (Mann-Whitney U test: p = 0.16)
• At the start of the follow-up period
Sibutramine (n=i2)
41
12
i
6
2
7
3
4
2
3
3
2
Placebo (n=i2
22
9
O
6
3
O
1
2
O
1
O
2
7oWe 6.6
s/butram/ne on heart rate (H/?;, rfnisto/fc (DB/»J and syrtoWc (SBPJ b/ood pressure /n obese odofescentf.
Baseline Intervention Follow-up
Group Sibutramine Placebo Sibutramine Placebo Sibutramine Placebo
n(F/M) 12(6/6) 12(5/7) 11(6/5) n(5/7) 11(6/5) 9(3/6)
HR
DBP (mm Hg)
SBP (mm Hg)
744
69.3
112.3
±
±
±
11.3
6.9
6.8
68.3
74.6
115.7
±
±
±
74
8.1
8.6
86.2
68.2
118.7
±
±
±
18.8
73
9.0
74-0
65.0
119.8
±
±
±
8.2
8.2
10.6
75-3
68.2
116.5
±
±
±
6.8
8.6
9-5
773
67.8
115.1
±
±
±
10.1
8-4
13.0
The changes in HR, DBP and SBP between the sibutramine and the placebo group were not statistically significant
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Discussion
The present study demonstrates that, in obese adolescents, sibutramine prevents
the decrease in BMR that normally occurs during weight loss caused by energy
restriction. BMR, adjusted for changes in body composition, decreased 8% in the
placebo group, resulting in a 0.65 MJ/day decrease in energy expenditure during
rest. In the sibutramine treated subjects no change in BMR was seen during
weight loss.
Both groups significantly lost weight during the three month intervention, based
on energy restriction and physical activity. The mean initial weight of the sibu-
tramine group was on average 8.4 kg lower than the initial weight of the placebo
group, however, this difference was not statistically significant, because of the
high variation in weight within both groups. Despite this finding, the weight loss
in the sibutramine group tended to be greater. The difference between both
groups in terms of mean change of BMI (the principal measure of efficacy) during
intervention was 2.0 kg/m* in favour of the sibutramine treated subjects, but was
not significant.
Since the present study is the first to measure the effect of sibutramine in adoles-
cents, it is difficult to compare the results with other reports. A comparable study
in adolescents (15.4 ± 0.2 years of age), using a different central acting compound
for a period of nine weeks, also reported no significant change in body composi-
tion between the treatment and placebo group (39). In adults, previous reports on
sibutramine intervention did demonstrate significant weight loss for the sibu-
tramine group compared with placebo (17,19,40), sometimes after only two
weeks of intervention (18). Moreover, our own center used a similar, albeit open
study protocol, conducted by the same study personnel in a clinical trial with
adults, which resulted in an average weight loss of 7.3% compared with 3.8% in
the present study. Even if the knowledge to be supported by an anti-obesity drug
might have influenced the outcome in the adult group, the difference between
adults and adolescents was striking.
Although it is tempting to compare adolescents with adults, energy metabolism
in adolescents is different because of the element of body growth. A practical con-
sequence therefore, is that BMI should be used as a measure of efficacy, instead of
weight, in order to correct for possible differences in growth rate. Indeed, both
groups had a significant and comparable increase in height.The similar bone age
and Tanner stage in both groups also indicate that it is unlikely that one of the
groups has a lower in biological maturation compared with the other group,
which, consequently, might result in a difference in growth rate between the
groups. Furthermore, in the age range from 12 to 17 years the BMI curve is close to
a straight line, which makes BMI a valid measure of efficacy.
From a theoretical point of view, one could speculate that, in order to protect
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growth, energy restriction in adolescents would be more likely to result in a
decrease in energy expenditure than in weight loss. The decrease in BMR in the
placebo group could be an indication of this metabolism lowering mechanism
and may partly explain the generally high failure rate of obesity treatment in
obese adolescents. This finding is in agreement with a recent study in obese ado-
lescent girls (41). Even when adjusted for FFM and FM, the BMR remained
decreased as long as the energy restriction was continued. A point of criticism
raised by the authors was the use of skinfold measurements for the assessment
of body composition, which may not detect certain changes in body composition,
e.g. water loss. In the present study, a 4C-model was used for the measurement of
body composition, allowing an adjustment of the assumptions of tissue density
by separately measuring water as well as bone mass. Furthermore, in a previous
study on BMR in adolescents, BMR was shown to be higher in the obese com-
pared with the non-obese subjects. When adjusted for FFM, FM, and gender, how-
ever, BMR was comparable (unpublished observations, E.G.A.H.Van Mil, 1999),
which is why BMR was adjusted for these factors in the present study.
Recently, the thermogenic effect of sibutramine at rest, both in the fasted as in
fed state has been demonstrated using a single dose of 30 mg of the compound
(22). Interestingly, the authors reported no significant thermogenic effects in the
first 3 hours after intake, while in the present study, a significant increase in BMR
was found within 45 minutes after intake of only 10 mg of the compound.
Presumably, the BMR effect is the result of a constant plasma concentration of
sibutramine throughout the intervention period. On the other hand, in an inter-
vention study in obese women using sibutramine 10,30 mg or placebo, sibu-
tramine did not result in a significant change in BMR, adjusted for FFM and FM.
Unfortunately, the number of subjects in the present study was too small to
assess the effect of gender within the sibutramine group.
The mechanism that explains the prevention of a decrease in BMR in humans
with sibutramine is not yet elucidated. Studies in animals have shown that sibu-
tramine, due to its combined re-uptake inhibition of both noradrenaline and sero-
tonine, increases energy expenditure via the central nervous system.The central
effect is mediated via pj receptors as blocking of these receptors inhibits sibu-
tramine's effect on energy expenditure (16,42). The mode of action of sibutramine
is most likely to be related to the arousal component, because SMR was not influ-
enced in the sibutramine treated subjects. Although it is accepted that the
increase in heart rate and blood pressure suggests that the thermogenic proper-
ties of sibutramine in humans are likely related to a stimulatory effect on the
sympathicoadrenal system, Hansen et al.(22) were not able to find consistent
increases in plasma noradrenalin. Moreover, in the present study, the increase in
heart rate was not significant between both study groups. In fact, the heart rate
in the placebo group increased throughout the trial. Possibly, the subjects were
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nervous during the visits, which also could explain the tendency of an increased
systolic blood pressure. On the other hand, the systolic blood pressure returned to
normal in the follow-up period, while the heart rate tended to increase further in
the placebo group. Another factor that is inconsistent with a rise in plasma nora-
drenalin is the increased RER that was found in the sibutramine treated adoles-
cents. An increased RER would suggest an increase in carbohydrate oxidation,
while noradrenaline is associated with increased free fatty acid oxidation.
In contrast, the placebo group seemed to become more physically active during
the intervention period, reflected by an increased PAL The increase in PAL, howev-
er, was mainly the result of the decrease in BMR in this group, which explains why
the seemingly increased physical activity did not lead to a significant change in
ADMR. Indeed, the increase in ADMRg^ was not significant, which is a more valid
approach to assess physical activity in cases with data with non-zero intercepts
(43). Sibutramine prevented the decrease in BMR, which consequently did not lead
to an artificially increased activity level. Furthermore, if the activity level in the
placebo group would have been higher, and the increase in ADMR in the placebo
group was a trend that would have been significant in a larger study, it is difficult
to explain why the weight loss in the sibutramine group tended to be higher. The
most reasonable explanation is that the sibutramine group lost weight because of
a decreased energy intake, whereas the placebo group was mainly successful as a
result of an increased activity level. A future longer trial might shed light to the
most effective strategy for intervention of adolescent obesity.
In terms of safety, the average heart rate as well as the blood pressure were well
within the limits, according the second task force on blood pressure control in
children (44). Four subjects treated with sibutramine had a heart rate of more
than 100 beats/min on 2 occasions, while in 2 of these subjects one of the visits
was during the follow-up period. Furthermore, 2 subjects, one receiving sibu-
tramine, the other placebo, had a diastolic blood pressure higher than 85 mm Hg
on 2 occasions.The highest measured systolic blood pressure was 155 mm Hg,
observed in the heaviest subject of the placebo group.
The most frequently reported adverse event in the sibutramine group was
'abdominal complaints'. Six of the 7 subjects mentioned these problems during
the intervention period, one during follow-up. In contrast to the symptoms report-
ed in sibutramine treated adults, only one adolescent reported constipation, while
most of the complaints could be grouped under' abdominal discomfort'. In gener-
al, recurrent abdominal pain is experienced in 10% of healthy school children
between 5 and 15 years of age, severe enough to affect daily routine (45). In the
present study, the abdominal problem was considered to be mild and did not
result in study withdrawal.
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Often abdominal pain in children is a reaction to emotional stress.This may
explain the high rate of abdominal complaints and no reports of nervousness,
which is another known complaint in treated adults. Anxiety, however, was
reported in the present study and did lead to a dose reduction in one of the sibu-
tramine treated subjects. Interestingly, none of the subjects reported dry mouth,
which is one of the most frequent adverse events in adults. Four subjects treated
with sibutramine mentioned increased appetite at the start of the follow-up peri-
od. Average weight increase of these subjects, however, tended to be lower than
the average weight increase of the whole sibutramine group (1.1 kg compared
with 2.6 kg)
One adverse event in the sibutramine group,'symptoms of clinical depression', led
to a withdrawal before the end of intervention. The symptoms consisted of
insomnia, headache and loss of interest and loss of appetite, while the subject, a
12 year old boy, gained weight during this period. Although the boy himself
reported no problems, his mother noticed that he was not'his normal self, which
is why it was decided to stop the treatment. After the termination of the study,
the symptoms disappeared, as was confirmed by both mother and son.
Overall, the adverse events during this study were mild and mostly transitory
throughout the intervention period, as evidenced by only one drop-out in the
sibutramine treated subjects compared with 3 withdrawals in the placebo group.
Each of these 3 subjects withdrew at the beginning of the follow-up period,
because of lack of efficacy during previous intervention period (average weight
gain: 2.1 kg, compared with 0.2 kg in the whole group).
In conclusion, the present study demonstrates that sibutramine is of potential
support in the treatment of obese adolescents. In a once daily dosing of 10 mg,
sibutramine prevented the significant decrease in BMR that was seen in the
placebo group during energy restriction. Treatment with a daily dose of 5 mgfor 2
weeks, followed by 10 mg for 10 weeks, in combination with an energy restricted
diet and physical activity, resulted in a significant weight loss, however, the
change in BMI or FM was not different compared with placebo. Sibutramine prob-
ably ensures a better individual compliance towards a hypocaloric diet, which
may lead to a significant higher weight loss in a longer trial.
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Obesity is a condition of excess fat mass (FM) and is defined as a body mass index
(BMI, kg/m*) above the 95^ percentile for age and gender. Despite the current
consensus on the diagnosis of obesity in children and adolescents, the actual
measurement of FM is challenging, because, /n w'vo, FM cannot be measured
directly. The validity of BMI as an individual measure of adiposity is discussed with
regard to the findings in the present thesis.
Obesity is caused by a positive energy balance, which is the result of increased
energy intake, decreased energy expenditure, or a combination of both. The
research presented in this thesis focuses on whole body energy expenditure in
children and adolescents, susceptible to obesity (i.e., patients with Prader-Willi
syndrome (PWS)), and obese adolescents. In both groups, the major components
of average daily metabolic rate (ADMR) were studied in relation to body composi-
tion. This chapter integrates and discusses the results from the different studies
to come to a general conclusion about the implications of this thesis to the aetiol-
ogy and treatment of obesity in the paediatric age group
The diagnosis of paediatric obesity
Obesity in adulthood is associated with increased risk of morbidity and mortality.
To diagnose paediatric obesity, a measure of overweight is used, namely BMI. By
choosing BMI to diagnose obesity, obesity during childhood can be tracked into
adulthood. This is of importance, since the risk of becoming an obese adult is a
major health implication of paediatric obesity.
Nonetheless, a measure of adiposity is needed to evaluate the effect of obesity
interventions. Although BMI correlates well with measures of adiposity in children
and adolescents on a population level, resulting in correlation coefficients ranging
from 0.39 to 0.90 (1,2,3,4,5), BMI has been reported not to be an appropriate
measure to assess fat mass on an individual level (3). This is especially true for
children with secondary causes of obesity, since in these cases the relationship
between fat mass (FM) and fat-free mass (FFM), with regard to age and gender, is
often changed. Chapters 2 to 4 have handled aspects of body composition in chil-
dren and adolescents with Prader-Willi syndrome (PWS). Although several of these
young subjects were not obese according to the current definition, their adiposity
level ranged from 29 to 60%. For example, one girl with PWS with a bone age of
16 years and BMI 27, had an adiposity level of 38%, whereas her non-PWS peer
who had the same bone age and BMI 28, had an adiposity level of 32%.
In chapter 5, the current definition of obesity was used to divide the pooled group
of adolescents reported in the literature, into obese and nonobese.The Dutch par-
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ticipants of this study, who were the same subjects as in chapter 6, were selected
upon the 97^ percentile of the age and gender specific BMI curves of a selection
of the Dutch population (6). A triceps skinfold thickness above the 97^ percentile
was used as an additional selection criterion, in order to ensure that the partici-
pants were not only overweight, but also had excess adiposity. Thus, %FM in the
selected subject group ranged from 33 to 52, where FM was measured by the four-
component (4C) model. Although the methods used in the 4C-model are time
consuming, expensive, and laboratory based, the 4C-model is increasingly accept-
ed as a reference in adults (7) and recently in children as well (8). In a study using
the 4C-model as a reference model, it was demonstrated that skinfold measures,
which is currently the most widely used method of assessing fatness in the paedi-
atric practice, underestimated FM in a sample of 8 to 12 year-old children, and pro-
duced individual values that were not accurate. In situations in which the 4C-
model could not be used, deuterium dilution was the most appropriate method
for assessing FM in children (8).
In conclusion, the current 95^ percentile cut-off level for BMI, although well suit-
ed as a measure for screening groups on obesity (9), is not valid as an individual
measure of adiposity. Indeed, the cut-off percentile of the current BMI definition
was defined as a screening measure for paediatric obesity with high specificity
rather than sensitivity, thus minimizing the proportion of children and adoles-
cents who would be incorrectly considered obese. The measurement of adiposity
in children and adolescents, therefore, especially with secondary or syndromal
causes of obesity, like PWS, is still limited to specialized laboratories.
Energy balance and the aetiology of paediatric obesity
Excessive accumulation of fat, as a consequence of a positive energy balance, is
due to interactions between genetic factors and environmental conditions. The
positive energy balance can be studied from two angles: energy intake and ener-
gy expenditure.
Energy intake
Most food intake measurements conducted in the paediatric age range, tend to
underestimate the actual energy intake (10,11), especially in the obese (12) and in
adolescents (13,14,15). On the contrary, one study in children has shown that a
food frequency questionnaire also can overestimate total energy intake, even up
to 50% (16). Repeated 24-hour recalls (17), dietary history and weighed diet records
(14), however, provide reasonably accurate group mean values for energy intake in
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young children up to 9 years of age (EI/EE : about 105 ± 18%). Unfortunately, the
values are not accurate on an individual basis, when compared with doubly
labelled water (18).
This leaves the question of whether the under-reporting of energy intake is in fact
caused by under-recording or under-eating. By assessing water loss by deuterium
labelled water, Goris et al. (19) were able to measure the amount of under-record-
ing by comparing water intake (reported and metabolic water) with water loss.
Mean body mass loss was used to measure under-eating, while the total amount
of under-reporting was determined using doubly labelled water (DLW) by measur-
ing total energy expenditure. The study demonstrated that 38 ± 15% under-report-
ing of food intake was explained by 25% under-recording and 14% under-eating
(19). Although this study was performed in obese adults rather than children, the
data shows that current measurements of energy intake are unreliable for the
assessment of energy balance on an individual and probably also on a group level.
In a dietary survey that was carried out on an Antarctic base, Acheson et al. (20)
demonstrated that, although the measurements of food intake were underesti-
mating the actual energy intake, one week is a valid period to measure habitual
food intake for assessment of the macronutrient composition of the diet. The
macronutrient composition is necessary for calculating the food quotient, thereby
estimating the respiratory exchange ratio for the calculation of ADMR (20,21).
In the present thesis, therefore, data from 7-day food questionnaires, filled out by
parents and subjects, were used to determine the macronutrient composition of
the diet, whereas the calculations of energy intake were not used in any further
analyses.
Energy expenditure
Each of the components of ADMR can form the basis of a decreased energy
expenditure and thus help to identify the basis of a positive energy balance, in
order to understand the aetiology or aetiologies of obesity. In chapter 2, we have
seen that basal metabolic rate (BMR, MJ/day) as well as sleeping metabolic rate
(SMR, MJ/day) is lower in children and adolescents with PWS. Furthermore, it was
demonstrated that fat-free mass (FFM, kg) was lower compared with obese con-
trols (chapter 2). The deficit in FFM seems to play a key role in understanding the
lower energy expenditure in PWS. First of all, the under-development of FFM is
the direct cause of the reduced resting energy expenditure in children and adoles-
cents with PWS, thereby decreasing ADMR, as resting energy expenditure is the
main component of ADMR. Secondly, ADMR is decreased further, by a decrease in
physical activity related energy expenditure. Moreover, as an increase in adiposity
is associated with a relative decrease in FFM as a proportion of body mass (chap-
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ter 2), physical activity related energy expenditure may decrease further in
patients with PW5 with increasing levels of adiposity, as indicated in chapter^
Unfortunately, it is not possible to draw conclusions on cause and effect in the
current study, as the data in these chapters were obtained cross-sectionally.This
leaves unanswered the question of whether the decreased physical activity is the
cause of the decreased FFM in PW5, thereby suggesting that the high adiposity in
PWS is the result of a low physical activity level, or, vice versa, whether the deficit
in FFM is in fact the reason for the decreased physical activity.
The relationship between adiposity and energy costs of physical activity in the
general population has been discussed in several meta-analyses (22). Westerterp
et al. (23) analyzed 96 existing data sets with observations on body composition
and physical activity level (PAL) in adults.Their conclusion confirmed that adiposi-
ty is related to a low PAL, however, only in males. Schuiz en Schoeller (24) analyzed
259 existing data sets with observations on body composition and physical activi-
ty, the latter defined as non-basal energy expenditure divided by body mass
(ADMR-BMR)/kg. Again the relationship between adiposity and physical activity
was highly significant, which led to the suggestion that low physical activity is a
permissive factor for obesity. As discussed in chapter 3, however, activity induced
energy expenditure per kg body weight incorrectly assumes that all physical activ-
ity is weight dependent, which over-corrects for body weight in obese individuals,
thus making them appear less active (25).
Prentice et al.(26) analyzed 319 sets of healthy subjects according to four cate-
gories of BMI, and demonstrated similar levels of physical activity in the three
lowest BMI groups. Only in the highest BMI was there a trend that suggested a
negative relationship between adiposity and physical activity. Westerterp and
Goran (27) quantified physical activity by analysis of covariance, adjusting ADMR
for BMR (28).This regression-based approach has been suggested as an alterna-
tive statistical technique to adjust data when non-zero intercepts are apparent
(29). Their findings confirmed the inverse relationship between physical activity
related energy and adiposity, which was most apparent in males.
From the combination of these approaches, based on different precepts, the uni-
fied conclusion can be drawn that, at least in males, adiposity is associated with
lower levels of physical activity related energy expenditure. Despite this relation-
ship, the literature on the causal relationship between exercise and FFM is still
ambiguous. There is one major difference, however, between patients with PWS
and nonsyndromal obese individuals, namely the deficit of FFM in PWS for
increasing levels of adiposity (chapter 2). In nonsyndromal individuals a positive
energy balance results in an increasing body mass and, therefore, an absolute
increase in resting metabolism by a compensatory increase in FFM. Additionally,
absolute non-resting energy metabolism will increase, by increased physical activ-
ity associated energy expenditure, due to higher energy costs of weight bearing
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activities, until the subject comes back into energy balance at an increased weight
and adiposity level (24).
If a patient with PWS is subjected to a positive energy balance, the deficit in
growth of FFM in this syndrome will lead to an increase in resting metabolic rate
that is reduced compared with the increase in an nonsyndromal person. The non-
resting metabolic rate will also be lower compared with nonsyndromal individu-
als, because the deficit in FFM in combination with an increased FM is likely to
result in a reduction in weight bearing activities.The impaired increase in resting
and non-resting energy expenditure further leads to a lower absolute ADMR com-
pared with people without PWS. Consequently, the increase in energy expenditure
as a compensatory effect of the increased energy intake will take place at a higher
adiposity level.
Therefore, if anything, it seems more likely that physical activity is decreased as a
result of increased adiposity, rather than the reverse causal relationship would
exist in PWS - i.e. low levels of physical activity are the cause of increased adiposi-
ty in this syndrome. The fact that FM did not negatively influence measures of
physical activity related energy expenditure in chapter 3, seems contradictory to
the statement above. In the obese control group, however, FM will most likely
increase energy expenditure, as a result of increased energy costs for weight bear-
ing activities, which might have compensated the negative effect of FM on energy
costs of physical activity in children and adolescents with PWS, leading to a non-
significant effect of FM on physical activity related energy expenditure in the
analysis of both groups combined. Unfortunately, because of the small number of
subjects, the analysis could not be performed for the PWS and control group sepa-
rately.
Finally, the present conclusions about whole body energy expenditure in PWS do
not hold necessarily for all syndromal obesities. In a study children with Down's
syndrome, for example, no significant differences were found in total and non-
resting energy expenditure compared with nonsyndromal controls (30). Although
Down's syndrome is also characterized by with stunted growth, the deficit in the
development of FFM does not seem to play an important role in the susceptibility
to obesity.
In children with PWS, the study of whole body energy expenditure has identified
components that form the basis of a decreased metabolic rate, thereby at least
partly explaining the pathophysiological background of the susceptibility to obe-
sity in this syndrome. Assuming that the deficit in FFM is indeed the key to the
understanding of the decrease in total energy expenditure, this finding will have
significant implications for the management of obesity in PWS.
Nonsyndromal obesity has been associated with decreased BMR (31,32,33)as
observed in the studies with PWS. Here, the decreased BMR is defined in terms of
144
scatter about the regression line between metabolic rate and metabolic body size,
suggesting that a person with a low adjusted metabolic rate is at greater risk of
gaining weight than one with a normal or high adjusted metabolic rate. Using
this approach, which is similar to the analysis of covariance used in this thesis,
some studies showed reduced resting energy expenditure in 6 -16 year old and 19
year old African American girls (34,35). After correction for differences in FFM and
FM, resting energy expenditure was 318 kJ/day lower compared with Caucasian
girls (34), with no race by FFM or FM interaction. Similarly, Griffith et al. (33) report-
ed that a low energy expenditure in girls age 5 years correlated negatively with
BMI in adolescence. Other authors reported decreased energy expenditure in 3
month-old infants from overweight mothers (32).Total adjusted energy expendi-
ture was even 20.7% lower in infants who later became overweight. These results,
however, were not confirmed in a more recent study, demonstrating that adjusted
resting energy expenditure was only 0.21 MJ/day (3% of TEE) lower in children
with one obese parent compared with children without obese parents (36).
Moreover, not all studies in children support the concept that obesity is associat-
ed with reduced energy expenditure. In a group of children, divided intotertiles by
FM, and matched for FFM, there was no significant difference in total, resting or
activity related energy expenditure between the groups (37). In a similar study,
measuring energy expenditure in obese and nonobese prepubertal girls, energy
expenditure was not different, when adjusted for body composition (38). Even in a
recent longitudinal study in children of obese and nonobese parents, none of the
components of energy expenditure were related to a change in fat adjusted for
FFM (39).
Therefore, despite some of these intriguing findings in at risk populations, the
question of whether the development of obesity can be related to variations in
the components of whole body energy expenditure is still unanswered. In
response to this question, Goran et al. (39) have calculated that, theoretically, a
daily imbalance of less than 0.11 MJ would be sufficient to cause 1 kg fat gain,
adjusted for FFM, during one prepubertal year.The best test-retest precision for
the measurement of average daily metabolic rate (ADMR) by doubly labelled
water (DLW), however, is 8% (27), resulting in an average error in total daily energy
expenditure of 0.57 MJ and 1.09 MJ for our groups of PWS patients and obese ado-
lescents, respectively. Although most subjects in both groups were older than the
subjects in the study of Goran et al. (39), these small amounts of daily imbalance
put the level of sensitivity of the current standard in indirect calorimetry into
question. Another limitation to the measurement of indirect calorimetry is that
the time span in which total energy expenditure by DLW is measured (e.g. 1-3
weeks) is quite short when compared with the prolonged period for the develop-
ment of childhood obesity. A possible solution could be to measure energy expen-
diture over a longer period. Indeed, if a small daily imbalance cannot be detected,
Chapter,
General discussion
it may be identified when the effect will accumulate over a prolonged period.
Moreover, it is conceivable that a prolonged positive energy imbalance in obesity
susceptible individuals, is in fact a failure to compensate periodic reductions in
energy expenditure (40). Unfortunately, at present, no method of indirect
calorimetry measures energy expenditure over a period longer than 3 weeks in a
free-living situation. For the time being, therefore, ADMR measured by DLW,
remains the most accurate technique to measure imbalances in whole body ener-
gy expenditure.
The current literature illustrates inconsistencies regarding the role of energy
expenditure in the aetiology of primary, nonsyndromal paediatric obesity.
Although methods of indirect calorimetry are reasonably accurate, research based
on whole body energy expenditure may be not sensitive enough to detect small
periodic changes in whole body energy expenditure. Unless an approach is devel-
oped to determine energy expenditure accurately over intervals of months or
longer, instead of weeks, it is unlikely that the causes of a prolonged positive ener-
gy imbalance will be detected by only measuring ADMR.
Treatment of paediatric obesity
The primary goal of paediatric obesity treatment is regulation of body weight and
fat with adequate growth and development, thereby preventing interruption of
linear growth, minimizing loss of FFM, and preventing endocrine disturbances
(41). The underlying mechanisms for the onset of obesity appears to be different
between syndromal obesity (i.e., children and adolescents with PWS) and nonsyn-
dromal, primary obesity. Thus, the treatment of these two distinct forms of paedi-
atric obesity will also differ.
In the obesity treatment of patients with PWS, it is not possible to reach a physio-
logical proportion of FM in relation to FFM, if the only focus is prevention of
excess weight gain by restriction of energy intake. Since the endogenous stimula-
tion of FFM growth is dysfunctioning, the PWS child will most likely maintain the
relatively high level of adiposity, even at a low body weight. The primary goal in
the treatment of PWS children, therefore, should be to increase FFM. In nonsyn-
dromal subjects, FFM can be increased by increasing physical activity, especially by
moderate to strenuous levels of exercise (42,43) and resistance training (44). Since
normal development of FFM is deficient in PWS, it is questionable whether
increased exercise training can give a substantial increase in FFM in children with
this syndrome. An alternative way of increasing FFM is by exogenous administra-
tion of recombinant human growth hormone (GH). Previous studies have shown
that intervention with GH has led to a significant increase in FFM (45,46,47,48,
49), a finding that has been confirmed by the positive relationship between IGF-I
and FFM in chapter 4. Furthermore, the concentration of serum IGF-I was also pos-
itively correlated with bone mass density in the limbs. Assuming that FFM indeed
plays a key role in the altered whole body energy expenditure in PWS, as suggest-
ed above, then the increased FFM would increase ADMR, by increasing BMR as
well as by facilitating physical activity. Several short-term studies have already
showed a positive effect of GH on body composition in PWS. Long term trials are
currently being undertaken, which will hopefully result in a better treatment regi-
men for young PWS patients in the future.
Although the condition of obesity during adolescence is associated with absolute
increases in BMR and ADMR, increasing energy expenditure by physical activity is
considered an important cornerstone in the treatment of obesity (50). Physical
activity is hypothesized to protect from the development of obesity not only
through an increase in energy expenditure, but also through beneficial effects on
substrate metabolism (51,52,53). Studies in children demonstrated that physical
activity has led to maintenance of weight loss (54), a decrease in FM in relation to
FFM (55), attainment of psychological well-being, and optimal bone health (56,
40). Epidemiological studies suggest that spontaneous activity decreases with
age (57).Thus, preventing this decrease in physical activity will reduce sedentary
behaviour, which is a major risk factor for obesity (40). Unfortunately, obesity
intervention solely based on exercise is not effective (58). For example, extra physi-
cal activity had no significant effect on weight in overweight boys (59,60).
On the other hand, targeting weight loss by strongly reducing energy intake may
compromise growth and necessary energy acquisition, and exacerbate the risk of
introducing eating disorders (40). Paediatric obesity treatment should therefore
combine exercise with dietary intervention. As stated by Epstein et al. (41), obesity
intervention in children and adolescents should modify eating and exercise
behaviours along with the factors that regulate these behaviours, so that the
new, healthier behaviours persist throughout development. Treatment should
therefore be focussed on small but permanent changes in this behaviour (9).
Some conditions that are associated with morbidity and mortality during child-
hood and adolescence, however, require more rapid weight loss (61).
In chapter 6, physical activity in combination with a moderate energy restricted
diet was demonstrated to be an effective weight-reducing regimen in obese ado-
lescents. Although after 3 months the average decrease in BMI in this group was
1.3 kg/m*, it is questionable whether this rate of weight loss could have been
extended for a longer period. Like in adults, obese adolescents, who are undergo-
ing restriction in energy intake, demonstrate a compensatory decrease in BMR
that may prevent further weight loss and even facilitate weight relapse. In adults,
the decreased BMR is mainly caused by a decrease in FFM. In chapter 6, however,
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obese adolescents demonstrated a decrease in BMR when adjusted for body com-
position and gender.This decrease in adjusted BMR, which is also demonstrated in
adults (62) and regarded as a metabolic opposition to reduced body weight (63), is
not well understood but probably caused by decreased sympathetic nervous sys-
tem activity. Compounds that compensate this energy saving mechanism during
weight loss (i.e. sibutramine) can be a valuable tool in enhancing the chance of
success for weight reducing regimens during adolescence and adulthood.
In formerly obese adults (62,63,64), metabolic opposition to the reduced body
weight continued, even after maintenance of reduced weight for several years,
indicating that long-lasting changes in metabolic efficiency constitute an impor-
tant part of the mechanism by which systems of energy homeostasis in adults
oppose the maintenance of an altered body weight (65). A critical question, there-
fore, is whether the compensatory changes opposing weight loss and mainte-
nance of an altered body weight, that occur in adults and adolescents also occur
in children. Maffeis et al. (66) studied the effect of 6 months weight loss on BMR
in obese prepubertal children and concluded that changes in BMR paralleled the
changes in FFM, measured by anthropometry.This may suggest that aggressive
treatment of obesity, early in childhood, may be accompanied by permanent
downward resetting of the regulatory systems controlling body weight (65).
Although this hypothesis needs further testing, it does indicate the importance of
early obesity intervention, i.e., before puberty.
Research needs in paediatric obesity
Several problems have been encountered when studying the energy balance in
the child or adolescent with regard to obesity. First of all, there is a need for a gen-
erally applicable measure of FM that can be obtained in a variety of clinical and
field settings, in order to evaluate the management of obese children and adoles-
cents. Now that the 4C-model increasingly is regarded as a reference for estima-
tion of FM (40), research should be aiming at finding an easy to use, relatively
inexpensive, but valid measurement of adiposity. Some studies have presented
bioelectrical impedance as an alternative technique for the assessment of body
composition in children and adolescents (40), as well as children with PWS (67).
The technique is based on the measurement of electrical resistance in the body to
a small imperceptible current (18) or on a series of measurements at different fre-
quencies (bio-impedance spectrometry). A major limitation, however, is that equa-
tions are needed to convert measurements of impedance to body composition,
that should be validated for specific populations (68). Although the accuracy and
usefulness are still under debate, the technique holds promise for the future (40).
Ideally, the broader applicability of such a measure in the daily paediatric practice
will result in a large body of data on adiposity in children and adolescents that, in
the long term, can be associated with morbidity and mortality outcome variables.
Consequently, appropriate adiposity cut-off levels will be determined, in order to
develop obesity intervention protocols to approach at risk groups.
To study the role of decreased energy expenditure in the development of obesity in
high-risk groups, longitudinal data are needed. Physical activity associated energy
expenditure plays a key role in energy balance, as the most variable and the best
influential component of daily energy expenditure. Valid longitudinal assessment
of physical activity in the paediatric age group, therefore, will give insight to the
periodic fluctuation in energy expenditure. Furthermore, several studies (69,70,71)
have suggested that the time devoted to physical activity may have an additional
role on energy regulation, supporting the notion that qualitative assessment of
physical activity would be of additional importance in the study of development of
paediatric obesity (40). Indeed, a limitation to the measurement of physical activity
associated energy expenditure is that it does neither provide any qualitative infor-
mation on physical activity pattern, nor does it differentiate between different
types of physical activity. Therefore, the ideal measure of physical activity should
provide quantitative information about type, intensity, duration and frequency of
the activity performed (18). A promising technique that does allow measurements
in free field is movement registration by a tri-axial accelerometer (72). The advan-
tage of movement registration over energy expenditure measurements is that the
first is capable of measuring activity patterns, addressing the question of whether
time devoted to physical activity can be of additional importance in the suscepti-
bility to obesity. Before studies can be conducted, however, this technique needs to
be validated for different subgroups with respect to age, race an gender. In the
search for the most appropriate method, average daily metabolic rate, in combina-
tion with resting energy expenditure can be used as a standard reference, to verify
the combined energy costs of physical activity derived by other techniques.
Finally, with regard to the study of energy metabolism, there is a need for valid
measurements of energy intake. In the situation of energy balance, energy intake
can be estimated well by measurements of energy expenditure (e.g. doubly
labelled water), however, in situations when body weight is not stable (i.e. weight
loss), it is unclear to what extend metabolic mechanisms may influence energy
expenditure and how the composition of FFM might alter total energy expendi-
ture, making it impossible to assess energy intake. Furthermore, the doubly
labelled water validation approach does not provide any validity of macronutrient
intake. Measurement of habitual food intake, therefore, remains one of the most
challenging aspects of human obesity research (18), especially since development
of new techniques for dietary intake are hindered by the inability to cross-validate
instruments with any known standard technique.
Until energy intake can be measured accurately, the assessment of energy balance
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will not be of much use when studying the aetiology of obesity. Even in the situa-
tion of energy balance, the variation of the activity component of ADMR is too
large to detect daily imbalances. Furthermore, as discussed earlier, the precision of
ADMR still is relatively large compared with the small imbalances to be detected.
Methods with a lower (around 2-3%) test-retest precision are BMR by ventilated
hood, or, respiration chamber and body composition by labelled water (27,40).
Unfortunately, these techniques cannot measure energy expenditure in a free-liv-
ing situation and are not suitable to calculate the energy balance. On the other
hand, resting energy expenditure analyzed by analysis of covariance using gender,
maturation and body composition, allows the measurement of metabolic predic-
tors for body weight gain, thereby helping to identify new pathways involved in
the pathophysiology of obesity.
Although we know that obesity is a complex phenotype with genetic, environmen-
tal and developmental determinants, the limitations in measuring energy intake
and energy expenditure over time have prevented a complete understanding of
the pathophysiology of the positive energy balance in the aetiology of paediatric
obesity. Furthermore, the increasing prevalence of obesity in the western world
illustrates the incapacity of treating obesity with maintenance of weight loss
regardless of age.
We have seen in the last chapter of this thesis that weight reduction during ado-
lescence is at least as difficult as during adulthood.Therefore, as stated by the
expert consultation on obesity, concentrating on children and adults who have a
high BMI and associated health problems will not stem the escalating numbers of
people entering the medically defined categories of ill health (73). It is thus essen-
tial to develop new preventive public health strategies, which affect the entire soci-
ety. Research is needed to develop strategies for modifying the environment to
increase physical activity and to discourage sedentary behaviour in children and
adolescents in general.
An approach that has proven its success was developed by Epstein et al. (50,54),
and uses behavioural modification techniques to modify diet and physical activity
in children and adolescents, which is a strategy not substantially different from
that used often in adults. Especially with respect to physical activity, this so-called
'lifestyle' exercise has proved successful in maintaining weight loss for more than
io years. Since it is clear that physical activity will have a crucial role in the life-long
prevention of obesity (74), the biggest challenge is to incorporate spontaneous
physical activity, as much as healthy eating, back into the daily lives of children
again. Schools, families, and communities must provide an atmosphere that
encourages a physically active existence in combination with sound nutritional
practices, in order to instill a general and permanent appreciation for this obesity
preventing behaviour.
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Daily energy expenditure is decreased in children and adolescents with Prader-
Willi syndrome (PWS) compared with obese controls
The decreased energy expenditure in PWS is explained by a decreased basal meta-
bolic rate as well as a decreased physical activity related energy expenditure
The decreased basal metabolic rate in PWS is explained by a deficit in fat-free
mass (FFM), probably caused by endocrine growth dysfunction
Physical activity related energy expenditure in PWS is inversely related to fat mass
(FM), corrected for height (FMI, kg/m*)
The extracellular water compartment in children and adolescents with PWS is
enlarged even when adjusted for FMI and bone age
Daily energy expenditure is increased in obese adolescents compared with
nonobese peers and is caused by increased basal metabolic rate
Basal metabolic rate in obese adolescents is increased, even when adjusted for
FFM, age and gender
Basal metabolic rate in male adolescents is increased, even when adjusted for
body composition and age
Physical activity related energy expenditure in obese adolescents is comparable to
nonobese adolescents, when adjusted for metabolic body size
During adolescence, physical activity related energy expenditure increases with
age
Sibutramine compensates for an energy intake restriction induced decrease in
basal metabolic rate in obese adolescents
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Summary
The prevalence of paediatric obesity is increasing world-wide and is now consid-
ered an epidemic in many industrialized countries.The exact consequences on
public health are not clear. The current opinion is that a large number of today's
obese children and adolescents will remain obese during adulthood, which is
associated with an increased risk for cardiovascular diseases and diabetes melli-
tus, leading to increased morbidity and mortality. Additionally, even a young child,
if severely obese, can suffer serious morbidity.
The aetiology of paediatric obesity is based on the interaction between genetic
predisposition with regard to the energetic efficiency to store body fat, and an
environment that is permissive to the expression of that genetic tendency.
Although the relative influence of each of these factors is unclear and may vary at
certain periods during growth, together they result in a prolonged positive energy
balance. When measuring energy balance, energy intake is difficult to assess
because most available methods rely on self report. Energy expenditure, however,
can be validly measured by indirect calorimetry.
A group of children with high susceptibility to the development of obesity, are
children with the Prader-Willi syndrome (PWS). In addition to an almost insatiable
appetite, the obesity of children with PWS has been associated with a decreased
basal energy metabolism. The pathophysiological background of impaired metab-
olism, as well as the main features of PWS (mental retardation, hypotonia in early
childhood, hypogonadism and short stature) are still poorly understood but are
most likely based on dysfunction of various hypothalamic centres.
In this thesis, energy expenditure and body composition were measured in a
group of 17 children and adolescents with PWS, and were compared with 17 non-
syndromal obese controls, matched for gender and bone age. In chapter 2, it was
demonstrated that energy expenditure at rest as well as during sleep is 21% and
23% lower in children with PWS compared with controls, respectively. The low
basal metabolic rate was explained by a low fat-free mass, in absolute terms as
well as when adjusted for height and, therefore, could not be the result of an
impaired energy metabolism at cellular level. Furthermore, it was shown that fat-
free mass was reduced in relation to fat mass in this syndrome. The fat-free mass
contains the metabolically active tissues in the body, such as organs and muscle.
The reduced growth of the fat-free tissues in children with PWS may well be relat-
ed to an abnormality of the hypothalamic-pituitary-gonadal axis that has been
suggested in the literature. Together with a possible functional growth hormone
(GH) deficiency, the decreased levels of gonadotropins might take away the natu-
ral urge to be lively and playful.
Physical activity induced energy expenditure is a major component of average
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daily metabolic rate, along with basal metabolic rate. Although physical activity
induced energy expenditure can be validly measured by combining measure-
ments of average daily metabolic rate and basal metabolic rate, the best way to
correct for body weight is still debated. In chapter 3, various methods for correct-
ing differences in body size were discussed, based on the results obtained in the
PWS and control groups. All methods support the same conclusion, namely that
activity related energy expenditure is lower (up to 38%) in children with PWS
compared with obese controls. Adjusted for biological maturation, gender and
body composition, the difference between groups was 18%.
Not only the reduced fat-free mass but also the pattern of adiposity in children
with PWS, in combination with an impaired bone mineral content, especially in
the limbs, have a close resemblance to the body composition present in children
with GH deficiency. Since not all children with PWS develop a diagnosed GH defi-
ciency, it has been suggested in the literature that PWS might be associated with
a functional GH deficiency. By using serum Insulin-like Growth Factor-I as a meas-
ure of GH function, fat-free mass as well as bone mineral density of the limbs,
were positively related to GH function in children with PWS (chapter 4).
Furthermore, in contrast to nonsyndromal obese children, adiposity was inversely
related to physical activity in these children. Finally, an increased extracellular-to-
intracellular water ratio was found, even when corrected for the higher adiposity
and lower biological maturation, which are characteristic of children with PWS.
It is still debated whether the development of obesity during adolescence (one of
the critical periods in the development of paediatric obesity) is associated with a
reduction in energy expenditure. In chapter 5, energy expenditure and body com-
position data of a group of nonsyndromal obese adolescents of the Maastricht
region were combined with individual data of obese and nonobese adolescents
reported in the literature. Contrary to children with PWS, nonsyndromal obese
adolescents showed a 15% increase in basal metabolic rate compared with their
nonobese peers, even when corrected for age, gender and fat-free mass differ-
ences. It was speculated that the increased basal metabolic rate in the obese
state was not caused by a metabolically more active fat mass, but by a shift in the
composition of the fat-free mass towards a relatively higher contribution of inter-
nal organ tissues compared with muscle mass.This change in fat-free mass com-
position would then lead to a higher basal energy expenditure per unit fat-free
mass. Furthermore, basal metabolic rate was 12% higher in adolescent boys com-
pared with adolescent girls, independent of body composition and age. Activity
related energy expenditure, however, when appropriately adjusted for body size,
was similar in both groups. Furthermore, the Food and Agriculture Organisation of
the United Nations, the World Health Organisation, and United Nations University
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(FAO/WHO/UNU)-equations for prediction of BMR overestimated energy expendi-
ture in obese male adolescents by 8%, whereas the adult FAO/WHO/UNU-equa-
tions, based on weight, did predict the measured basal energy expenditure cor-
rectly. For obese adolescents, therefore, the adult FAO/WHO/UNU-equations were
recommended.
Treatment of paediatric obesity is primarily based on dietary advice and stimula-
tion of physical activity. Pharmacological therapy is only recommended when
complications of obesity require rapid weight loss. The increasing prevalence of
paediatric obesity and the disappointing results in the traditional treatment of
obesity, however, urges the need for new treatment strategies. In chapter 6 of this
thesis, the effect of sibutramineon body composition and energy expenditure, in
combination with an energy restricted diet and exercise programme, was evaluat-
ed in a double blind, placebo-controlled, randomised trial. During an intervention
period of three months, sibutramine, which is a recently developed satiety
enhancing drug, prevented the decrease in basal metabolic rate, that occurred in
the placebo group. Furthermore, sibutramine probably ensured a better individual
compliance towards a hypocaloricdiet.
In conclusion, the studies described in the present thesis demonstrate that chil-
dren and adolescents with PWS have a low average daily metabolic rate, based on
an impaired growth of fat-free mass, leading to a low basal metabolic rate as well
as a low physical activity related energy expenditure.These altered components in
energy expenditure may be related to an impaired function of various hypothala-
mic centres.The basal metabolic rate in nonsyndromal obese adolescents is, how-
ever, increased compared with their nonobese peers, which is not only caused by
an increase in fat-free mass, but also, most likely, by a shift in fat-free tissue com-
position. During energy intake restriction, however, basal metabolic rate decreases
in obese adolescents, impairing the effect of the obesity intervention. Sibutramine
can prevent the decrease in basal metabolic rate and, therefore, can be of poten-
tial support in the treatment of obese adolescents. Nonetheless, drug therapy in
the management of paediatric obesity should only be used if conventional treat-
ment has failed.
~l
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Samenvatting I
Samenvatting van het proefschrift
'Energiemetabolisme in kinderobesitas'
De huidige toename in de wereldwijde prevalentie van kinderobesitas geeft aan
dat er sprake is van een epidemic De exacte gevolgen voor de volksgezondheid
zijn nog onduidelijk. De verwachting is dat een groot aantal van de hedendaagse
obese kinderen en adolescenten obees zal blijven op volwassen leeftijd, hetgeen is
geassocieerd met een toegenomen risico voor hart- en vaatziekten en diabetes
mellitus. Dit zal een toename van de morbiditeit en mortaliteit tot gevolg heb-
ben.Tevens is bekend dat extreme obesitas, zelfs bij jonge kinderen, tot ernstige
morbiditeit kan leiden.
De etiologie van kinderobesitas vindt zijn basis in de interactie tussen enerzijds
een genetische predispositie met betrekking tot de energetische efficientie om
lichaamsvet op te slaan, en anderzijds een omgeving die de expressie van de
genetische predispositie toestaat. De relatieve invloed van elk van deze processen
is nog niet opgehelderd en lijkt bemvloed te worden door bepaalde perioden tij-
dens de groei. Het uiteindelijke resultaat is een langdurige positieve energieba-
lans. Een positieve energiebalans kan het gevolg zijn van een verhoogde energie-
inname of een verlaagd energiegebruik. Een verhoogde energie-inname is moeilijk
te bepalen omdat de meest gebruikte methoden gebaseerd zijn op zelfrapporta-
ge. Het energiegebruik echter, kan met behulp van indirecte calorimetrie wel vali-
de worden gemeten.
Een voorbeeld van kinderen met een verhoogde predispositie voor het ontwikke-
len van obesitas zijn kinderen met het Prader-Willi syndroom (PWS). Naast een
vrijwel onstilbare honger, is obesitas in dit syndroom geassocieerd met een ver-
laagd basaal energiemetabolisme. De pathofysiologie van het verlaagd metabo-
lisme, evenals van de hoofdkenmerken van PWS (mentale retardatie, hypotonie op
vroege kinderleeftijd, hypogonadisme en klein gestalte), is nog onduidelijk, maar
hoogstwaarschijnlijk gebaseerd op dysfunctioneren van hypothalame centra.
In dit proefschrift werden energiegebruik en lichaamssamenstelling gemeten in
een groep van 17 kinderen en adolescenten met PWS en vergeleken met 17 niet-
syndromale obese controle kinderen van hetzelfde geslacht en met dezelfde bot-
leeftijd. In hoofdstuk 2 werd aangetoond dat het energiegebruik in rust en tijdens
de slaap respectievelijk 21 en 23% lager is bij kinderen met PWS in vergelijking met
obese controles. Het lage basaal energiegebruik kon worden verklaard door een
lagere vetvrije massa bij deze kinderen, zowel in absolute zin als gecorrigeerd voor
lengte, en bleek daarmee niet het gevolg te zijn van een afgenomen energiemeta-
bolisme op cellulair niveau. Tevens werd bij kinderen met PWS aangetoond dat de
vetvrije massa lager was in relatie tot vetmassa.
De vetvrije massa omvat de metabool actieve weefsels van het lichaam, zoals
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organen en spieren. Volgens de huidige wetenschappelijke literatuur is de vermin-
derde groei van vetvrije weefsels bij kinderen met PWS waarschijnlijk gerelateerd
aan afwijkingen in de hypothalamo-hypofysaire-gonadale as. Het is denkbaar dat
verlaagde gonadotrofiene spiegels, mogelijk in combinatie met een functionele
groeihormoon (GH) deficientie , een remmend effect hebben op de spontane
lichamelijke activiteit.
Het energiegebruik voor lichamelijke activiteit behoort, samen met het basaal
energiegebruik, tot de hoofdbestanddelen van het totale dagelijkse energiege-
bruik. Lichamelijke activiteit kan worden bepaald door een meting van het totaal
dagelijkse energiegebruik te combineren met een meting van het basaal energie-
gebruik. Er bestaat echter nog geen consensus over hoe lichamelijke activiteit
gecorrigeerd dient te worden voor lichaamsgewicht. In hoofdstuk 3 worden de
gangbare methoden om te corrigeren voor lichaamsgewicht behandeld, geba-
seerd op waarnemingen bij kinderen met PWS en controles. Alle methoden
komen tot dezelfde conclusie, namelijk dat het energiegebruik voor lichamelijke
activiteit lager is (tot 38%) bij kinderen met PWS in vergelijking met obese contro-
les. Na correctie voor de mogelijke effecten van biologische rijping, geslacht en
lichaamssamenstelling, was het verschil tussen beide groepen 18%.
Niet alleen de lage vetvrije massa, maar ook de vetverdeling bij kinderen met
PWS, samen met de afgenomen hoeveelheid botmineralen, met name in de lede-
maten, hebben een sterke gelijkenis met de lichaamssamenstelling van kinderen
met GH deficientie. Aangezien niet alle kinderen met PWS een gediagnostiseerde
GH deficientie hebben, wordt PWS ook wel geassocieerd met een functionele GH
deficientie. In hoofdstuk 4 werd gevonden dat zowel de vetvrije massa als de bot-
dichtheid positief gecorreleerd is aan GH functie bij kinderen met PWS, waarbij
GH functie werd gemeten aan de hand van de concentratie somatomedine-C
(IGF-I) in het serum. In tegenstelling tot niet-syndromaal obese kinderen, bleek de
vetmassa bij deze kinderen negatief gecorreleerd met lichamelijke activiteit.
Tenslotte werd een toegenomen ratio extracellulair-intracellulair water aange-
toond, zelfs na correctie voor de hogere mate van adipositas en lagere biologische
rijping, welke karakteristiek zijn voor kinderen met PWS.
Over het ontstaan van obesitas tijdens de adolescentie (een van de kritische perio-
den in de ontwikkeling van kinderobesitas) en de relatie met verlaagd energiege-
bruik is nog veel onduidelijk. In hoofdstuk 5 werden de energiegebruik en lichaams-
samenstelling gegevens van een groep van 24 niet-syndromaal obese adolescen-
ten uit de regio Maastricht gecombineerd met individuele gegevens van obese en
niet-obese adolescenten uit de literatuur. In tegenstelling tot kinderen met PWS,
hadden de obese adolescenten vergeleken met hun niet-obese leeftijdsgenoten
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een 15% hoger basaal energiegebruik, zelfs nadat gecorrigeerd was voor verschil-
len in leeftijd, geslacht en vetvrije massa. Waarschijnlijk is het verhoogde basaal
energiegebruik niet het gevolg van een metabool actievere vetmassa, maar van
een verschuiving in de samenstelling van de vetvrije massa naar een relatief
hogere bijdrage van weefsels van interne organen (zoals de lever) ten koste van
spierweefsel. Deze verandering in de vetvrije massa samenstelling leidt vervol-
gens tot een hoger basaal energiegebruik per eenheid vetvrije massa. Tevens was
het basaal energiegebruik bij adolescente jongens 12% hoger dan bij adolescente
meisjes, onafhankelijk van lichaamssamenstelling en leeftijd. Het energiegebruik
voor lichamelijke activiteit, gecorrigeerd voor verschillen in lichaamssamenstel-
ling, was vergelijkbaartussen allegroepen.Tenslotte bleken de berekeningsfor-
mules voor basaal energiegebruik, opgesteld door de 'Food and Agriculture
Organisation of the United Nations, the World Health Organisation, and United
Nations University (FAO/WHO/UNU)'en gebaseerd op gewicht, het energiege-
bruik bij obese adolescenten met 8% te overschatten.terwijl de FAO/WHO/UNU-
vergelijkingen voor volwassenen, tevens gebaseerd op gewicht, het gemeten
basaal energiegebruik wel goed voorspelden. De FAO/WHO/UNU-vergelijkingen
voor volwassenen werden aanbevolen voor het berekenen van het basaal energie-
gebruik van obese adolescenten.
De behandeling van kinderobesitas is primair gericht op dieet advisering en sti-
mulering van lichamelijke activiteit. Farmacologische therapie wordt alleen toege-
past indien door complicaties snel gewichtsverlies noodzakelijk is. De toenemen-
de prevalentie van kinderobesitas en de teleurstellende resultaten van traditione-
le behandeling, nopen tot de ontwikkeling van nieuwe behandelingsstrategieen.
In hoofdstuk 6 van dit proefschrift werd in een dubbel-blind, placebo-gecontro-
leerd.gerandomiseerd onderzoek het effect geevalueerd van sibutramine op
lichaamssamenstelling en energiegebruik, in combinatie met een energiebeperkt
dieet en een activiteitenprogramma. Gedurende een interventieperiode van 3
maanden voorkwam sibutramine, een recent ontwikkeld geneesmiddel dat het
verzadigingsgevoel langer doet aanhouden, de daling van het basaal energiege-
bruik die optrad in de placebo groep.Tevens leek de sibutramine groep het ener-
giebeperkt dieet beter vol te houden.
Concluderend tonen de studies die beschreven worden in dit proefschrift aan dat
kinderen en adolescenten met PWS een lager dagelijks energiegebruik hebben,
gebaseerd op een afgenomen groei van vetvrije massa, hetgeen zowel een verla-
gd basaal energiegebruik als een verlaagd energiegebruik voor lichamelijke acti-
viteit tot gevolg heeft. De veranderingen in energiegebruik zijn mogelijk gerela-
teerd aan dysfunctionele hypothalame centra. Het basaal energiegebruik in niet-
syndromaal obese adolescenten is echter toegenomen vergeleken met hun niet-
obese leeftijdsgenoten. De oorzaak hiervan ligt niet alleen in een toegenomen
vetvrije massa, maar hoogstwaarschijnlijk ook in een verschuiving in de vetvrije
massa samenstelling. Indien obese adolescenten echter energie-inname restrictie
ondergaan, zal het basaal energiegebruik dalen, hetgeen het effect van de obesi-
tas interventie voor een deel teniet zal doen. Sibutramine kan deze compensatoire
verlaging tegengaan en heeft daarmee de potentie om ondersteuning te bieden
tijdens de behandeling van obese adolescenten. Onveranderd blijft het standpunt
dat farmacologische therapie in de behandeling van kinderobesitas alleen ge'i'ndi-
ceerd is als conventionele therapie heeft gefaald.
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Wetenschap, zoals beschreven in de hoofdstukken van dit proefschrift, richt zich
op het heden en vormt de basis voor de toekomst. Er gelden strikte regels waar-
binnen veilige uitspraken kunnen worden gedaan. Aangekomen bij het nawoord
wordt de promovendus plots geconfronteerd met de behoefte een retrospectieve
beschouwing te geven van het recente verleden. De geschiedenis wordt echter
beinvloed door persoonlijke interpretaties uit een selectief geheugen en vormt
daarmee een schril en gewaagd contrast met de vorige hoofdstukken. Ironisch
genoeg is het nawoord juist het meest gelezen hoofdstuk van een wetenschappe-
lijke verhandeling. Ook door onderzoekers. Zij weten als geen ander dat de vor-
ming tot zelfstandig onderzoeker niet alleen gebaseerd is op de oefening in de
wetenschap, maar ook in het leren omgaan met tijdsdruk, de variabele viscositeit
van de universitaire bureaucratie, de media, de wispelturigheid van editorial
boards, professionele proefpersonen.en zeker ook je collega's.
Het voert te ver om al deze facetten uitvoerig te beschrijven. Wat nu volgt is enkel
een korte en ongetwijfeld onvolledige opsomming van diegenen die direct of indi-
rect een bijdrage hebben geleverd aan de totstandkoming van dit proefschrift.
Mijn interesse in de kindergeneeskunde en daarmee de allereerste aanzet van dit
proefschrift werd iets meer dan 10 jaar geleden gewekt bij Dr. Van Drumpt. Als
eerstejaars student geneeskunde kreeg ik de mogelijkheid kennis te maken met
de kinderafdeling van het voormalige St. Nicolaas ziekenhuis in mijn geboorte-
stad.
Mijn eerste schreden in het wetenschappelijk onderzoek zijn echter moeilijker te
traceren. De eerste pogingen werden weliswaar gedaan in het oude Annadal, bij
Jaap Schrander, destijds nog werkzaam aan zijn eigen promotieonderzoek naar
koemelkeiwitintolerantie bij zuigelingen, maar het werkelijk zelfstandig opzetten
en uitvoeren van onderzoek vond het eerste plaats onder de bezielende leiding
van professor Oded Bar-Or, aan het Children's Exercise and Nutrition Centre in
Canada. Dear Oded, //you wou/d have to/c/ me Mat /t wou/d ta r^e unt/7 the next m/7-
/en/um to do my PhD / wou/dn't have fee/Zevedyow. P/ease be//eve me, when / te//
you, that my stay at the Cf WC was a very bene//c/'a/ experience, both as a/uture
sc/ent/st and as a person. As o/ten sa/d, wr/tte/i or ma/7ed - Let's keep each other
posted.'
Tijdens de periode in Canada was professor Wim Saris mijn interne begeleider en
dat is de hele promotietijd zo gebleven.'Kom maar met een voorstel', is de eerste
zin die in me opkomt.'in principe is alles mogelijk'. M m j e was getu/ae van m//n
eerste boMensprongen /n de wetenschap en a. a/me de vn/Tie/d om m//n e/gen r/ch-
t/ng te bepa/en. Ve ster/te ger/chthe/d op de n/euwste ontw/Me//ngen /n de weten-
schap weritte te/fcens enthous/asmerend. l//te/nde///7< /s de bes//ss/ng over m///i pro-
mot/e-onderiverp geva//en /n de metro von Borce/ona, tert/gtomenrf von een 'soda/
even/'ng! D/t gee/t ene/zyds di//de///fr aan dot er n/et a/t//'d vo/doende t//d was voor
over/eg, moor datje anderzyds a/tyd open stond voor d/sa/ss/e op wot voor tydst/p
o/p/aats don oo<r.
Helaas leidde deze afspraak niet meteen tot een daadwerkelijke start van mijn
promotie-onderzoek. Het viel dan ook zwaar om, na eindelijk officieel gestart te
zijn bij Humane Biologie, de eerste twee jaar als promovendus volledig opgeslokt
te zijn in een multicentre studie, waarin eigen wetenschappelijke inbreng vrijwel
niet mogelijk was. In deze tijd werden diverse studies besproken o.a. met profes-
sor James O'Hill van de Universiteit van Denver, Colorado (VS) en professor Carlos
Blanco van de vakgroep Kindergeneeskunde van het academisch ziekenhuis
Maastricht (azM). Cor/os, von meet o/oon hebjeje opgeste/d o/s een du/de/yte
voorstonder von wetenscnappe/y/te scho//ng von toe/romst/ge Wnderartsen, hetgeen
/fc a/tyd o/s een ster<re st/mu/ons neb ervoren. De fomendeyaren zu//en /eren ;'n hoe-
verre deze scho//ng oo/ir /n de W/'n/ek zyn vruchten zo/ a/vverpen.
Ondanks verwoede pogingen kwamen er in deze periode geen additionele studies
van de grond. Achteraf bezien, blijkt een dergelijke lange start dan toch een hele
leerzame geweest te zijn, waar ik nu met plezier aan terugdenk. Tanja, jij was
heel duidelijk de spil van de SibuTrial en ik beschouw mezelf nog altijd als een
geluksvogel dat we samen hieraan hebben kunnen werken. Mede door jouw grote
gevoel voor verantwoordelijkheid was het mogelijk naast de SibuTrial mijn eigen
werk opte zetten. Margot, je opgewektheid en interesse maakte je altijd een
graag geziene gast, je daadkracht en begrip voor onze'niet-klinische' klinische
trial, een echte teamgenote. Later zou Lenke je taak overnemen, hetgeen ze op
heel eigen wijze deed. En dan natuurlijk niet te vergeten, Ellen, mijn redster in
dietistische nood, die vrijwel vanaf de eerste dag de draai in ons team wist te vin-
den. Ook Marleen van Baak wil ik graag langs deze weg bedanken voor de pret-
tige samenwerking en betrokkenheid in mijn studies, ook al vielen die de laatste
twee jaar niet meer onder haar hoede.
De eerste praktische uitvoerbare studie voorstellen kwamen tot stand nadat con-
tact was gelegd met Paul Curfs en Connie Schrander, van de Stichting Klinische
Genetica Limburg. Paul en Connie, het multidisciplinaire karakter dat jullie aan
het Prader-Willi onderzoek geven zou voor veel vakgroepen als model kunnen fun-
geren. Het gevolg is wel dat er nog veel werk op ons ligt te wachten. Marleen
Manders, mijn allerbeste en enige stagiaire. Marleen, ons gezamelijke artikel laat
nog altijd op zich wachten, maar ooit zal het er echt van komen! Vanwege het sta-
tistiek onderwijs (met name na de cursus), is Arnold Kester onmisbaar gebleken in
de opzet en de latere rapportage van het onderzoek. Arnold, ik vond onze
besprekingen niet alleen erg leerzaam, maar ook erg plezierig. Bedankt voor je tijd
en de hulp bij de stellingen! Ook Wouter van Marken Lichtenbelt mag in dit rijtje
niet ontbreken. Wouter, naast je onuitputtelijke hulp bij het puzzelen naar goede
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literatuur over lichaamssamenstelling van kinderen, wist je me ook altijd met een
brede grijns je kantoor uit te sturen. Je brede biologische kennis gecombineerd
met je sterke relativeringsvermogen en gevoel voor humor maakte het overleg
altijd weer een prettig intermezzo. Ook Willem-Jan Gerver verstaat de kunst om
moeilijke materie zo simplistisch uit te leggen dat je bijna gaat geloven dat je het
daadwerkelijk begrijpt. Na enige tijd klaart de euforie op en niet zelden bleek
daarna de oorspronkelijke vraag nog niet beantwoord. Gelukkig heeft de
toekomst nog vele vragen in het verschiet...
Als dan, na een periode van tweejaar, in de zomer van'97, eindelijk'mijn eigen'
proefpersonen druppelsgewijs in het lab worden uitgenodigd, bleek het soms
moeilijk het hoofd koel te houden, beseffend dat de resterende onderzoekstijd zo
efficient mogelijk benut diende te worden. Vanaf dat moment is de begeleiding
van professor Klaas Westerterp van essentieel belang geworden. K7aas, te/tens
w/stje me weer op rietju/ste spoor te zetten a/s /It de rode draod Uriv/j't was.
A/leerdere mo/en riebbenje he/dere £>//Men op de data me waMer geschud en je ont-
nuchterende opmerk/ngen me de ogen doen opener). Zonder jouw bege/e/d/ng zou
d/'t schr//ven nu n/et voor ons //ggen.
Ondanks de hoge tijdsdruk waren er gelukkig collega's die je met beide benen op
de grond weten te zetten. Jos, een man van weinig woorden, dus.. moet ik hier
nog iets aan toevoegen? Truus, met o/youiv mensen/renn/s fa/nje maWre///<r ze//
eens een boe/c/e scnr//ven. Joan, ge/ufc<r/g g/ngen onze gespreMen ze/den over onder-
zoefc. Jouw entnous/asme voor sport toee/t o/t//d een st/'mu/erende /nv/oed op me
gehod. Het zo/ o//een nog we/ even duren voordot ;<r voory'e /n de A/lesscrier 6erg/oop
za/ e/nd/gen. Desiree en later zeker ook Claudia en Peggy, ondanfrs ju///e dru^/ce
secretar/e/e werfczaamrieden ton //c_/u///e o/t//d storen met m//n /ost/'ge vrogen, nog-
moo/s bedon/ct doorvoor.' Paul en Loek, de werkpaarden annex wizz-kids ofwel
willi-wortels van HB. Kbrtom, zonderjuW/e /s wetenscnop n/et meer moge///<r op p/o-
net-H8. Trouwens over bedanken gesproken... Arjen, waar b///ft ons ioncet ort/fce/
Dan is er natuurlijk nog de grote groep promovendi en overig voetvolk, zoals Luc,
the barbarian,'Frolijke Freddy.de ritselaar.'leptine'Chris, 'Enkhuizer-irritantje'-
Erwin.'Beaker'-Joost,'Professor' P. Schrauwen, met dank voor het lezen van de
Nederlandse samenvatting, snelle Marco/big' Bert, mijn bevallige vrouwelijke col-
lega's Sandra, Dorien, Annelies, Eva en Marleen en de immer 'brave ende oprechte'
collega's van de voormalige divisie 2. In het begin voelde ik me als enige arts een
vreemde eend in de bijt, maar al snel werd duidelijk dat het hele gezelschap uit
exotisch pluimvee bestond, dat van's ochtends vroeg tot's avonds laat en vaak in
de weekenden aardig wat veren kon doen opwaaien (om maar niet te spreken
over het kakelende kippenhok bij het koffiezetapparaat). Het valt niet mee om van
zo'n gemeleerde bende afstand te moeten nemen, dus vandaar dat ik ongevraagd
nog af en toe mijn gezicht zal laten zien op de laatste donderdag van de maand.
Inmiddels ben ik weer aan een nieuwe uitdaging begonnen, die zeker zo groot is.
Weer ben ik enigszins een vreemde eend, nu vanwege mijn absolute non-ervaring
op klinisch gebied. Maar gelukkig neb ik het weer getroffen met mijn collega's,
ditmaal van het azM, die de landing in de kliniek wisten te verzachten: Clarry,
Rony, Annemiek, Singrid, Ingrid, Maartje, Eric, Henriette, Monique, Phillip, Colleen,
Paola, Derek-Ian en Jaap houd moed, met jullie hulp ben ik binnenkort een echte
dokter.
Tenslotte wil ik dit betoog bee'mdigen met enkele personen die de afgelopen peri-
ode een bijzondere rol hebben gespeeld. Dean,/org/Ve me that / address these/ew
words toyou /n fng//sri /nstead o/Dutc/i, wh/'di /syour -a/most- second /anguage.
Dur/ng these /ast/ew months you have been a tremendous he/p to me, both by
/nw't/ng me to stay at your house so / cou/d /oofc/or my own appartment, as we// as
correct/ng my Dutcb-£ng//sh /n my thes/s. Vbu have become a /-ea//r/end and / hope
that / can return the/avour /n the near/uture. /n the meanwh/'/e stay the pos/t/ve/y-
th/nk/ng andgenu/ne Sc/ent/st, that you are, and /et's stay /n touch no matter where
your env/ab/e department may need you.
Michiel, collega! Je behoort tot een zeldzame groep mensen die duidelijke keuzes
durft te maken en zich daarook aan weten te houden. Ik ben blij dat jeop mijn
verzoek koos mijn paranimf te worden.en ik weet dat ik opje kan rekenen.
Steven (wereldwijd beter bekend als Dr. Damink),tijdens mijn promotietijd heb je
voor mij als een bron van inspiratie gefungeerd. Je hebt me niet alleen betrokken
bij de atletiekvereniging DDS, waaraan ik nieuwe vrienden, Rogier, Dennis en
Michiel, heb overgehouden, maar je hield me ook regelmatig een spiegel voor als
ik weer eens te hard van stapel liep. Ik ben niet alleen verheugd, maar ook trots
dat je mijn paranimf wilt zijn. En, Rogier, bedankt voor je altijd beschikbare luiste-
rend oor. De kwaliteit van de schaatscursussen mag dan wisselend zijn, de heen-
en terugreis was altijd van grote klasse!
Pap en Mam, al vanaf het prilste begin gelden jullie, samen met Harald en
Annabelle, als mijn fanatiekste supporters. Nog altijd beschouw ik jullie als mijn
grote voorbeeld, al zal het niet makkelijk zijn om dit te evenaren. Dankzij jullie
steun vond ik het vertrouwen terug als ik dat soms even kwijt was.
Sandra, nu het moment eindelijk daar is dat er een punt achter deze promotie kan
worden gezet, schieten woorden tekort. Ondanks mijn matige voorspellingen over
de afronding van het proefschrift en de gepaard gaande perioden van vorst in ons
sociale leven, kon ik tijdens de moeilijkste momenten altijd opje steun rekenen.
De laatste jaren heb jeer veel alleen voor moeten staan en 'onze' beslissingen
vaak grotendeels zelf moeten nemen.Telkens kon je weer begrip opbrengen voor
mijn afwezigheid tijdens belangrijke gebeurtenissen. Ik heb er grote bewondering
voor dat je altijd achter me bent blijven staan. San, dit boekje is klaar, maar 6ns
laatste hoofdstuk is nog lang niet geschreven!
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